Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39119,0.144162036615864,0.00463065457672646,0.13508595364548,0.153238119586248,2.36874855330537e-206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39077,0.0860503381368401,0.00430884518360328,0.0776050015769776,0.0944956746967025,1.31096482684758e-87
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39182,0.0848745611144247,0.00426333873061326,0.0765184172024227,0.0932307050264267,4.36450724655056e-87
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,38987,0.0511866099486936,0.0026227159156617,0.0460460867539967,0.0563271331433906,8.48660192695498e-84
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39210,-0.0627498442008861,0.00324690635442091,-0.069113780655551,-0.0563859077462211,3.07078204896985e-82
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39145,0.0508169430776921,0.00304632009928789,0.0448461556830878,0.0567877304722964,6.30974607929749e-62
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39099,0.0691924105278376,0.00416047706756568,0.0610378754754088,0.0773469455802663,1.45194819216644e-61
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,36693,0.0517506432105517,0.00314143149781388,0.0455934374748365,0.0579078489462669,2.36227285110847e-60
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39128,0.0314503195403773,0.00204110589870371,0.0274497519789181,0.0354508871018366,3.6070268190305e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39229,0.0268910075490899,0.00175101341093183,0.0234590212636635,0.0303229938345163,7.7981122916345e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39234,0.0292046359055034,0.00191348701219874,0.0254542013615939,0.0329550704494129,3.27981110180886e-52
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39291,0.0725562033994472,0.00476025362967159,0.0632261062852909,0.0818863005136035,4.44997987347812e-52
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39072,0.0386283708480446,0.00260890751320692,0.033514912122159,0.0437418295739302,2.93569875317903e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39291,0.048713205881489,0.00329384707711594,0.0422572656103418,0.0551691461526363,3.73503551123558e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39162,0.035001423518469,0.00237820564171634,0.0303401404607049,0.039662706576233,1.06988917485701e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,38994,0.0988283710145945,0.00681789092723263,0.0854653047972185,0.11219143723197,2.6850455615114e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,38832,0.0516911930889937,0.00359293637529301,0.0446490377934194,0.058733348384568,1.27936990745354e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,36806,-0.085543525265262,0.00600770077926603,-0.0973186187926234,-0.0737684317379005,1.1604357429521e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39092,0.0400311150309759,0.00285891015312849,0.034427651130844,0.0456345789311077,2.84175567106484e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39093,0.0301590559751393,0.00215573692150576,0.025933811608988,0.0343843003412906,3.36125044853957e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39145,0.0230335382091795,0.00165281314291036,0.0197940244490752,0.0262730519692838,7.10595803825268e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39222,0.0472032939513141,0.00341191866252945,0.0405159333727564,0.0538906545298719,2.85566952181307e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,38832,0.0805269923703441,0.00582875074196196,0.0691026409160987,0.0919513438245896,3.78164924568175e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39068,0.0476210433879985,0.00345141679088544,0.040856266477863,0.054385820298134,4.79105495779761e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39241,0.0726452500423436,0.00528747528016942,0.0622817984932116,0.0830087015914757,1.0577605048134e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39117,0.0365916018931098,0.00266821082734574,0.0313619086715122,0.0418212951147075,1.49846393896232e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,36806,0.0673468866087162,0.0049381164256324,0.0576681784144767,0.0770255948029556,4.6347647195823e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39079,-0.0558707124582178,0.00410441782197277,-0.0639153713892844,-0.0478260535271511,5.95449777540068e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39283,0.0264925212970564,0.0019477178300628,0.0226749943501334,0.0303100482439795,6.81259223226747e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39133,0.0367849032058811,0.00271849293494003,0.0314566570533986,0.0421131493583635,1.77059965244876e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39283,0.0638105213409394,0.00472666003118118,0.0545462676798243,0.0730747750020545,2.67892533015348e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39053,0.0654926613732562,0.00485825191579056,0.0559704876183067,0.0750148351282056,3.503886191978e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39255,0.0800460693224783,0.00594661744151654,0.0683906991371059,0.0917014395078507,4.54301531891979e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39255,0.0412412695663121,0.00307596990727393,0.0352123685480552,0.047270170584569,9.2440148344755e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,36747,0.091997638067172,0.00697741198211179,0.0783219105822329,0.105673365552111,1.92522903467206e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39255,0.0393063171446087,0.0030087818103564,0.0334091047963102,0.0452035294929073,8.51765689626353e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39106,0.035669829749924,0.00274123457499587,0.0302970099829321,0.0410426495169159,1.66965668221149e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39162,0.0484342433701445,0.00373480036274024,0.0411140346591736,0.0557544520811154,2.94188226274848e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39283,-0.0399790909460946,0.00308575562084376,-0.0460271719629483,-0.0339310099292408,3.43737184598377e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39291,0.0300897834350984,0.00233964066803766,0.0255040877257446,0.0346754791444522,1.16683323797845e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39132,0.030960849265711,0.00241137378209532,0.0262345566528041,0.0356871418786178,1.54024541981206e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39291,0.0392076961294447,0.0030815507004897,0.0331678567564849,0.0452475355024045,6.7203979887838e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,36779,-0.0430648740834001,0.00338683387646979,-0.0497030684812809,-0.0364266796855193,8.0720395492969e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,38630,0.0419644012814851,0.00331980762703854,0.0354575783324895,0.0484712242304806,1.94657862969108e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39106,-0.054042887128857,0.00428977718397367,-0.0624508504094454,-0.0456349238482686,3.27815982098945e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,38987,0.0653844151706547,0.00522368414791223,0.0551459942407467,0.0756228361005626,9.07338461457709e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",38741,0.0569149853026726,0.0046085583721582,0.0478822108932425,0.0659477597121026,7.23172306134103e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39093,-0.0409188506577681,0.00331532094399764,-0.0474168797080035,-0.0344208216075328,7.85911574015388e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39255,0.0362198380940052,0.00294495872921933,0.0304477189847353,0.0419919572032751,1.33412538037275e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39283,0.0471801881726418,0.00385552641962612,0.0396233563901746,0.054737019955109,2.84221253752273e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39019,0.0791758994725868,0.0064776071473098,0.0664797894638596,0.091872009481314,3.39305567850718e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39093,0.0304698075917895,0.00249405138163776,0.0255814668837795,0.0353581482997996,3.64487001758391e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39055,0.0218966646544464,0.00181381857138408,0.0183415802545336,0.0254517490543592,2.10773764387283e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39241,-0.0230737916030911,0.00193209446659359,-0.0268606967576145,-0.0192868864485677,9.93022747384318e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39095,0.0302740912058855,0.00254655683737343,0.0252828398046336,0.0352653426071375,1.89572614460403e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,36785,0.0208190209722488,0.00175077098097049,0.0173875098495467,0.024250532094951,1.93771428443015e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39079,0.0544699440349058,0.00461681418743112,0.0454209882275408,0.0635188998422708,5.49835504356604e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36500,0.0443941629819153,0.003766230268485,0.0370123516556847,0.0517759743081459,6.65663471845124e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39031,0.043172041245337,0.00368404923763364,0.0359513047395751,0.050392777751099,1.39956549261876e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39099,0.0353123192320018,0.00301548177345005,0.0294019749560397,0.0412226635079639,1.54002650707513e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39145,0.0251601800032889,0.00215903369827295,0.0209284739546739,0.0293918860519039,2.98738581460972e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36141,0.024923292840664,0.00214354978900212,0.0207219352542198,0.0291246504271081,4.36522130314826e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39291,-0.041342984611392,0.00357520658594604,-0.0483503895198462,-0.0343355797029377,8.42067361124093e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39206,0.062389339106196,0.00541316922063671,0.0517795274337481,0.072999150778644,1.31212341194782e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,38841,0.0438018653748622,0.00380785530367585,0.0363384689796575,0.0512652617700669,1.7104517482533e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39106,0.0649853410176486,0.0056611478311589,0.0538894912685772,0.07608119076672,2.23750448655765e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39145,-0.0276635215877241,0.0024166608357974,-0.032400176825887,-0.0229268663495612,3.23199920406738e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36466,0.0403292158190768,0.00352398098737934,0.0334222130838133,0.0472362185543403,3.54195751025152e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39093,0.0804199395320265,0.00703759492341882,0.0666262534821256,0.0942136255819274,4.05686300754755e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39093,0.0361064536062009,0.00318252802954219,0.0298686986682982,0.0423442085441036,1.03087896061441e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,36806,0.0269022708942042,0.00237822966915526,0.0222409407426599,0.0315636010457485,1.57657188657432e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,36791,0.0411876023972726,0.00365840759168223,0.0340171235175754,0.0483580812769697,2.88246707435427e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36157,-0.0440879461467478,0.00394477788669785,-0.0518197108046756,-0.03635618148882,7.33753242495353e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39147,0.0344688682885287,0.00308783177238228,0.0284167180146594,0.040521018562398,8.01404798751594e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39241,0.139765561290009,0.0126008872130541,0.115067822352423,0.164463300227595,1.7646053041312e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,36779,0.028398069101597,0.00256827941368787,0.0233642414507687,0.0334318967524252,2.70854064075547e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36418,0.0263535991058716,0.00238411340292115,0.0216807368361462,0.0310264613755971,2.83563905804508e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,38987,0.0318985817858777,0.00288945426515522,0.0262352514261735,0.037561912145582,3.15254955579408e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39093,-0.0257106777709895,0.00233873789130987,-0.0302946040379569,-0.0211267515040222,5.23917436737766e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39062,0.0262972392296402,0.00239389348341996,0.021605208002137,0.0309892704571433,5.74024662115108e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39023,0.106437737211877,0.00969435572582064,0.0874367999892686,0.125438674434486,6.12044483206235e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39291,0.0251059185731554,0.00229688960908307,0.0206040149393526,0.0296078222069582,1.04222774511394e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39086,0.0279918630294723,0.00256454502302237,0.0229653547843484,0.0330183712745961,1.23784945684729e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39162,0.0655153595086042,0.00602126143407026,0.0537136870978265,0.0773170319193819,1.79661507491723e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39023,0.0657329483421889,0.00604600518684382,0.053882778175975,0.0775831185084028,1.97577593634165e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39291,0.0745261107050551,0.00689167203438195,0.0610184335176665,0.0880337878924437,3.70015223993132e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",38999,0.102888629801738,0.00951718471705649,0.0842349477563076,0.121542311847169,3.84333353059092e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,38727,0.119434036918592,0.0111206875603956,0.0976374893002165,0.141230584536967,8.29995805584377e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,38727,0.0612886519619176,0.00570998176295514,0.0500970877065255,0.0724802162173096,8.87252040686261e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39162,-0.0275558198676627,0.00256941747413006,-0.0325918781169576,-0.0225197616183678,9.71683165303336e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39029,-0.0616975939417452,0.00577658329725154,-0.0730196972043582,-0.0503754906791322,1.55819612355884e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39283,0.0281362258185384,0.00263443261078284,0.0229727379014041,0.0332997137356728,1.56020894966227e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39162,-0.0420784119164687,0.00395269411618859,-0.0498256923841984,-0.0343311314487391,2.26315874675433e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39093,0.0321018426847063,0.00302309604228242,0.0261765744418328,0.0380271109275799,3.00808888484676e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39099,0.0637660226046546,0.00601623126691121,0.0519742093215086,0.0755578358878006,3.71452665429735e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39023,0.083333311462696,0.00788089038983355,0.0678867662986222,0.0987798566267697,4.84165218474751e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39023,0.0288114224388586,0.00273544624548296,0.023449947797712,0.0341728970800052,7.50530929274417e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,38789,0.0481652381962965,0.00457316784944518,0.0392018292113839,0.0571286471812091,7.56792112052388e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39099,0.0558408324207897,0.00530391997436925,0.045445149271026,0.0662365155705534,7.85405905893817e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,38727,0.105801272319442,0.0100557433849759,0.0860920152848887,0.125510529353994,8.47547224523056e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,36796,0.024202222377892,0.00230987518844913,0.0196748670085317,0.0287295777472523,1.3843054501988e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39079,0.0577373988891005,0.0055188542228473,0.0469204446123198,0.0685543531658812,1.57849727904842e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39255,0.0606571523542277,0.00579840756474453,0.0492922735273285,0.072022031181127,1.58890281148174e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39165,-0.0310810491368928,0.00297799905043877,-0.0369179272757528,-0.0252441709980328,2.0474698191422e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39147,0.0329325568131961,0.00316697024883319,0.0267252951254831,0.0391398185009092,3.04914269129241e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39093,0.0412394518975878,0.00397226134357726,0.0334538196641764,0.0490250841309992,3.63821524647278e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,36584,0.0310671563282348,0.00300041090511049,0.0251863509542182,0.0369479617022514,5.02939816825219e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36500,-0.0284015838956411,0.00274494401513912,-0.0337816741653138,-0.0230214936259684,5.43987704110084e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39023,0.0577758381706791,0.00558742740615256,0.04682448045462,0.0687271958867381,5.6043684145045e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39099,0.0344745772315046,0.00334199069004662,0.0279242754790133,0.041024878983996,7.23369534410787e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39071,0.0331893702123759,0.00322151985739172,0.0268751912918882,0.0395035491328637,8.29238742262541e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,36792,0.066680857160192,0.00647746774538763,0.0539850203792323,0.0793766939411518,9.31775593944385e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39039,0.0375393648844395,0.00366101871949124,0.0303637681942367,0.0447149615746423,1.36853101663486e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,36806,0.0172562935450618,0.0016869179170491,0.0139499344276456,0.0205626526624781,1.81273318471371e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,38727,0.0771773009513261,0.00754875605412546,0.0623817390852402,0.091972862817412,1.86833853952872e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,38990,0.0211910801777541,0.00208148430541644,0.0171113709391378,0.0252707894163703,2.89373616081957e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39211,0.0670837674685265,0.00660282145505151,0.0541422374166256,0.0800252975204275,3.57158208024022e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39255,0.103085214999459,0.0101528973610175,0.0831855361718644,0.122984893827053,3.81736052448135e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39023,0.0781925835489239,0.00770314410919482,0.063094421094902,0.0932907460029457,3.92798653892885e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36224,0.0297118888253998,0.002926106552729,0.023976719982051,0.0354470576687487,3.95206416731014e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39111,0.0435416442454288,0.00430408871900058,0.0351056303561877,0.0519776581346699,5.5655352120845e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39117,0.0292683092716557,0.00289529223317965,0.0235935364946236,0.0349430820486878,5.99970818567341e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39208,0.062502198690258,0.00619670362809419,0.0503566595791934,0.0746477378013226,7.53266581759353e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39211,0.0311715557107992,0.00309328349702458,0.025108720056631,0.0372343913649673,8.2658401724682e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39043,0.0176361143471023,0.00175541890807629,0.0141954932872728,0.0210767354069318,1.12667894895131e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,38960,0.0252842312634347,0.00251761667022999,0.0203497025897839,0.0302187599370855,1.17111173042726e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39165,0.0925771550397831,0.009229200289614,0.0744879224721397,0.110666387607427,1.31885201971608e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39241,0.0273387769366427,0.00272902229359842,0.0219898932411898,0.0326876606320956,1.50339527868319e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39147,0.0314506500300026,0.00314147601252574,0.0252933570454522,0.0376079430145531,1.60434018422269e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39145,0.0234914789895444,0.00234877925646558,0.0188878716468718,0.0280950863322169,1.7712163577207e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39162,0.04428678533708,0.00443129690446275,0.035601443404333,0.052972127269827,1.90883536387479e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",36743,0.0930316840495197,0.0093398122417864,0.0747256520556183,0.111337716043421,2.74729024274078e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39229,0.0513368724142981,0.00517030295890202,0.0412030786148502,0.0614706662137461,3.6494998647349e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39241,0.0701973548631485,0.00707810693365251,0.0563242652731896,0.0840704444531074,4.09785637700026e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39221,0.0346732536513881,0.00349851413969021,0.0278161659375953,0.0415303413651809,4.38041540815513e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39147,0.0255875387865138,0.00259003885680806,0.02051106262717,0.0306640149458576,6.00218488830003e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39016,0.0350603891998933,0.00355189276378238,0.0280986793828798,0.0420220990169068,6.52614275284154e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36517,0.0276934168281022,0.00280796899687651,0.0221897975942242,0.0331970360619801,7.32141587935883e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,36806,0.0178630361468901,0.00181461694098266,0.0143063869425641,0.0214196853512161,8.74960011766644e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39291,0.0291302340544144,0.00296246847647754,0.0233237958405184,0.0349366722683103,9.45824681898521e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39283,0.0386130999753388,0.00393959300841726,0.0308914976788409,0.0463347022718366,1.29410346166766e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39197,0.0371513761479928,0.00379880075749281,0.0297057266633069,0.0445970256326787,1.6004155626469e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39106,0.0300115357128888,0.0030733905673566,0.0239876902008698,0.0360353812249077,1.85227231321898e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36430,0.0768851244005156,0.00787901984340322,0.0614422455074453,0.0923280032935859,2.04335924247339e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),36552,0.156927174851577,0.0160906949719911,0.125389412706475,0.18846493699668,2.15344619275549e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,38922,0.0413647680599533,0.00424742155208694,0.0330398218178629,0.0496897143020437,2.39749693781567e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,38951,0.0708552186402286,0.00729091484832115,0.0565650255375192,0.085145411742938,2.92834211926055e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39291,0.0495487391417195,0.00510023430140097,0.0395522799109736,0.0595451983724654,3.01411054544905e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36500,0.0320841175320125,0.00330205853241409,0.0256120828084808,0.0385561522555441,3.07053414783104e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,38841,0.0755248204291187,0.00777845946719342,0.0602790398734196,0.0907706009848178,3.19447785520429e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36527,0.0200700885100648,0.00206657992668523,0.0160195918537617,0.0241205851663678,3.21186502283615e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39093,-0.0346655190950578,0.00357614127398976,-0.0416747559920777,-0.0276562821980379,3.72148644451988e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39093,0.0338667076777642,0.00349886750752715,0.0270089273630109,0.0407244879925174,4.27357501392088e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,38699,-0.105118863747443,0.0108601779492294,-0.126404812527933,-0.0838329149669538,4.2918045906453e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39023,0.0762183022619869,0.00787864351745465,0.0607761609677758,0.091660443556198,4.50228424905297e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,36806,0.0150657931043557,0.00155759214493419,0.0120129125002847,0.0181186737084267,4.68635464694254e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39058,-0.0559007139391864,0.00578498373337258,-0.0672392820565966,-0.0445621458217761,5.00649889256354e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39243,0.0720780228956739,0.00748349087335768,0.0574103807838928,0.086745665007455,6.77960057610498e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,35946,0.0212940435236027,0.00221388653263101,0.0169548259196459,0.0256332611275594,8.00453281500389e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,38805,0.033359558416586,0.00346997247131058,0.0265584123728173,0.0401607044603548,8.08748535008853e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,36628,0.0361956623220669,0.00377170157948678,0.0288031272262728,0.043588197417861,9.7785569022141e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39291,0.0397250835099331,0.00414263102989547,0.031605526691338,0.0478446403285282,1.01915001933378e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",36743,0.0767164776147627,0.00800414467493883,0.0610283540518826,0.0924046011776428,1.09640531002631e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,36743,0.123143156714586,0.0128503627704283,0.0979564456845462,0.148329867744625,1.11490251483277e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,38812,0.0355780300229174,0.00372217782990471,0.0282825614763041,0.0428734985695306,1.37854614597702e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39093,0.0229833287073351,0.00241590413913294,0.0182481565946345,0.0277185008200357,2.11704534878938e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,36792,0.071836005211655,0.00755870489072026,0.0570209436258433,0.0866510667974667,2.37710261791572e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39147,0.0790560329368615,0.00832260781626099,0.0627437216169899,0.095368344256733,2.42795638297288e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39099,0.0236323792238877,0.002491534904404,0.0187489708112558,0.0285157876365195,2.77287370427086e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36430,0.0804933679081683,0.00848521338716186,0.063862349669331,0.0971243861470055,2.81969979159221e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36500,0.0322112456893579,0.00339671472673603,0.0255536848249552,0.0388688065537605,2.90572302546618e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39106,0.0391448768224514,0.0041466863043896,0.0310173716658478,0.047272381979055,4.25488163888835e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,38832,-0.0201505022101994,0.00213609014799563,-0.0243372389002709,-0.015963765520128,4.54415829852057e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39093,0.0485499939305728,0.00515653208393605,0.0384431910460581,0.0586567968150874,5.38252638341347e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,38973,-0.0286616216729162,0.00304685937904565,-0.0346334660558457,-0.0226897772899868,5.8283235130128e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39162,0.0556213016950282,0.00591928373348159,0.0440195055774043,0.0672230978126521,6.41456415251516e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39241,0.0585547899406272,0.00624626395429456,0.0463121125902099,0.0707974672910446,7.9083357435385e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39136,0.0282971725881131,0.00303029436267964,0.022357795637261,0.0342365495389652,1.11344169975379e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36500,0.0244068138586802,0.00262414304328359,0.0192634934938443,0.029550134223516,1.61962527681255e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39153,0.0498337295751801,0.00535998819349459,0.0393281527159307,0.0603393064344295,1.63066436904554e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36500,0.0989290433431445,0.0106436329362263,0.078067522788141,0.119790563898148,1.71619553317597e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39092,0.0427971336605724,0.00460700678649486,0.0337674003590425,0.0518268669621024,1.75457296344654e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39162,0.0275859176216357,0.00297572413184186,0.0217534983232257,0.0334183369200457,2.09876599968001e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39147,0.0285058995673915,0.00308057680862078,0.0224679690224948,0.0345438301122882,2.45669877401077e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39023,0.0577614377882347,0.00624854271055523,0.0455142940755464,0.0700085815009229,2.68494531323167e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,38727,0.057113045859034,0.00617927761037345,0.045001661742702,0.0692244299753659,2.72451211403728e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39093,0.0336202948330011,0.00364159403602913,0.026482770522384,0.0407578191436182,2.99116421821309e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39099,0.0508433388624936,0.00550979790110225,0.0400441349763332,0.061642542748654,3.11854239041812e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,38987,0.0281969135853525,0.00305716132211062,0.0222048773940157,0.0341889497766893,3.25657168352067e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,36747,-0.035255101168092,0.00382269900498434,-0.0427475912178613,-0.0277626111183227,3.34661440162271e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,38925,0.0423271819135569,0.00459628589605496,0.0333184615572892,0.0513359022698246,3.7178709079762e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39255,0.061528535945103,0.00668795508892179,0.0484201439708163,0.0746369279193897,4.03400812436761e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39023,0.104442486920024,0.0113526476466396,0.08219129753261,0.126693676307437,4.04383620846469e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39218,0.060049807380374,0.00653084852470178,0.0472493442719585,0.0728502704887895,4.23047110459959e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39035,0.0669288700535979,0.00728037780711273,0.052659329551657,0.0811984105555389,4.30543703278339e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39140,0.0488994191817023,0.00533315389836912,0.0384464375408989,0.0593524008225058,5.37442644473564e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39106,0.0245999101256799,0.00268864514815712,0.0193301656352919,0.0298696546160678,6.42777181337188e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39093,-0.0433535109582831,0.00474099616994906,-0.0526458634513832,-0.0340611584651829,6.74153717932891e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39095,0.0780467092955724,0.00854177906777152,0.0613048223227402,0.0947885962684046,7.21178151618908e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39147,0.0604731776135871,0.00662134195219936,0.0474953473872763,0.0734510078398978,7.47793948304375e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39255,-0.0137308085112386,0.00150591986239647,-0.0166824114415357,-0.0107792055809415,8.58965558201494e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,38727,0.0613853413979599,0.00675753849282607,0.0481405659520208,0.0746301168438989,1.17648808336159e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36500,0.0344321848882103,0.00379596197842634,0.0269920994104947,0.0418722703659259,1.35505963458643e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39099,0.0684399775363231,0.00756623621978318,0.0536101545455481,0.0832698005270981,1.66737228129118e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39165,0.0475653471247433,0.00526045270770487,0.0372548598176418,0.0578758344318449,1.71867676059438e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39209,0.0210049403553988,0.00232380421804333,0.0164502840880339,0.0255595966227637,1.76618906866001e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",36747,0.0317445027365475,0.00351164150178782,0.0248616853930434,0.0386273200800517,1.79148459458825e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39140,0.0429533912173738,0.00475612179768914,0.033631392493903,0.0522753899408445,1.89787503902931e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39030,0.0374466938843165,0.00414829394568874,0.0293160377507665,0.0455773500178664,1.97274958562259e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39274,0.031524425451858,0.0034984423338039,0.0246674784776024,0.0383813724261136,2.27762506812397e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39147,0.031913744048938,0.00354350432014446,0.0249684755814549,0.0388590125164212,2.37944100292544e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36420,0.0753001398665766,0.00836454762417978,0.0589056265231842,0.0916946532099689,2.52579745368217e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39059,0.0267988900276834,0.00297831309052862,0.0209613963702473,0.0326363836851194,2.56593933630963e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39291,0.0628876365429334,0.00699267225865814,0.0491819989159634,0.0765932741699034,2.67182984479403e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39095,0.0306165449740835,0.0034056013157298,0.0239415663952531,0.0372915235529139,2.75684381353154e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39283,-0.0202357989688444,0.00225277558867206,-0.0246512391226416,-0.0158203588150472,2.94510315590358e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,38960,0.0731938593626256,0.00814965111351872,0.0572205431801289,0.0891671755451223,2.98897948958795e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39023,0.0570213720087941,0.00637331287751125,0.044529678768872,0.0695130652487161,4.07269490932737e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39023,0.0730219759056915,0.00816294986245214,0.0570225941752853,0.0890213576360977,4.12285720982796e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,38960,0.0419048727094107,0.00468815149461981,0.0327160957799559,0.0510936496388656,4.39595260471138e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",38832,0.0742824458640866,0.00832320466816491,0.0579689647144833,0.0905959270136898,4.97792643346119e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39241,0.027396270739148,0.00307612907604125,0.0213670577501071,0.0334254837281888,5.86872962462816e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39255,0.0474147902491148,0.00533940950489922,0.0369495476195123,0.0578800328787173,7.40233361115333e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",36767,0.0740214963698551,0.00833985922019972,0.0576753722982637,0.0903676204414465,7.86204352953089e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39023,0.0363327355350918,0.00409469166868003,0.028307139864479,0.0443583312057047,7.89456539735263e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39049,0.0326403002497693,0.00368012105978206,0.0254272629725965,0.0398533375269421,8.16400175212576e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36430,0.0685562673340137,0.00773864601707908,0.0533885211405387,0.0837240135274887,9.1535191680535e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36500,0.0223650762911212,0.00252683714557588,0.0174124754857925,0.02731767709645,9.81710559397001e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36500,-0.0265790138966998,0.00300536447342841,-0.0324695282646194,-0.0206884995287801,1.04631572615159e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39229,0.0264918455098588,0.00299739312145596,0.0206169549918052,0.0323667360279125,1.07566881292984e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39162,0.0216778819056806,0.00245437746683876,0.0168673020706767,0.0264884617406846,1.13478314298705e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36420,0.0782755478910815,0.00887653997865873,0.0608775295329104,0.0956735662492526,1.31470669569352e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39093,0.0269412012313179,0.00306630854742077,0.0209312364783732,0.0329511659842626,1.70971851835333e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,38741,0.0844978795746122,0.00962571842431907,0.0656314714629468,0.103364287686278,1.83709174740383e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,38741,0.0233127157286505,0.00266105412107606,0.0180970496513415,0.0285283818059596,2.14688606914307e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",38841,0.0578113116904717,0.00661190959533338,0.0448519688836183,0.0707706544973252,2.49672170433797e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36538,0.102904935371362,0.0117733349119067,0.0798291989440246,0.125980671798699,2.61027400892853e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,36665,0.0747537276989497,0.00861148323910069,0.0578752205503124,0.0916322348475871,4.40536859886862e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39283,0.0383099528849914,0.0044148444516688,0.0296568577597206,0.0469630480102623,4.44326666490093e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36500,0.086500312600829,0.00998241479736479,0.066934779597994,0.106065845603664,5.04847309025738e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36195,0.0364676506830277,0.00421133107179075,0.0282134417823179,0.0447218595837376,5.32802392165043e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39241,0.0525548313141609,0.00608426545588827,0.0406296710206199,0.0644799916077019,6.28509024334395e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36421,0.0630277571133076,0.0073010130950003,0.048717771447107,0.0773377427795082,6.70674625515076e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",36743,0.0813246598800632,0.00943715447692861,0.0628278371052832,0.0998214826548433,7.63491705042233e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39023,0.0805684868077697,0.00935996455922894,0.062222956271681,0.0989140173438585,8.17219158547935e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,38841,0.0427628574342888,0.00497402012452756,0.0330137779902148,0.0525119368783628,8.96405741890381e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39099,0.0257146942052643,0.0029932864736415,0.0198478527169269,0.0315815356936016,9.46466973003075e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39241,0.0466944563727423,0.00543863677691125,0.0360347282899962,0.0573541844554883,9.88359312698864e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39131,0.0294199382250323,0.0034269247203499,0.0227031657731465,0.0361367106769181,9.95466758214067e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,36670,0.019636057718545,0.00229200312755199,0.0151437315885432,0.0241283838485469,1.18070211280298e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,36743,0.0697053663179987,0.00814735885602999,0.0537365429601799,0.0856741896758175,1.304453903585e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,38841,0.0618511879762164,0.00723259126663423,0.0476753090936133,0.0760270668588195,1.32856723945226e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,36743,0.0890957524661202,0.0104249187415032,0.0686629117327738,0.109528593199467,1.41153404078101e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39023,0.0588920639794199,0.00689481983895968,0.0453782170950589,0.0724059108637808,1.44955218879069e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39023,0.0644449145926225,0.00755593931748334,0.0496352735303552,0.0792545556548899,1.61357884080064e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39106,-0.0208212977775647,0.00244290990302117,-0.0256094011874862,-0.0160331943676432,1.69653941025583e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39023,0.0617360199419614,0.00724519703308213,0.0475354337571204,0.0759366061268023,1.72970417182412e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39006,0.0221226021862928,0.00259659272236056,0.0170332804504661,0.0272119239221195,1.74630173667586e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,36792,0.0786034544277734,0.00924534986669272,0.0604825686890556,0.0967243401664911,2.0675046914236e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39114,0.0454537174174586,0.00534886199961631,0.0349699478982107,0.0559374869367066,2.10841335400886e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39092,0.0734416226094257,0.00865518090339281,0.0564774680387757,0.0904057771800756,2.3480092122114e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39093,0.0368481156530698,0.00434804600484595,0.0283259454835718,0.0453702858225679,2.57175360024674e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39023,0.0653059251281671,0.00771079520405062,0.0501927665282279,0.0804190837281064,2.69022392417359e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,38832,0.0404726598100778,0.00478862615216774,0.0310869525518291,0.0498583670683266,3.12929128308983e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39083,0.0259580766852227,0.0030723686539927,0.019936234123397,0.0319799192470484,3.2043999807698e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",38727,0.0641097504402337,0.00759217310647861,0.0492290911515357,0.0789904097289318,3.34191483978414e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39022,0.0218547882654858,0.00258871691970825,0.0167809031028577,0.026928673428114,3.3896753129056e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,36796,0.0475374371819139,0.00564210996753895,0.0364789016455376,0.0585959727182903,3.96990724370127e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,36747,0.0834272232734735,0.0099189499856919,0.0639860813015174,0.10286836524543,4.49449982710717e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39023,0.0299142408107025,0.00355880155317484,0.0229389897664798,0.0368894918549252,4.62730836305562e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,36767,0.0493404645617267,0.00586917775083841,0.0378368761700834,0.0608440529533699,4.65609492535089e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,36796,0.0167768243290645,0.00199767336293678,0.0128613845377084,0.0206922641204206,5.00376436841978e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39045,0.0873836652586979,0.010409792283539,0.0669804723829614,0.107786858134434,5.09333258625091e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39291,0.0565005081963278,0.00674217059980322,0.0432858538207135,0.0697151625719421,5.73649392704147e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39095,0.0403688756478805,0.00482078807161936,0.0309201310275066,0.0498176202682545,6.05409591174204e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,38979,0.0299798298715459,0.00358082906678639,0.0229614049006445,0.0369982548424472,6.1404405037696e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39099,-0.0259125410145451,0.00309615677483824,-0.031981008293228,-0.0198440737358621,6.29687955584353e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39086,0.0240876537047068,0.00288050168868389,0.0184418703948863,0.0297334370145272,6.67780138345709e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,36743,0.0737086841696911,0.0088143750423127,0.0564325090867582,0.090984859252624,6.77732181676743e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38630,0.0939507537104985,0.0112473290080601,0.0719059888547007,0.115995518566296,7.23189665996222e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39162,0.0810129392380373,0.00970530682263229,0.061990537865678,0.100035340610397,7.57702243170259e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,36767,0.0874674522314194,0.0104769007537909,0.0669327267539893,0.10800217770885,7.60700297678052e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39291,0.0313169903070128,0.00375359266648728,0.0239599486806978,0.0386740319333279,7.836544973021e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39028,0.0341374664693995,0.00409618788643972,0.0261089382119776,0.0421659947268213,8.48241048429985e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,38727,0.0351641930312421,0.00423237562059914,0.0268687368148678,0.0434596492476164,1.0532555524031e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,36806,0.0131920493485458,0.00158976705965809,0.0100761059116159,0.0163079927854757,1.16199604724842e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39099,0.0422323876930267,0.0050923476839877,0.0322513862324108,0.0522133891536426,1.1927245977635e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,38987,0.0601425820241248,0.0072523409702255,0.0459279937224828,0.0743571703257668,1.197962554782e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,36806,-0.0544826205310534,0.00657647261314576,-0.0673725068528191,-0.0415927342092877,1.30228680498074e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39075,0.0724166131788288,0.00875620142257353,0.0552544583905847,0.089578767967073,1.44559906380844e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,36655,0.0754494308402924,0.00912354941135352,0.0575672739940395,0.0933315876865453,1.47433382608064e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,36743,0.059668259594628,0.00722456734520506,0.0455081075980261,0.07382841159123,1.61045778175592e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39283,0.0321841945150583,0.00390210333718361,0.0245360719741784,0.0398323170559382,1.74088226765188e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39093,0.0919029919348253,0.0111452673512308,0.070058267926413,0.113747715943238,1.77164608010508e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36421,0.0917205394965942,0.0111250669507558,0.0699154082731128,0.113525670720076,1.82264355822332e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,38733,0.0215059965997838,0.00261084202831917,0.0163887462242783,0.0266232469752894,1.908769077772e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39106,0.0291353567689003,0.00353782603296825,0.0222012177442825,0.036069495793518,1.93387122265773e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39165,0.043166347632671,0.0052432702720464,0.0328895378994601,0.0534431573658819,1.97669313148274e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,36796,0.0207038353182825,0.00251475997027725,0.015774905776539,0.0256327648600259,2.00113611358723e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39062,0.0499621006522002,0.00607233652460535,0.0380603210639737,0.0618638802404267,2.05981114832663e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39093,0.0386250113439522,0.00469642658555193,0.0294200152362704,0.0478300074516339,2.11991264344716e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,36646,0.0239235508455049,0.00290971636097732,0.0182205067779893,0.0296265949130204,2.19434453813834e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39162,0.0974164008784588,0.0118533502522645,0.0741838343840204,0.120648967372897,2.22503544325144e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36500,0.0543241252961757,0.00661427475268701,0.0413601467809092,0.0672881038114423,2.3627106817143e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39093,-0.022782847566989,0.00278151316312023,-0.0282346133667047,-0.0173310817672734,2.79915136136716e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39218,0.0209654009410121,0.00255976739906947,0.015948256838836,0.0259825450431883,2.80801895350453e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39241,0.0717525604837548,0.00876682489212524,0.0545695836951893,0.0889355372723203,2.94563657572115e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39023,0.0235160916682691,0.00287938808533856,0.0178724910210055,0.0291596923155326,3.40757875464934e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39099,0.0376408475116315,0.00461521149817119,0.028595032975216,0.0466866620480471,3.73649089470744e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,38824,0.107000522072122,0.013148749459151,0.0812289731321859,0.132772071012058,4.3435458828909e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39099,0.0454700347122528,0.00558981147951818,0.0345140042123971,0.0564260652121084,4.45499932562503e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36466,0.028227908869103,0.0034721383965657,0.0214225176118342,0.0350333001263717,4.69858925918198e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39291,0.0735841926745237,0.00905738789910233,0.0558317123922832,0.0913366729567643,4.8411114883717e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,38832,0.0626692173219,0.00772022759368717,0.0475375712382731,0.0778008634055268,5.12530339875751e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39093,0.0177990619101278,0.00219340373542936,0.0134999905886862,0.0220981332315693,5.23431334389832e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39071,0.0656203374449068,0.0080915425534533,0.0497609140401384,0.0814797608496753,5.45696989853788e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,36792,0.0326065553823802,0.00402072264146068,0.0247259390051172,0.0404871717596431,5.53276832968752e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39130,0.0370698806804719,0.00457357520991602,0.0281056732690365,0.0460340880919073,5.66092321486178e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39099,0.0656188983492901,0.00809693879390989,0.0497488983132267,0.0814888983853534,5.71154054726186e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39162,0.0206898195211982,0.00255937628961436,0.0156734419935541,0.0257061970488424,6.7373121056661e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39237,0.0314950221035406,0.00389817377019196,0.0238546015139644,0.0391354426931168,6.98711051412069e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,35989,-0.0802354003096507,0.00995309650531757,-0.0997434694600731,-0.0607273311592282,8.25116967621578e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39023,0.0649876123319142,0.00808643939579652,0.049138191116153,0.0808370335476754,9.91182203291272e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39069,-0.0127377653847383,0.00158521204685428,-0.0158447809965727,-0.00963074977290393,1.00105469159736e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,36792,0.0457387571736511,0.0056923307169525,0.0345817889684241,0.056895725378878,1.01527978728887e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39023,0.0692732791050845,0.00863592508917192,0.0523468659303075,0.0861996922798615,1.12033483240691e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39229,0.0440747961280565,0.00549469952582125,0.0333051850574468,0.0548444071986662,1.12104858049067e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,36767,0.0620833697646724,0.00773849474915673,0.0469159200563252,0.0772508194730196,1.12365484441571e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39147,-0.0209194188586604,0.00260874335775405,-0.0260325558398584,-0.0158062818774625,1.14318002036452e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38294,0.0262175565425226,0.00327102157120361,0.0198063542629636,0.0326287588220817,1.18440045868674e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,36796,0.0194816415347342,0.00243090058478777,0.0147170763885502,0.0242462066809183,1.20352553569498e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,36792,0.0721874965782134,0.00901716906650947,0.0545138452078549,0.089861147948572,1.29033994230508e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36420,0.0562227957585626,0.00703106895967747,0.0424419005975948,0.0700036909195305,1.39355111599491e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39023,0.0322103743292206,0.00403261946868674,0.0243064401705946,0.0401143084878466,1.47592231951111e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,38987,0.039165849170617,0.0049192074649438,0.0295242025393271,0.0488074958019068,1.81509132813325e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36500,0.033626648664155,0.00422650973549443,0.0253426895825859,0.0419106077457241,1.92574406041064e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39283,-0.019281657991019,0.00242611613788008,-0.024036845621264,-0.014526470360774,2.03336163307078e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36420,-0.0261971434310028,0.00329773571448687,-0.032660705431397,-0.0197335814306085,2.12420834522014e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,36767,0.0381924077956771,0.00480920957167272,0.0287663570351986,0.0476184585561557,2.16191556952461e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39147,0.040198572305796,0.00506735806803162,0.0302665504924541,0.050130594119138,2.28935706025169e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,38987,0.0684020928344726,0.00862453108882219,0.0514980119003811,0.0853061737685641,2.32311985706514e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39023,0.0236807789318433,0.00298790342674341,0.0178244882154262,0.0295370696482604,2.42860103381713e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,38962,0.0424812058047735,0.00536794655530711,0.0319600305563716,0.0530023810531755,2.66757548050926e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36391,0.0494531626431307,0.00625155338756438,0.0372001180035046,0.0617062072827569,2.7771289710134e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39162,0.061843863977661,0.00782204515268708,0.0465126554783943,0.0771750724769277,2.83030242203987e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,36792,0.0493450258212619,0.00626284793003221,0.0370698438783988,0.0616202077641251,3.5627679270523e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,38841,0.066431129231171,0.00847109121643373,0.0498277904469609,0.0830344680153811,4.72824955336841e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39071,0.065601480418973,0.00836589981092414,0.0492043167895616,0.0819986440483843,4.74484272338537e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,38739,0.0397844758211192,0.00507465791177134,0.0298381463140474,0.0497308053281911,4.81607056205451e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,36657,0.0196610645042815,0.00250804762888043,0.0147452911516758,0.0245768378568871,4.89224806511948e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39241,0.0372287605572165,0.00475896574467485,0.0279011876976538,0.0465563334167792,5.49733455368575e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,36629,0.0213392315756291,0.00272748225457063,0.0159933663566706,0.0266850967945875,5.52786073512933e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,36767,0.0712346906900396,0.00911561545225444,0.0533680844036209,0.0891012969764583,5.94037737918842e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,38926,0.0258703392140845,0.00331792153889237,0.0193672129978555,0.0323734654303136,6.74485598826081e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39069,0.0315424039584623,0.00404746522044919,0.0236093721263818,0.0394754357905427,6.95841140653389e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39255,0.0191070180148008,0.00245441999242492,0.0142963548296479,0.0239176811999536,7.42836786202856e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,36743,0.0183698896406149,0.00236010706508435,0.0137440797930496,0.0229956994881802,7.59135230002331e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39162,0.0854850383602674,0.0109891917517529,0.0639462225268317,0.107023854193703,7.7740285344792e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36420,0.0378274645147065,0.00486419434258361,0.0282936436032426,0.0473612854261704,8.02237754844217e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39147,0.017993368188762,0.00231832476059968,0.0134494516579866,0.0225372847195374,8.93162985641262e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,38832,0.0386030881675273,0.00497419610030239,0.0288536638109346,0.04835251252412,8.9922440877832e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,38913,0.0831604137322525,0.0107316069946424,0.0621264640227534,0.104194363441752,9.84278304712853e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36430,0.0628279586280575,0.00810695150923168,0.0469383336699634,0.0787175835861516,9.90268993643124e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,36767,0.0746805750707357,0.00963835817792805,0.0557893930419967,0.0935717570994746,1.00099420298331e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39106,0.0179873292951973,0.00232225541782198,0.0134357086762662,0.0225389499141284,1.01073455824114e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39099,0.0219911795610085,0.00284037063178682,0.0164240531227063,0.0275583059993107,1.03697611437627e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,38713,0.0646145480805577,0.008364402175351,0.0482203198168697,0.0810087763442456,1.19031451451401e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,36792,0.064012743432495,0.00828551688907208,0.0477731303299137,0.0802523565350762,1.19269563242172e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,36743,0.075126936886004,0.00972688225526889,0.0560622476656769,0.094191626106331,1.2138922706905e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",36743,0.103910778365258,0.0134707776694968,0.077508054133044,0.130313502597472,1.31091525436272e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,36727,0.0623672701876078,0.00808627653707662,0.0465181681749377,0.078216372200278,1.32193712308207e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39023,0.0801399013971397,0.0103981427712749,0.0597595415654408,0.100520261228839,1.36624129878307e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39023,0.0966478623276601,0.0125460916857491,0.0720575226235919,0.121238202031728,1.40638178321671e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,36792,-0.0257950671544999,0.00335117680149121,-0.0323633736854227,-0.0192267606235771,1.49017930497356e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39241,0.040650534647797,0.00528380919798026,0.0302942686197556,0.0510068006758383,1.51920770890386e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39147,0.0664965743858445,0.00865044935735629,0.0495416936454261,0.0834514551262628,1.59676557661853e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39093,0.0291627086191595,0.00379517019072821,0.0217241750453322,0.0366012421929868,1.63357768779338e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39291,0.0544701859666714,0.00709687699669584,0.0405603070531475,0.0683800648801952,1.7497292325364e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39093,0.0263442023363333,0.00343318794199977,0.0196151539700138,0.0330732507026529,1.77625520400473e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39099,0.0573959097196502,0.00748267537197088,0.0427298659905873,0.0720619534487131,1.81650091887108e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,36791,-0.0180620690244961,0.00235755429478156,-0.0226828754422679,-0.0134412626067242,1.97050899554365e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,38863,0.0295917610164077,0.00386376331089449,0.0220187849270545,0.0371647371057609,1.99120331970888e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,36743,0.0636482373601175,0.00831314561961542,0.0473544719456713,0.0799420027745637,2.0492448472204e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,36743,0.0830627946769928,0.0108550849134099,0.0617868282467093,0.104338761107276,2.11971489548707e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,38987,0.0289290881926622,0.00378211351452385,0.0215161457041955,0.036342030681129,2.14848096871514e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39106,0.0564079141072274,0.00737933645390894,0.0419444146575659,0.0708714135568889,2.2302958585927e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36500,0.0405018904446806,0.00529841001600182,0.0301170068133171,0.0508867740760442,2.25477242282654e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39023,0.0201578178119954,0.00263838084551289,0.0149865913547901,0.0253290442692006,2.29781720007007e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,36743,0.0331770754478297,0.00434427884432213,0.0246622889129584,0.0416918619827011,2.38076483429697e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36420,0.0609980354598723,0.00799771090903583,0.0453225220781621,0.0766735488415826,2.57683253573745e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,36747,0.0645898298978719,0.00848740868979418,0.0479545088658753,0.0812251509298685,2.92943844716555e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39139,0.0204253758130691,0.00268503133636263,0.0151627143937983,0.0256880372323398,2.96554233769538e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39171,0.0780479137045524,0.0102606079681073,0.0579371220870622,0.0981587053220426,2.97822435119685e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,38994,0.018033600313182,0.00237121459760145,0.0133860197018831,0.0226811809244808,3.01115282816206e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39023,0.0490644254650054,0.00645151590045417,0.0364194543001152,0.0617093966298956,3.01352098401262e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39106,0.0851152732229437,0.0112017917331354,0.0631597614259984,0.107070785019889,3.17301116180869e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39099,0.0583822191343207,0.00769437625686115,0.0433012416708729,0.0734631965977686,3.44565801924171e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36394,0.0595409166091124,0.00784567439904274,0.0441633947869886,0.0749184384312362,3.45116720672257e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39283,0.0216237934002025,0.00285011033283989,0.0160375771478363,0.0272100096525687,3.46049377972341e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,36737,0.0523057770802821,0.00689495896423268,0.038791657510386,0.0658198966501782,3.52311464143277e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,38733,0.0762306990365768,0.0100692179431129,0.0564950318680755,0.0959663662050781,3.9308543090451e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39255,0.0891322800622476,0.0117737914267061,0.0660556488659036,0.112208911258592,3.93141494778391e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39291,0.0308659668886154,0.00407808239327101,0.0228729253978043,0.0388590083794266,3.98103277906336e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,36740,0.018907683797106,0.00250052843604113,0.0140066480624654,0.0238087195317466,4.25484835714027e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,36767,0.0524409648168555,0.00693641316143208,0.0388455950204486,0.0660363346132624,4.29460584070191e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39241,0.0421955068236321,0.00558259784698515,0.0312536150435412,0.053137398603723,4.31025134833151e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,36791,0.0157379401584062,0.00208489717702417,0.0116515416914389,0.0198243386253736,4.69599006707933e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39241,0.0151637769974421,0.002010337954211,0.0112235146071885,0.0191040393876956,4.85292344161492e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39211,0.0339040769968589,0.00449842581350563,0.0250871624023879,0.0427209915913299,5.08200831582276e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,38832,0.0668600135672879,0.00887513673864755,0.0494647455595387,0.0842552815750371,5.22556533212177e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39202,0.0413029923061365,0.00548300492531345,0.0305563026525221,0.0520496819597509,5.23833860267002e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",36767,0.0534490438092494,0.00709518054706368,0.0395424899370046,0.0673555976814942,5.28247252072178e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39274,0.0247007169280663,0.00328205892273541,0.0182678814395048,0.0311335524166277,5.52135787487922e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39023,0.037961348913122,0.00504703418936906,0.0280691619019587,0.0478535359242854,5.71766004006754e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,38923,0.0227288310262363,0.00302481497707069,0.0168001936711777,0.0286574683812948,6.05111336888773e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,38741,-0.024271411384469,0.00323353359215498,-0.0306091372250928,-0.0179336855438452,6.43355626442173e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,36708,0.0606787941824143,0.00808340274795304,0.0448353247964263,0.0765222635684022,6.46835954652282e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39162,0.0865776389347772,0.0115361199056354,0.0639668439197318,0.109188433949823,6.48465329128119e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,38727,0.0526063005713186,0.00702672049194007,0.0388339284071161,0.0663786727355212,7.46398426740587e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36500,0.019976312627144,0.00266822047823842,0.0147466004897967,0.0252060247644913,7.52747305287277e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,38841,0.0250934221813093,0.00335430569033208,0.0185189830282584,0.0316678613343602,7.78751699215883e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,36791,0.042148444960106,0.00563484213580094,0.0311041543739362,0.0531927355462759,7.91337492894788e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,38706,0.0268310291007299,0.00358930556993776,0.0197959901836519,0.0338660680178079,8.13457533866748e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39023,0.0797144202862954,0.0106735804012828,0.0587942026997811,0.10063463787281,8.56022286974495e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39067,0.0453501622716151,0.00607410059223483,0.0334449251108348,0.0572553994323954,8.70483620245706e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,38832,0.0259636549162365,0.00347811116045885,0.0191465570417371,0.0327807527907358,8.79686099654879e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39255,-0.0308753596209269,0.00414371777309826,-0.0389970464561995,-0.0227536727856543,9.74601061209824e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36420,0.0213743930473524,0.00286804353739113,0.0157530277140658,0.026995758380639,9.75065639477721e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,36731,0.0545191884340031,0.0073227290264861,0.0401666395420903,0.0688717373259158,1.02951488542277e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39106,0.0589453578675036,0.00792324706912233,0.0434157936120238,0.0744749221229833,1.0641499922242e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39140,0.0348277829432327,0.00468659584966835,0.0256420550778827,0.0440135108085826,1.13174693533049e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,36792,0.0193666330877804,0.00260712326174885,0.0142566714947526,0.0244765946808081,1.16851653566172e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39226,0.0172347685893935,0.00232152489492175,0.0126845797953469,0.0217849573834401,1.19680692963553e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36500,0.0811772698082178,0.0109375762425258,0.0597396203728673,0.102614919243568,1.22863862006302e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39131,-0.0302597751445261,0.00408051421974824,-0.0382575830152326,-0.0222619672738195,1.27358458177977e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39218,0.0471204163654642,0.00635572868997863,0.0346631881331061,0.0595776445978223,1.29082906234683e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36420,-0.0408219543128932,0.00550861252370106,-0.0516188348593472,-0.0300250737664391,1.33804695346963e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,36726,0.0554308782971386,0.00748732491566969,0.040755721462426,0.0701060351318512,1.41104806796191e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36401,0.0247455634363452,0.0033446606569188,0.0181900285487844,0.0313010983239061,1.46469285461313e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39099,0.0762365313924593,0.010311264959494,0.0560264520718511,0.0964466107130676,1.50427012282958e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39147,0.0489978453463846,0.00663131942374256,0.0360004592758492,0.0619952314169201,1.55755740017127e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39023,0.049128441517315,0.00665246756737394,0.0360896050852621,0.0621672779493679,1.60388431975516e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,36737,-0.0126170069564505,0.00170923756344195,-0.0159671125807967,-0.00926690133210424,1.65926790512296e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,38832,0.0494043727410435,0.0066980487470245,0.0362761971968755,0.0625325482852115,1.7175200111118e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,36767,0.0661032686805382,0.00896122689554498,0.04853926396527,0.0836672733958063,1.7231638271573e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36420,0.0617998426038526,0.00838621001676641,0.0453628709709904,0.0782368142367148,1.82361907303528e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39114,0.0620564169066343,0.00844896377624313,0.0454964479051978,0.0786163859080709,2.16398794454049e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39162,0.0737781605503821,0.0100481162384791,0.0540838527229631,0.0934724683778011,2.20216703489839e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,36806,0.0205177092854581,0.00279408774243193,0.0150412973102916,0.0259941212606247,2.20915513865184e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,36796,0.0178341339104501,0.00242977392113246,0.0130717770250305,0.0225964907958697,2.26630887275286e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36430,0.0530241434833196,0.00722573246437188,0.0388617078531508,0.0671865791134885,2.29721958097805e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39023,0.051438425700449,0.00701503851730422,0.0376889502065327,0.0651879011943653,2.3715037430656e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39093,0.0519812730588289,0.00708980250325757,0.0380852601524441,0.0658772859652137,2.38435362690957e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39093,0.0169253079180819,0.00231276964607911,0.0123922794117669,0.021458336424397,2.63864658724071e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39255,-0.0165799242464077,0.00226627632434872,-0.0210218258421312,-0.0121380226506842,2.68204302446033e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39106,0.015934548384628,0.0021791139578528,0.0116634850272365,0.0202056117420195,2.75460482625171e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,36731,0.0633425821810538,0.00866171675924729,0.0463656173329291,0.0803195470291785,2.76823531338659e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39093,-0.0177691567451115,0.0024306758763531,-0.0225332814627635,-0.0130050320274594,2.79632538082517e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39274,0.033464915400294,0.00457987248307647,0.0244883653334641,0.0424414654671239,2.86658792434803e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",38832,0.0621364260556358,0.00851370731771509,0.0454495597129142,0.0788232923983574,3.05846683959519e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39079,0.0567522700301868,0.0077791985290379,0.0415050409132725,0.0719994991471011,3.12491385863034e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39099,0.0797806351330882,0.0109610444802578,0.0582969879517829,0.101264282314393,3.53867678359303e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36466,0.0691033233648995,0.00950140394282653,0.0504805716369595,0.0877260750928395,3.72478543274859e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39099,0.0352646005761572,0.00485291158808406,0.0257528938635124,0.0447763072888019,3.86269798069151e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,38728,0.046477693104263,0.00639788222975961,0.0339378439339342,0.0590175422745918,3.92892061585337e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38444,0.0139863635158297,0.00192762271369235,0.0102082229969927,0.0177645040346667,4.1955536264242e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,36792,0.0441733065982875,0.00608814714225285,0.0322405381994719,0.056106074997103,4.22608428402386e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,38987,0.0537174814135252,0.00741344718277839,0.0391871249352795,0.0682478378917708,4.50153970248008e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39217,0.0155828589149631,0.00215110910458302,0.0113666850699804,0.0197990327599458,4.55989318300454e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39147,0.0260785614499913,0.00360681264989185,0.0190092086562033,0.0331479142437793,5.04528362660127e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,38963,0.046563747406195,0.00644238835178513,0.0339366662366961,0.0591908285756938,5.14712317919521e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36414,0.0281931437111166,0.00390005229690321,0.0205490412091863,0.0358372462130469,5.15062934171441e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39099,0.0634582691662957,0.0087808196216045,0.0462478627079509,0.0806686756246405,5.17512573409166e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,36767,0.0564855429396396,0.00782086437105974,0.0411566487723625,0.0718144371069167,5.3935634765964e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,36782,0.0370766779020666,0.00513751036067788,0.0270071575951379,0.0471461982089952,5.61736000071239e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39165,0.0194770755778679,0.00270110927673145,0.0141829013954742,0.0247712497602615,5.82407384952438e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,38741,0.0561565450964093,0.00778939889876023,0.0408893232548393,0.0714237669379794,5.89230245932354e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,38987,0.063799324657297,0.00884981674902979,0.0464536838291986,0.0811449654853954,5.89828502034263e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39099,0.0554582853406327,0.00769606924447342,0.0403739896214648,0.0705425810598006,6.02974713945069e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,38924,0.0252657674078092,0.0035108278734229,0.0183845447759003,0.0321469900397181,6.46804977961513e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39106,0.0842818187621989,0.0117163147071427,0.0613178419361992,0.107245795588199,6.60692161900024e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,38992,0.0175810267419062,0.00244469782335766,0.0127894190081252,0.0223726344756872,6.70888631660067e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,36747,-0.0176135464714987,0.00245099461984908,-0.0224174959264029,-0.0128095970165945,7.02426022670205e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,36792,0.0647238114064009,0.00901311571061284,0.0470581046135997,0.0823895181992021,7.29507747850268e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,38707,0.0500640006172322,0.00697988820290245,0.0363834197395434,0.063744581494921,7.70600637497894e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",38951,0.0631625597822346,0.00880698495330607,0.0459008692737547,0.0804242502907145,7.74169459264402e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,38987,0.0660792058924546,0.00921431739000061,0.0480191438080534,0.0841392679768558,7.76959894808331e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,36792,0.0536166987274192,0.00747677346441372,0.0389622227371684,0.0682711747176701,7.84428306336582e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39147,-0.0155963763233394,0.00217621689294188,-0.0198617614335055,-0.0113309912131733,8.0317640364155e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39165,0.0334986003639109,0.00467515411314067,0.0243352983021552,0.0426619024256666,8.11937217244792e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36430,0.0321731287849288,0.0044976589200394,0.0233577173016516,0.0409885402682061,8.94083613479774e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39099,0.0681225662530047,0.00953116143845975,0.0494414898336236,0.0868036426723858,9.24820019059453e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39291,0.0615597465582569,0.00863320517127042,0.0446386644225668,0.0784808286939469,1.04383626025318e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39044,0.0675175325765434,0.00947160214350564,0.0489531923752723,0.0860818727778144,1.06104578465179e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,36767,0.0473336685944616,0.00664544044668961,0.0343086053189499,0.0603587318699732,1.11421871553009e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,36743,0.0499635106202737,0.00702002189440984,0.0362042677072304,0.063722753533317,1.15902063251451e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,38945,0.0179416269990328,0.0025247441902434,0.0129931283861557,0.0228901256119099,1.24521944813686e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,36806,0.0165442134662725,0.00233233375914,0.0119728392983581,0.0211155876341869,1.37644394001418e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39099,0.0473766876239948,0.00668403897180065,0.0342759712392656,0.0604774040087241,1.42001413691991e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39093,-0.0172630549901038,0.00243582838811012,-0.0220372786307997,-0.012488831349408,1.42920336974266e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36430,0.0288737874676294,0.00407649973660087,0.0208838479838917,0.0368637269513671,1.48597079200226e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39023,0.0363204257711931,0.00513243537501282,0.026260852436168,0.0463799991062182,1.54158104457995e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39023,0.0581348663511197,0.00821739112193482,0.0420287797521274,0.0742409529501119,1.56426272708664e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36420,0.0549017486641707,0.00776429522996409,0.039683730013441,0.0701197673149003,1.61903705207602e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39162,0.0169692394454379,0.00240137454235623,0.0122625453424197,0.0216759335484561,1.65786225239787e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,38841,0.0312117425187158,0.0044177623225435,0.0225529283665305,0.0398705566709011,1.67626884551845e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,36747,0.0707422493315608,0.010016057310158,0.0511107770036511,0.0903737216594704,1.71454609430509e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39023,0.0180224371676769,0.00255392169282219,0.0130167506497454,0.0230281236856084,1.77802782137311e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36500,0.0557128422735916,0.00789395932751744,0.0402406819916574,0.0711850025555258,1.78176791500636e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,38644,0.0377001021830083,0.00534308284175899,0.0272276598131607,0.048172544552856,1.79146499913977e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,38951,0.0490792874877097,0.00695712158029156,0.0354433291903382,0.0627152457850811,1.80704949742755e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,36614,0.0165006692764192,0.00234144419430662,0.0119114386555782,0.0210898998972601,1.91916151593604e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,36767,0.0503705262344809,0.00714878066384123,0.0363589161333521,0.0643821363356097,1.93440189695916e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,38907,0.0678237107389227,0.00962857388766802,0.0489517059190934,0.086695715558752,1.9489244433026e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38475,-0.0242229592070074,0.00343917756245316,-0.0309637472294156,-0.0174821711845992,1.96203481748584e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,38727,0.0520978441185767,0.00739785226450686,0.0375980536801432,0.0665976345570101,1.97394058779397e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36500,0.0415865249133941,0.00590602024862216,0.0300107252260947,0.0531623246006935,2.00193231711854e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,36743,0.0384447489285174,0.00546172638834292,0.0277397652073653,0.0491497326496696,2.03525109277848e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,36743,0.0494123444611393,0.00703503499045372,0.03562367587985,0.0632010130424286,2.26834742334632e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39131,-0.0224235263924956,0.00319480027081911,-0.0286853349233011,-0.0161617178616902,2.33275635732102e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,36743,0.0664425158192911,0.00946744184057854,0.0478863298117572,0.0849987018268251,2.36331247971969e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39106,0.0492626532184705,0.00702275639279336,0.0354980506885955,0.0630272557483455,2.40108697767157e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,38987,0.0246195476525276,0.00350975069347093,0.0177404362933246,0.0314986590117306,2.40363295226664e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,38987,0.0228901462417718,0.00327077111731699,0.0164794348518305,0.0293008576317131,2.6979187696924e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39114,0.0682708770434914,0.0097662126865094,0.049129100177933,0.0874126539090498,2.85234198053552e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36420,0.0657993452403734,0.00941783865886286,0.0473403814690022,0.0842583090117446,2.95687700351501e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,38960,-0.0291232312498641,0.00417714210706502,-0.0373104297797116,-0.0209360327200167,3.25314539995908e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,38832,0.0308735390728856,0.004428980700179,0.0221927369005347,0.0395543412452364,3.28315678491777e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39291,0.043861802543824,0.00629518157848041,0.0315232466500024,0.0562003584376456,3.35627042198829e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39162,-0.041061319261773,0.00589364418407065,-0.0526128618625515,-0.0295097766609945,3.36855941882851e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36721,0.0697105672320456,0.0100045901349909,0.0501015705674634,0.0893195638966277,3.37481015241221e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,36731,0.044282067083858,0.00637218160303159,0.0317925911419161,0.0567715430257999,3.84842506706264e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36430,0.0508817257301879,0.00732360514651101,0.0365274596430264,0.0652359918173495,3.89776183839251e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,36747,0.0343068636878925,0.00493963313824982,0.0246251827369229,0.0439885446388622,3.95991753139339e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,38642,0.0122149724904395,0.0017601808699798,0.00876501798527914,0.0156649269955999,4.0953109116563e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39099,0.0307828085102167,0.00443724985460371,0.0220857987951935,0.03947981822524,4.15576862386606e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,36743,0.0545390093084178,0.0078776350839625,0.0390988445438513,0.0699791740729843,4.62249566286858e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37339,-0.0194279987494595,0.00280700089049926,-0.0249297204948381,-0.013926277004081,4.67864292881622e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36500,0.0801436320019896,0.0115834133198853,0.0574401418950144,0.102847122108965,4.77352851715991e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39106,-0.0161156051575264,0.00232998864599229,-0.0206823829036713,-0.0115488274113816,4.81002921808478e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,38987,0.0329340513689221,0.00476193923695613,0.0236006504644881,0.0422674522733561,4.82851063081076e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39183,0.0196077200802241,0.00283593334989045,0.0140492907144388,0.0251661494460094,4.89697880259014e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,36791,-0.031296873857216,0.0045274597080781,-0.0401706948850491,-0.0224230528293829,4.97907615808905e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,36747,0.0573218298126809,0.00829439570136644,0.0410648142380027,0.0735788453873591,5.04207858047405e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,38727,0.0493263551684072,0.00714395983387549,0.0353241938940112,0.0633285164428031,5.23764408454949e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,38741,0.0388708463691485,0.00563274875023712,0.0278306588186838,0.0499110339196133,5.37742846206994e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,38841,0.049336687736764,0.00716092317051142,0.0353012783225616,0.0633720971509663,5.81346501848001e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39135,-0.0225609700922394,0.00327537154789529,-0.0289806983261142,-0.0161412418583646,5.87649214149278e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,38741,0.0500393908818074,0.00726749228456746,0.0357951060040552,0.0642836757595597,5.99440555135566e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39147,0.0441664944202396,0.00641629634428613,0.0315905535854388,0.0567424352550404,6.06774159773675e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,36796,0.0460964328292032,0.00670187417490358,0.0329607594463922,0.0592321062120142,6.34271787233595e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,38832,0.0532923850830899,0.00775105897822598,0.038100309485767,0.0684844606804128,6.42177841835923e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,38832,0.0215852149451052,0.00314122609437987,0.0154284118001207,0.0277420180900898,6.5996645457187e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,38841,0.0410401271999462,0.00598559514436785,0.0293083607169852,0.0527718936829072,7.33364856004239e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,36767,0.0481075237058253,0.00702024144773239,0.0343478504682698,0.0618671969433808,7.57661579630416e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,38832,0.0700987607484871,0.0102493732386433,0.0500099892007464,0.0901875322962279,8.26512285257016e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36500,0.056159399647984,0.00821308239251047,0.0400617581586635,0.0722570411373045,8.41177814171453e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39093,0.0203117382941861,0.00297238522562162,0.0144858632519677,0.0261376133364045,8.6022151683533e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,38987,0.0555752618899649,0.00813829326260108,0.0396242070952668,0.071526316684663,8.88533045114205e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,36791,-0.024646935267398,0.0036096931883457,-0.0317219339165556,-0.0175719366182404,8.99619223170813e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,36792,0.0569276931367087,0.00834886146735704,0.0405639246606889,0.0732914616127285,9.60043692795855e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36500,0.0597788878972592,0.00876698612028798,0.0425955951014947,0.0769621806930236,9.60882220083911e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39099,0.0269491771608201,0.00395415411064976,0.0191990351039466,0.0346993192176937,9.75225993066318e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39291,0.0399110480447729,0.0058565855100975,0.0284321404449818,0.051389955644564,9.79381581344213e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,36747,0.0287938168573854,0.00422915081236615,0.0205046812651478,0.0370829524496231,1.0305257275336e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39099,0.0203496167763848,0.00298962565452936,0.0144899504935072,0.0262092830592623,1.03558878274434e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39067,0.0171260662699663,0.00251659438161933,0.0121935412819924,0.0220585912579402,1.04640587162081e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,36767,0.0486857351859386,0.00715344517615813,0.0346649826406687,0.0627064877312086,1.04845758403746e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,36731,0.0239451969194607,0.003527554365196,0.0170311903636765,0.0308592034752448,1.18646954120911e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,38832,0.0471476181294978,0.00695577348915521,0.0335143020907536,0.060780934168242,1.26230796612601e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39093,0.0323927420239109,0.00478363687818417,0.0230168137426699,0.0417686703051519,1.32050438390839e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39291,0.0184375003051678,0.00272326137765634,0.0130999080049614,0.0237750926053743,1.33083374778487e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,38987,0.0584883849164956,0.00864606025222936,0.0415421068221261,0.0754346630108652,1.38445219734831e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,36743,0.0435667273780784,0.00644707078393007,0.0309304686415754,0.0562029861145813,1.46331931382663e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36500,-0.030961530736558,0.00458829063773616,-0.0399545803865209,-0.0219684810865951,1.56494698755977e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,36791,0.0522349391271296,0.00774292915300411,0.0370587979872416,0.0674110802670177,1.58285959362531e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39062,0.0175011594567227,0.00259979931671275,0.0124055527959657,0.0225967661174797,1.73654772690535e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,36731,0.0440008888261199,0.00653582363914494,0.0311906744933958,0.0568111031588439,1.74129883755001e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,38951,0.0687771312354228,0.0102190811910118,0.0487477321010397,0.0888065303698059,1.75457240212987e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36343,0.0343184329667758,0.00510089778908731,0.0243206733001647,0.044316192633387,1.79618393632564e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39237,0.0353617263562706,0.00525746714701106,0.0250570907481289,0.0456663619644122,1.8054094388285e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,36792,0.03932682357244,0.00584838660106461,0.0278639858343534,0.0507896613105266,1.83741206862823e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39291,0.0256445363665235,0.00381789457172852,0.0181614630059356,0.0331276097271114,1.92078926692355e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39006,0.0415427811873677,0.00618628380713524,0.0294176649253826,0.0536678974493527,1.94353053339974e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39093,-0.0146003060667581,0.00217603762409361,-0.0188653398099815,-0.0103352723235346,2.02063770429314e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39093,-0.0281054103822584,0.00419104679737051,-0.0363198621051046,-0.0198909586594122,2.0698630341227e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36421,0.0815203085071568,0.0121584885973222,0.0576896708564053,0.105350946157908,2.10302678868977e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39099,0.0525470128349069,0.00784155421150051,0.0371775665803659,0.0679164590894479,2.14116492984656e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39110,0.0240519228921804,0.00358935375992994,0.0170167895227177,0.031087056261643,2.14389651901915e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,36747,0.0614073874174633,0.00916327146937574,0.0434473753374868,0.0793673994974397,2.14917037264309e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39291,0.0220138785855697,0.0032877915381279,0.0155698071708391,0.0284579500003004,2.22137278058889e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,36792,0.0326635044262342,0.00487922131035781,0.0231002306579329,0.0422267781945355,2.25483351656684e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,36767,0.0263537230612357,0.00393752387267423,0.0186361762707942,0.0340712698516772,2.27725605283023e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36500,0.0530002817324688,0.00792266878057055,0.0374718509225506,0.0685287125423871,2.33049565141492e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39093,0.0250871593597918,0.00375153646862279,0.0177341478812912,0.0324401708382925,2.35446282064521e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36500,0.0540671260956362,0.00809457353644651,0.038201761964201,0.0699324902270713,2.49920245890715e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,36792,0.0439986441400404,0.00658836285990452,0.0310854529346275,0.0569118353454532,2.51721707442106e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39283,0.0437360003527869,0.00655078625872348,0.0308964592856889,0.0565755414198849,2.53157203926547e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,36792,0.046598250791156,0.00698009826334892,0.0329172581949921,0.0602792433873199,2.55797754064679e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,38741,0.041301524723808,0.00619042313619821,0.0291682953768595,0.0534347540707565,2.61532383177313e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39099,0.0743261204945391,0.0111480730580577,0.052475897300746,0.0961763436883321,2.69743037014146e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39140,0.0529097611735973,0.00793597358458366,0.0373552529478133,0.0684642693993813,2.69889403063162e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,36731,0.0507005513697603,0.00761017443653099,0.0357846094741596,0.065616493265361,2.80722623337307e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39098,0.0160674770426111,0.00241214876206866,0.0113396654689565,0.0207952886162657,2.81163236033877e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39093,0.0442478334736535,0.00664927172964261,0.031215260883554,0.057280406063753,2.93889496995568e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39023,0.0178181431421024,0.0026780494449358,0.0125691662300283,0.0230671200541766,2.96204949801028e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36420,0.0473438378813381,0.00711914489128338,0.0333903138944226,0.0612973618682535,3.04787700102225e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,36729,0.0518487484331277,0.00779689741928724,0.0365668294913247,0.0671306673749307,3.05097382000995e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,36731,0.0510208906875065,0.00768101732701217,0.0359660967265626,0.0660756846484503,3.2088309976545e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,36743,0.0395687265876389,0.00596881638893256,0.0278698464653311,0.0512676067099467,3.50862740681692e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39165,0.0257238844362218,0.00388107778888308,0.0181169719700109,0.0333307969024326,3.51578634041819e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39024,0.0529062862868965,0.00802024836911907,0.0371865994834232,0.0686259730903699,4.34655205952148e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39162,0.0559879933850771,0.00848927759414233,0.0393490093005581,0.072626977469596,4.38775722922463e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39076,0.0392924712648745,0.00595930615900485,0.027612231193225,0.050972711336524,4.43832956170767e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39136,-0.0387007165477793,0.00587177567973203,-0.0502093968800541,-0.0271920362155045,4.51265518751417e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,38832,0.029000417727883,0.00440113802132162,0.0203741872060926,0.0376266482496734,4.56664272418352e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,38987,0.0471748263308093,0.00717220595754116,0.0331173026540286,0.0612323500075899,4.94289226502057e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,38987,0.0444741110313973,0.00676715948434661,0.0312104784420779,0.0577377436207166,5.12503618464186e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39099,0.0380168073508989,0.00578983317829587,0.026668734321439,0.0493648803803588,5.3309564707545e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39093,0.071155319697593,0.0108396262733135,0.0499096522018986,0.0924009871932874,5.39424040092402e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39099,0.0485265576376675,0.00739809185998327,0.0340262975921002,0.0630268176832347,5.57897053872e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,38741,0.0372446240099139,0.00568128013511949,0.0261093149450797,0.0483799330747481,5.72148211582768e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39046,0.01605866296435,0.00245065188223662,0.0112553852751662,0.0208619406535338,5.8281513102307e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39283,0.0403351095812727,0.00616541528998236,0.0282508956129073,0.0524193235496381,6.25479971496352e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39095,-0.0239567038802649,0.00366256878701314,-0.0311353387028107,-0.0167780690577192,6.3074436977784e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39099,0.0604617585787826,0.00924698198867529,0.0423376738809791,0.0785858432765862,6.40986264208735e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36500,0.0626082620023997,0.00957522367601684,0.0438408235974067,0.0813757004073928,6.44991112573665e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39291,0.0404830525970405,0.00619298644671837,0.0283447991614725,0.0526213060326085,6.47695153956165e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,38741,0.0283594997053599,0.00433946379473425,0.0198541506676808,0.036864848743039,6.55667759445598e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,36724,0.0424790915515894,0.00650284957897738,0.0297335063767938,0.0552246767263851,6.71687139753835e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,36806,0.024747698854073,0.00378913915139517,0.0173209861173385,0.0321744115908076,6.76743505990105e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36420,0.0434120977872996,0.00664857062342829,0.0303808993653802,0.0564432962092191,6.85125751171051e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",36747,0.0636723865096532,0.00975209013972657,0.0445582898357891,0.0827864831835173,6.86463829934532e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39147,0.0404506426200494,0.00619633380360347,0.0283058283649866,0.0525954568751122,6.86818086939752e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39241,0.0318050594356212,0.00487200784224455,0.0222559240648219,0.0413541948064205,6.86852133701595e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38571,0.054652746507075,0.00837279348178794,0.0382420712827706,0.0710634217313793,6.9103070518342e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,36791,-0.0221295912702008,0.0033899921578524,-0.0287739758995915,-0.0154852066408101,6.91803481689919e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36500,0.0495007686524798,0.00758403056719079,0.0346360687407858,0.0643654685641737,6.96749272889901e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36420,0.0385958636257909,0.00591615145448257,0.027000206775005,0.0501915204765767,7.11719700933549e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,36792,0.0531225075938848,0.00814832935205734,0.0371517820638524,0.0690932331239172,7.31938605534319e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,38841,-0.0232824489217799,0.00357186553467253,-0.0302833053697381,-0.0162815924738217,7.33878647743178e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39140,-0.0458874254525606,0.00704297298140497,-0.0596916524961143,-0.0320831984090068,7.47894673699649e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39099,0.038740577236718,0.0059460469090562,0.0270863252949678,0.0503948291784681,7.47950075881612e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36430,0.0545292597446156,0.00836960262319579,0.0381248386031518,0.0709336808860793,7.53835076545813e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39095,0.0147786806315862,0.00227003191192414,0.0103294180842149,0.0192279431789576,7.73259749559429e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39024,0.0146757653562728,0.00225464034793011,0.0102566702743298,0.0190948604382158,7.79568640134196e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,36743,0.0404081751158765,0.00620742726251552,0.0282416176813461,0.0525747325504069,7.811844691743e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36500,0.0348307096784774,0.00535187145299724,0.0243410416306028,0.045320377726352,7.89615377276177e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,36747,0.0162816510468222,0.00250870132433349,0.0113645964511285,0.0211987056425158,8.89368512726848e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36420,-0.0205512275815347,0.00317031560660742,-0.0267650461704852,-0.0143374089925841,9.36568026355722e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36391,0.0353827342233514,0.00546057350260524,0.0246800101582451,0.0460854582884577,9.53618751634872e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39004,0.0274866635993338,0.00424749000258748,0.0191615831942624,0.0358117440044053,1.00167317770233e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,36698,0.0280109491703078,0.00432935226874673,0.0195254187235642,0.0364964796170514,1.0155471023212e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39023,0.0334372567756013,0.00517334334564568,0.0232975038181358,0.0435770097330668,1.05520338803648e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39136,0.0422304314524479,0.00653440934673363,0.0294229891328499,0.0550378737720458,1.05913383370058e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39079,0.0362485818128037,0.00560902537178486,0.0252548920841053,0.047242271541502,1.06087081185812e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39255,0.0323327341750269,0.00500759213844206,0.0225178535836804,0.0421476147663733,1.10184723910675e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,36796,0.0131216155332214,0.00203575094476392,0.00913154368148414,0.0171116873849587,1.19238254315544e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39241,0.0374187597575583,0.00581230173139835,0.0260266483640175,0.048810871151099,1.24763812362307e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,36743,0.0650457226263527,0.0101175253541374,0.0452153729322434,0.084876072320462,1.32963756421655e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39123,0.0703362849225846,0.0109519077079993,0.048870545814906,0.0918020240302632,1.38213629992647e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,36733,0.0349006450386646,0.005433663990821,0.0242506636166554,0.0455506264606737,1.3827690329632e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39255,0.0163502595692629,0.00255274258507706,0.0113468841025118,0.0213536350360139,1.54754249894107e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39093,0.015060780131818,0.00235188498412229,0.0104510855629384,0.0196704747006977,1.56093324121767e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,36743,0.0579611809387964,0.00905811151810304,0.0402072823633144,0.0757150795142783,1.62008383217483e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39064,0.0396975884866446,0.00620766961574493,0.0275305560397846,0.0518646209335047,1.65314899416299e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,36806,-0.0206257188334079,0.00322565336951107,-0.0269479994376496,-0.0143034382291662,1.66850882045559e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,36743,0.0296715440492374,0.00464190997463928,0.0205734004989445,0.0387696875995304,1.69265979750823e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,36770,0.0261634067890161,0.00409385375354216,0.0181394534320734,0.0341873601459587,1.70582309143665e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39099,-0.0269146763476985,0.00421465825113617,-0.0351754065199254,-0.0186539461754716,1.75249455654839e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39147,0.0359031869875796,0.00562266417276318,0.0248827652089637,0.0469236087661954,1.75838401207586e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36420,0.0302222992131595,0.00473323146944235,0.0209451655330525,0.0394994328932665,1.77283756392699e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,38727,0.0198823549373275,0.00311566600599462,0.013775649565578,0.0259890603090769,1.80657083067479e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39283,0.0333667074586304,0.00522962174144999,0.0231166488453885,0.0436167660718724,1.81747375363139e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,38987,0.0257962490287293,0.00404337703600214,0.0178712300381651,0.0337212680192935,1.82383093909804e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,36792,0.0331021424492633,0.00519045815844332,0.0229288444587144,0.0432754404398123,1.8612913695388e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,36792,0.0538035393054812,0.00844244274753322,0.0372563515203161,0.0703507270906464,1.91678725864148e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39140,0.0508099887131446,0.00797426950835417,0.0351804204767704,0.0664395569495187,1.92244810189503e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39023,0.0198072556655807,0.00310961689137849,0.0137124065584789,0.0259021047726825,1.94886257368541e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,38727,0.0287894108984511,0.00452321645528441,0.0199239066460936,0.0376549151508086,2.0126429540589e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,36767,0.0740572609981939,0.0116342553789698,0.051254120455413,0.0968604015409748,2.01309357598988e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,38727,0.0262674077822632,0.00412919087754493,0.0181741936622751,0.0343606219022512,2.05780082965963e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36421,0.0247051919750656,0.0038845455035652,0.0170914827880778,0.0323189011620534,2.08929727515913e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36500,0.0396801980068529,0.00624065507417195,0.0274485140614759,0.0519118819522299,2.10966917449215e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,36806,-0.0158531643142679,0.00249555632317147,-0.020744454707684,-0.0109618739208518,2.18852654023407e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36258,0.0470116921194122,0.00740224344394211,0.0325032949692856,0.0615200892695387,2.21385328075013e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,38741,0.035717369257563,0.00562586458570998,0.0246906746695714,0.0467440638455545,2.23323956096218e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,38987,0.0334696456281534,0.00527756424181993,0.0231256197141864,0.0438136715421205,2.334329434646e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39114,0.0362085338800074,0.00571147733273778,0.0250140383078413,0.0474030294521734,2.36825464971033e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36500,-0.0164159096310721,0.0025902008608894,-0.0214927033184153,-0.0113391159437288,2.41148179903464e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,36767,0.0278175540857987,0.00438970868446476,0.0192137250642477,0.0364213831073496,2.42082239665411e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39106,0.0358355245538693,0.00566073029356602,0.0247404931784799,0.0469305559292587,2.51125651539247e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36420,0.0266445683105523,0.00421002377481706,0.0183929217119108,0.0348962149091937,2.55410525503095e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,36743,0.0338160445416353,0.00534365164259607,0.023342487322147,0.0442896017611236,2.5614680823137e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39255,0.0375299678669286,0.00593520065041294,0.0258969745921192,0.0491629611417379,2.63120107701347e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36538,0.0657712189514246,0.0104046688966556,0.0453780679139797,0.0861643699888695,2.68036948766818e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39088,0.0452890667971295,0.00717035507508212,0.0312351708499685,0.0593429627442904,2.75595521411052e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,38951,0.0351768779867355,0.0055740005907123,0.0242518368289394,0.0461019191445317,2.85189562761379e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,36792,0.0159472294479024,0.00252748664695665,0.0109933556198673,0.0209011032759374,2.890302568806e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,38987,0.0225822457414652,0.00358011472883133,0.0155652208729558,0.0295992706099746,2.91107432221643e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39234,0.0183545369645286,0.00291329955702705,0.0126444698327556,0.0240646040963016,3.05239107589167e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39106,0.0327100111801262,0.00519202200064325,0.0225336480588655,0.042886374301387,3.05710547842181e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39195,-0.0234680474984503,0.00372515251140574,-0.0307693464208056,-0.0161667485760951,3.05984264537152e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39050,0.0514095049555218,0.00816461795680557,0.0354068537601829,0.0674121561508607,3.12565371245919e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36500,0.0429008387674554,0.00681410704658534,0.0295451889561481,0.0562564885787626,3.1576535557849e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36391,0.0433566844173469,0.00688791892367147,0.0298563633269508,0.056857005507743,3.1847810489461e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,38927,0.0330244854651336,0.00524868688999581,0.0227370591607418,0.0433119117695254,3.22161395760003e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36403,0.045949094686387,0.00730272529522489,0.0316357531077462,0.0602624362650278,3.23730695663351e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36420,0.0403868635272912,0.00642112991987422,0.0278014488843377,0.0529722781702446,3.28672533266823e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39139,0.0282986787945026,0.00450051400629492,0.0194776713421646,0.0371196862468407,3.305824866935e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39234,0.028409985973141,0.00451884853006044,0.0195530428542226,0.0372669290920595,3.32401950060795e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39283,-0.0168398439472274,0.00268131685921648,-0.0220952249912917,-0.0115844629031631,3.46666499459349e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36391,0.0291412602126731,0.00464038648790617,0.020046102696377,0.0382364177289692,3.49941937795831e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39099,0.0314253412817322,0.0050059252957759,0.0216137277020114,0.0412369548614529,3.53081890742568e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,36796,0.0305567501546387,0.00486830142163257,0.0210148793682389,0.0400986209410385,3.56935290009534e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,36591,0.0320400038127327,0.00510945298300339,0.0220254759660461,0.0420545316594194,3.7097872199438e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,38727,0.0292377533576109,0.00466532796414151,0.0200937105478936,0.0383817961673283,3.78144363419834e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,36792,0.0260789802395566,0.00416666040136677,0.0179123258528778,0.0342456346262355,3.99785276954087e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39093,0.0266435059738509,0.00425880162615897,0.0182962547865793,0.0349907571611225,4.05259254834023e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39099,0.0228832778546252,0.00365809405139559,0.0157134135138899,0.0300531421953606,4.06772589263113e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,36747,0.0174941559603185,0.00279669190736497,0.0120126398218832,0.0229756720987539,4.09293850166485e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,36747,0.0471257311056575,0.00754404031273361,0.0323394120926996,0.0619120501186153,4.32266502587234e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36420,0.0346450292932172,0.00554817027291282,0.023770615558308,0.0455194430281263,4.39129486625894e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,38727,0.0338659320873518,0.00542418545790894,0.0232345285898503,0.0444973355848533,4.39494434799916e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39025,0.0413062979460082,0.00662200436717602,0.0283271693863432,0.0542854265056732,4.55733844265848e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36420,0.0551450335423613,0.00884222479645595,0.0378142729413076,0.0724757941434149,4.61658962675562e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39069,0.0448201020289477,0.00719432724763595,0.0307192206235812,0.0589209834343141,4.78948354249274e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,36587,0.00768544420673302,0.00123355161057331,0.00526768305000933,0.0101032053634567,4.80103611643407e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39106,0.0474213902332184,0.00761328980856876,0.0324993422084236,0.0623434382580131,4.82461888490413e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,36792,-0.0148709421399145,0.0023882479380225,-0.0195519080984386,-0.0101899761813904,4.9105619904444e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,38741,0.0185074491785322,0.00297355968390678,0.0126792721980749,0.0243356261589895,4.97613717859742e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36420,0.0423889849414943,0.00681681283154017,0.0290280317916756,0.0557499380913131,5.18508731369666e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39099,0.036398563233881,0.00585732525599967,0.0249182057321216,0.0478789207356403,5.29299702125269e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39147,0.0321777685408714,0.00518231308693922,0.0220204348904705,0.0423351021912723,5.46479468767823e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,36767,0.0341347871333762,0.00549753071413369,0.0233596269336742,0.0449099473330783,5.49187911691604e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,36731,0.0414209743865425,0.00667423941809833,0.0283394651270698,0.0545024836460153,5.59841244226976e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39023,0.0160146515096454,0.00258123625421524,0.0109554284513835,0.0210738745679072,5.63835528237999e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36391,0.0384742014988848,0.00621289820354482,0.0262969210199369,0.0506514819778326,6.1017375704709e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39069,0.0510537067533703,0.00825317244166226,0.0348774887677123,0.0672299247390284,6.33097358628431e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",36767,0.0455838413953648,0.00737059553722358,0.0311374741424066,0.060030208648323,6.41588002867704e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39162,0.0497474837326798,0.00806319245034525,0.0339436265300032,0.0655513409353565,7.01417866520838e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,38741,0.0633622549246419,0.0102802774429709,0.043212911136419,0.0835115987128648,7.30000750851319e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,36767,0.0673320223166216,0.010937582989521,0.0458943596571604,0.0887696849760828,7.68052231022768e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,38832,-0.012198978189371,0.00198268328831473,-0.0160850374344678,-0.00831291894427407,7.80835183126921e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39106,0.0438037202690591,0.00712273052544562,0.0298431684391857,0.0577642720989325,7.94914227119188e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36430,0.017668134193532,0.00287277007388593,0.0120375048487156,0.0232987635383484,7.97286664270444e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39062,0.049457888946502,0.00804541614629848,0.0336888732997569,0.065226904593247,8.07626606476725e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,36792,0.0422519606024827,0.00687832924496968,0.0287704352823421,0.0557334859226233,8.34761435661803e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36420,-0.0117447457295226,0.00191192603659039,-0.0154921207612398,-0.00799737069780545,8.34835373235502e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36420,0.0355496030835088,0.00578789767762316,0.0242053236353674,0.0468938825316502,8.39192578943217e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,36743,0.0643375061737392,0.010475885126095,0.043804771326593,0.0848702410208853,8.41582641919101e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,36743,0.0400909886484459,0.00652943707182564,0.0272932919876677,0.0528886853092242,8.49272128333475e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36500,0.0341209797168312,0.00555854111738908,0.0232262391267486,0.0450157203069137,8.5810434535896e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,36731,0.0245681184512691,0.00400758809029268,0.0167132457942955,0.0324229911082428,9.02216064593714e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,36747,0.0425879683144041,0.00694847556059766,0.0289689562156327,0.0562069804131755,9.09509754923911e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,36792,0.0400410483016707,0.00653438166684461,0.0272336602346553,0.0528484363686862,9.17207075632286e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36506,-0.0118008066038503,0.00192818974477033,-0.0155800585036001,-0.00802155470410042,9.62531349430743e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,38841,0.0267285185053442,0.00437303248620464,0.0181573748323831,0.0352996621783053,1.00750205227248e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39106,0.0487213912762329,0.00797165900870714,0.0330969396191669,0.0643458429332989,1.00895590099353e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",36747,0.0548085088456685,0.00897081752734855,0.0372257064920653,0.0723913111992717,1.02730466901085e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39147,0.0351875374553661,0.00576326636160869,0.0238915353866131,0.0464835395241191,1.04967019642742e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39093,0.01306608995457,0.00214159572095467,0.00886856234149883,0.0172636175676411,1.07889899364783e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36430,0.0279846949272823,0.00459001829598474,0.0189882590671522,0.0369811307874124,1.11343104336256e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36538,0.0196682291662688,0.00322607848548642,0.0133451153347154,0.0259913429978222,1.11470088491617e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,38741,0.0286865383825984,0.00471055634021011,0.0194538479557866,0.0379192288094103,1.15802954138799e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39283,-0.0151606245670151,0.00249121933514569,-0.0200434144639007,-0.0102778346701296,1.18783661152288e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,38832,0.0279236825930323,0.00459060923661866,0.0189260884892597,0.0369212766968048,1.20987874670881e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,36796,-0.0338859706757946,0.00557483517318515,-0.0448126476152374,-0.0229592937363517,1.24817207225901e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,38741,0.0272125322263699,0.00447807857705402,0.018435498215344,0.0359895662373958,1.25569597879673e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39031,0.0468483604457059,0.00771727669321549,0.0317224981270036,0.0619742227644083,1.30483635636752e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36420,0.0344021983629886,0.00566826271062579,0.0232924034501621,0.0455119932758151,1.32197610610954e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39106,0.0369619702769483,0.00609273130801909,0.0250202169132309,0.0489037236406657,1.33761561170537e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36391,0.0334926816940041,0.00552676054281577,0.0226602310300852,0.044325132357923,1.39948310475263e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36420,0.0426966821241275,0.00704830550697045,0.0288820033304655,0.0565113609177896,1.4200975173175e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36500,0.0372409695678196,0.00614775502402386,0.0251913697207328,0.0492905694149063,1.42045616996965e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39283,0.0491234306320956,0.00811101057014488,0.0332258499146116,0.0650210113495796,1.42443235092785e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39255,-0.018500471153301,0.0030561076846406,-0.0244904422151966,-0.0125105000914055,1.44927040519614e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39106,0.0192453733169512,0.00318775945972267,0.0129973647758947,0.0254933818580076,1.60376307495387e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,36747,0.0466323041388389,0.00772560233116909,0.0314901235697475,0.0617744847079304,1.62246963350615e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39147,0.0461441916624225,0.00765097714938152,0.0311482764496347,0.0611401068752102,1.66547743921719e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36363,0.0549870461520666,0.00913158482316681,0.0370891398986597,0.0728849524054736,1.77511273104419e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39147,0.0118859733988895,0.00197419528155715,0.00801655064703753,0.0157553961507415,1.7767396092507e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,38987,-0.0154056563250971,0.0025651591752605,-0.0204333683086077,-0.0103779443415866,1.94833801715954e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,38951,0.0393636376760856,0.00656207097262492,0.0265019785697408,0.0522252967824305,2.03497733831794e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36500,0.0381537046297669,0.00637310450421159,0.0256624198015122,0.0506449894580216,2.19982447626234e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,36792,-0.0146292366671228,0.00244501169507081,-0.0194214595894616,-0.00983701374478405,2.24444069625986e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39023,0.0326095969913228,0.00545412066358118,0.0219195204907037,0.0432996734919419,2.29703934345747e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,36743,0.0355642044099132,0.00595276312521692,0.0238967886844881,0.0472316201353384,2.3702833407669e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36420,0.0160386265690368,0.00268482589644024,0.0107763678120139,0.0213008853260597,2.38055420997316e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39241,0.0360536645924914,0.00603616096842601,0.0242227890943764,0.0478845400906064,2.3814229814619e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39241,0.0156487202890435,0.00262329647269716,0.0105070592025571,0.02079038137553,2.49557327437165e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36430,0.0229663163429499,0.00385097056592096,0.0154184140337448,0.030514218652155,2.5309929175753e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39153,0.0180211218270419,0.003023165190135,0.0120957180543773,0.0239465255997065,2.56195236381056e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36430,0.0498133479885102,0.00835699822509951,0.0334336314673151,0.0661930645097052,2.57932548541543e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,36767,0.0379116307762588,0.00636444694622354,0.0254373147616606,0.0503859467908569,2.63948020071394e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36391,0.0370976769819385,0.00622865092682012,0.0248895211653711,0.0493058327985059,2.65459658622843e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36403,0.0313947437992352,0.00527122561667782,0.0210631415905466,0.0417263460079237,2.65616947507102e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,36767,0.0240207203836179,0.00403425979411466,0.0161135711871531,0.0319278695800826,2.68167040080685e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,36796,0.0500529611087132,0.00840720294716439,0.033574843332271,0.0665310788851554,2.6913786126273e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39106,0.0233654860192753,0.00393121377718687,0.015660307015989,0.0310706650225616,2.84944516626338e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39283,0.0126763836893964,0.00213378709139187,0.00849416099026832,0.0168586063885244,2.89753110394941e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,38844,0.0123102175264415,0.00207257894488308,0.00824796279447071,0.0163724722584124,2.92105250709393e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39241,0.0241124715918741,0.00406342462133124,0.0161481593340649,0.0320767838496833,3.01942609843876e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36420,0.0379746585654584,0.00639893106115923,0.0254327536855863,0.0505165634453305,3.02455859093512e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39093,0.0311480854513633,0.00525586546654624,0.0208465891369326,0.0414495817657939,3.1643129484602e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,38727,0.0286137787014578,0.00483015298939741,0.0191466788422389,0.0380808785606768,3.21161161265206e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39241,0.0302500141382616,0.00510816651527653,0.0202380077683196,0.0402620205082036,3.25038731525081e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,36767,0.0415308977079547,0.00701761836964752,0.0277763657034456,0.0552854297124639,3.33965443870345e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,36791,0.0603316140685558,0.0101965069265496,0.0403464604925186,0.0803167676445931,3.36387235528182e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39117,0.0179122280108004,0.0030287736955048,0.011975831567611,0.0238486244539898,3.40992314547372e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39099,0.0303202191873461,0.0051286215043192,0.0202681210388804,0.0403723173358117,3.4527833180808e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,38987,0.0196924097669731,0.00333203307801363,0.0131616249340664,0.0262231945998798,3.49402742062102e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36500,0.0611706801058587,0.0103547542840785,0.0408753617090647,0.0814659985026526,3.56282515173625e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,38727,0.0218775521515984,0.00370430164064147,0.0146171209359411,0.0291379833672557,3.58193421737985e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,38727,0.0458475476649736,0.00776615826136774,0.0306258774726928,0.0610692178572544,3.63612632433602e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39023,0.0397215458077316,0.00672880469114673,0.026533088613084,0.0529100030023792,3.64107827016492e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39106,0.0146435272376209,0.00248101688464008,0.0097807341437264,0.0195063203315155,3.66234946632666e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36466,0.0467753641849082,0.00792432998944999,0.0312436774055862,0.0623070509642302,3.66679640921584e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39140,0.0482795820905639,0.00818306553066465,0.0322407736504612,0.0643183905306666,3.71324531228783e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,36792,0.0390553889524251,0.0066199023186206,0.0260803804079287,0.0520303974969215,3.73289055473467e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39023,0.0290761920311576,0.00493037855310033,0.019412650067081,0.0387397339952343,3.77230513852946e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39032,0.0233916537045318,0.00396932414719374,0.0156117783760321,0.0311715290330316,3.87032506444816e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",36767,0.025313976650782,0.00429677424918849,0.0168922991223726,0.0337356541791914,3.92503607901144e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39099,0.0287294742394102,0.00488830847140574,0.0191483896354549,0.0383105588433654,4.26023875307147e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36373,0.0274957249445832,0.0046785821227601,0.0183257039839734,0.036665745905193,4.28576054000017e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39023,0.0389981346670175,0.00664834798151842,0.0259673726232414,0.0520288967107936,4.56174616059124e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,38960,0.0124228652978331,0.00211805484039669,0.00827147781065556,0.0165742527850106,4.57903427041603e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39140,0.0240640182879554,0.0041052744328836,0.0160176803995035,0.0321103561764073,4.67503161619097e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36430,0.0483030759492212,0.00824634804566312,0.0321402337797215,0.0644659181187209,4.81613443089768e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,36796,0.0255345890495998,0.00436068128012741,0.0169876537405501,0.0340815243586496,4.86707308733708e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36500,0.0445236941201408,0.0076042159158867,0.0296194309250029,0.0594279573152788,4.88471059241887e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,38727,0.0526775499669278,0.00900078094912543,0.0350360193066419,0.0703190806272136,4.94275029366104e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39093,0.013228133725926,0.0022630548676677,0.0087925461852973,0.0176637212665547,5.16131643755779e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39162,0.0222662289512482,0.00381024921741481,0.0147981404851152,0.0297343174173812,5.20692413189974e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",38705,0.0250679493631039,0.0042905754123667,0.0166584215548652,0.0334774771713427,5.24809300585007e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,38741,0.0379885631974725,0.00650339555903317,0.0252419079017675,0.0507352184931775,5.28627141453824e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39145,-0.0154082638583994,0.00263784722610332,-0.0205784444215619,-0.0102380832952369,5.28706460195148e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39064,0.0345350096897957,0.00591556791411682,0.0229404965781267,0.0461295228014646,5.39121485275973e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36500,0.0417658130545938,0.00715367802428003,0.027744604127005,0.0557870219821827,5.40092763794238e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,38727,0.0345918973306034,0.00592861794684159,0.0229718061547939,0.0462119885064129,5.49978875197166e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39099,0.0535249186338295,0.00917515803202718,0.0355416088910563,0.0715082283766028,5.53180445591282e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36500,0.0271289094111576,0.00465068284131743,0.0180135710421755,0.0362442477801398,5.56663654872811e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,38977,0.019627135943285,0.00336660240286585,0.0130285952336679,0.026225676652902,5.65732833756738e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,36743,0.055656128374467,0.00954936066291904,0.0369393814751457,0.0743728752737883,5.73498412462879e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,36743,0.0470802261612474,0.00808005087243698,0.0312433264512709,0.0629171258712239,5.78775277118073e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,36747,0.025202567493827,0.00433725514970052,0.016701547400414,0.03370358758724,6.36762609443984e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36420,0.049031473840717,0.0084594460949047,0.0324509594947038,0.0656119881867302,6.95214100178711e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36430,0.029219786353828,0.00504248985060241,0.0193365062466473,0.0391030664610087,7.00792796939554e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,36806,0.0080804435769549,0.00139648841947375,0.00534332627478636,0.0108175608791234,7.36373438856199e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36500,-0.0173988960344773,0.0030079175725021,-0.0232944144765814,-0.0115033775923732,7.45102707356013e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39147,0.029146123433096,0.00504313058332703,0.0192615874897751,0.039030659376417,7.64412514825057e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,38727,0.0337388151988325,0.00583890399114712,0.0222945633761842,0.0451830670214809,7.69798610707444e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,36705,0.0148272391460786,0.00256621899429339,0.00979744991726355,0.0198570283748936,7.74146524548116e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39291,0.0300889832986518,0.0052111809283013,0.0198750686791812,0.0403028979181223,7.89337576532435e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",36792,0.0391337080183561,0.00678000561212699,0.0258448970185872,0.052422519018125,8.01679167279237e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,38727,0.0199075884282026,0.00345037729198296,0.013144848935916,0.0266703279204892,8.10011223169753e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39206,0.0303231663116764,0.00525921199421565,0.0200151108030137,0.040631221820339,8.28713678230843e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,36792,0.0341209693795241,0.00591753953054652,0.0225225918996529,0.0457193468593953,8.29942983104592e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39075,0.0499098426546179,0.00865733767714811,0.0329414608074076,0.0668782245018282,8.32243468357083e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,36791,-0.0172883383019845,0.00299885535317126,-0.0231660947942002,-0.0114105818097689,8.35335516069318e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39023,0.0430047176466911,0.00747158059387561,0.0283604196826949,0.0576490156106873,8.79137868094965e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,38841,0.0422415321241709,0.00734577884885527,0.0278438055804146,0.0566392586679272,9.07417579016937e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36420,0.0281924096328395,0.0049023743100682,0.0185837559851058,0.0378010632805731,9.09095365137347e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39023,0.0268868549551741,0.00468039368951579,0.0177132833237231,0.036060426586625,9.39221218937865e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39089,0.0297125237681488,0.00518177125032335,0.0195562521175151,0.0398687954187826,9.99213254769042e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36538,0.0352695633899987,0.00615588216502798,0.0232040343465439,0.0473350924334536,1.03073605947613e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36538,0.0385233068491911,0.00673091187891961,0.0253307195665087,0.0517158941318735,1.06814755441061e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39099,0.0498262512667172,0.00871048607346474,0.0327536985627263,0.066898803970708,1.08357452424199e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",36792,0.0282681002823299,0.00494162328546972,0.0185825186428093,0.0379536819218506,1.08623151441172e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36391,0.0328589352208751,0.00574456097903261,0.0215995957019712,0.044118274739779,1.08954567207177e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39291,0.0224285229980902,0.00392234765530033,0.0147407215937015,0.0301163244024788,1.09691593941557e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36420,0.0323333511947867,0.00565882140963912,0.021242061231894,0.0434246411576793,1.12993034418212e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,38741,0.0270421887233109,0.00473433937093926,0.01776288355627,0.0363214938903519,1.13841375003496e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,36792,0.0244637680570896,0.00428598014934737,0.0160632469643688,0.0328642891498104,1.16919485851177e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36548,0.0189738841855023,0.00332549557764881,0.0124559128533107,0.025491855517694,1.1853914380846e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,38869,0.0360824965747054,0.00632745427127947,0.0236806862029976,0.0484843069464131,1.20265300291195e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,36792,0.0561345687688871,0.00984359619798371,0.036841120220839,0.0754280173169351,1.20541866292578e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36421,0.0360022134918337,0.00632085772721972,0.023613332346483,0.0483910946371843,1.25564313359875e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,38909,0.0241491322057997,0.00424052611037222,0.0158377010294701,0.0324605633821292,1.25792278626668e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",36767,0.036513342250219,0.00642474592226481,0.02392084024258,0.049105844257858,1.35030205382765e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,38987,0.0318490370349084,0.00560524726790052,0.0208627523898234,0.0428353216799935,1.35578076742732e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,36731,0.0252645282121418,0.00444759170590117,0.0165472484685755,0.0339818079557081,1.37213247223609e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39190,0.0355099308466965,0.00626435373407837,0.0232317975279029,0.0477880641654901,1.46586954131621e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,38823,0.0174847176850949,0.00309083371743875,0.0114266835989149,0.0235427517712748,1.56899711208815e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,38948,-0.0142923278674404,0.00252795000132876,-0.0192471098700447,-0.00933754586483598,1.59853478043436e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,38741,0.0383764035404028,0.00679026070562868,0.0250674925573706,0.051685314523435,1.61798103914852e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,36743,0.0498989471594738,0.0088372669455266,0.0325779039462417,0.067219990372706,1.67282536036875e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36108,0.0565095807091936,0.0100095635852438,0.0368908360821157,0.0761283253362715,1.68304836839925e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,36767,0.0350505257818059,0.0062124840029024,0.0228740571361172,0.0472269944274946,1.71670202094796e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36500,0.0255184257336484,0.00452292366542022,0.0166534953494247,0.034383356117872,1.71676178918911e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,38841,0.0363204477984154,0.00644021139655161,0.0236976334611742,0.0489432621356565,1.73488626473886e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39023,0.0281186016950897,0.00498778978258216,0.0183425337212287,0.0378946696689507,1.75624233166558e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39162,0.0536265973035392,0.0095125943529114,0.0349819123718328,0.0722712822352455,1.75653081270823e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,38741,0.0229788071202883,0.00407651894095129,0.0149888299960238,0.0309687842445528,1.76312338444536e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36391,0.0345774313298678,0.00613489960934718,0.0225530280955473,0.0466018345641883,1.77609753453201e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39283,0.0302723799126334,0.00537894038244771,0.0197296567630359,0.0408151030622309,1.8554298281222e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39246,0.0150257746237492,0.00267157650066135,0.00978948468245294,0.0202620645650454,1.89491660758219e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39023,0.016746764789842,0.00297986368066557,0.0109062319757375,0.0225872976039466,1.94345324308113e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,36785,0.0247800275965584,0.00440922917031471,0.0161379384227416,0.0334221167703753,1.94865700437926e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39118,0.00998427053578428,0.0017768821463243,0.00650158152898866,0.0134669595425799,1.95442871975175e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39093,0.0124512599499126,0.00222016029892952,0.0080997457640107,0.0168027741358144,2.07910160843619e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39140,0.0391757629759599,0.00699356862964839,0.0254683684618491,0.0528831574900708,2.1594033209388e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39046,0.0140141969771583,0.00250462830692205,0.0091051254955911,0.0189232684587256,2.24020055467019e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39023,0.0499575637876519,0.00892987621879211,0.0324550063988193,0.0674601211764844,2.25176205117983e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36538,0.0378004050419269,0.00675949383177296,0.0245517971316519,0.0510490129522019,2.28854185495426e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39147,-0.0231586224509403,0.00414757037861428,-0.0312878603930243,-0.0150293845088563,2.39518244648996e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,36743,0.0272215077889686,0.00488450481399703,0.0176478783535345,0.0367951372244028,2.55367791974384e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39241,0.0584332562993843,0.010507326735518,0.037838895897769,0.0790276167009997,2.72401245943428e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36430,0.0199926986075866,0.0036017434795281,0.0129332813877116,0.0270521158274617,2.90062070889318e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39057,0.0555276758006207,0.0100251462124134,0.0358783892242904,0.0751769623769509,3.09535045713722e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36420,0.0131268907357686,0.00237291368421334,0.00847597991471047,0.0177778015568268,3.22987476063911e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39051,0.0240789056935857,0.00435522228368869,0.0155426700175559,0.0326151413696155,3.2784913905109e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,38951,0.0152235077498015,0.00275418369583831,0.00982530770595837,0.0206217077936445,3.30376591531494e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,36619,0.0557042185307358,0.0100844867785403,0.0359386244447968,0.0754698126166748,3.38330503085126e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39083,0.0196198145478367,0.00355392865282635,0.012654114388297,0.0265855147073763,3.43371011157471e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36391,0.0340884930692536,0.00617833572290281,0.0219789550523641,0.0461980310861432,3.50834931631601e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36430,-0.0150167197967225,0.00272417773217667,-0.0203561081517888,-0.00967733144165625,3.60981117328154e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",38727,0.0408003336115015,0.00741164167228743,0.0262735159338182,0.0553271512891849,3.75499118184128e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,36796,-0.0120506525531265,0.00218916397034681,-0.0163414139350063,-0.00775989117124675,3.76879866472232e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39066,0.0179315312916199,0.00326805834853681,0.0115261369284877,0.0243369256547521,4.15571169245919e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,38856,0.0372189922992847,0.00678736018483311,0.0239157663370118,0.0505222182615575,4.23558157872067e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,38754,0.0396012692607914,0.00723050235445872,0.0254294846460523,0.0537730538755305,4.39674073388972e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,36747,0.0314613465256358,0.00574733989160733,0.0201965603380854,0.0427261327131862,4.48042190588312e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36430,-0.0604496176318443,0.01104932409414,-0.0821062928563587,-0.0387929424073299,4.56357599128615e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,36748,0.00991044416740857,0.0018139926702263,0.00635501853376502,0.0134658698010521,4.75955351964156e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39099,0.0529829302003248,0.00970232867485896,0.0339663659976013,0.0719994944030484,4.81287717300764e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,38727,0.0368899562688429,0.00675590293028561,0.0236483865254832,0.0501315260122027,4.8267580647202e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,36743,0.0512526570350069,0.00939238785672467,0.0328435768358265,0.0696617372341872,4.9367315067941e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36421,0.0247632251507496,0.00453862372243622,0.0158675226547746,0.0336589276467246,4.95906878726808e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39093,0.0179770073371775,0.00329968388437492,0.0115096269238027,0.0244443877505524,5.17008937163052e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,38951,0.0319690941409211,0.0058758769647754,0.0204523752899613,0.0434858129918809,5.38878706313793e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,36806,0.0104078004439793,0.00191322325800119,0.00665788285829697,0.0141577180296616,5.4270303398608e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36421,0.0306435916094114,0.00564437758956325,0.0195806115338675,0.0417065716849554,5.77090042860157e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39255,0.0295424281757412,0.00544417651547743,0.0188718422054054,0.0402130141460769,5.83624238279092e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",36767,0.031294430078268,0.0057669267430732,0.0199912536618445,0.0425976064946915,5.84960073818932e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39255,0.0157351743680789,0.00291003684154025,0.01003150215866,0.0214388465774978,6.49692952519606e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39023,0.0167908548027636,0.00310653777595863,0.0107020407618847,0.0228796688436425,6.57858974823702e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,36767,0.0272147584335623,0.00503509308985852,0.0173459759774397,0.037083540889685,6.59546685115199e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,36607,0.0115662857057496,0.00214253135615985,0.00736692424767635,0.0157656471638229,6.84346069865745e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39106,0.0335531290892498,0.0062245101140243,0.0213530892657622,0.0457531689127374,7.13130620063678e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39291,0.0166224446528439,0.00308674678836311,0.0105724209476522,0.0226724683580356,7.34637630577393e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36421,0.0402174886145633,0.00746789112696929,0.0255804220057035,0.0548545552234231,7.3590834138819e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,36747,0.0675304720733211,0.0125493755320176,0.0429336960305666,0.0921272481160756,7.52934176656897e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39162,0.0122612767046582,0.00228089763685278,0.00779071733642679,0.0167318360728897,7.74315581616554e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,36796,0.0339039098539341,0.00632040891633928,0.0215159083779092,0.0462919113299591,8.27109308711805e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,38741,0.0329936256533758,0.0061641837572337,0.0209118254891978,0.0450754258175539,8.8046897544366e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39255,0.0145171704322763,0.00271350637357871,0.00919869794006199,0.0198356429244905,8.92284753007166e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,36792,0.0195760937573377,0.00366250010464653,0.0123975935522306,0.0267545939624449,9.19486540088129e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39283,0.0264824950880871,0.00495595550733274,0.0167688222937149,0.0361961678824593,9.24287999520681e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39147,0.0405445336929211,0.00759114865788686,0.0256658823234629,0.0554231850623794,9.37440139083473e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,38741,0.0133426836949703,0.00250043107651804,0.00844183878499492,0.0182435286049457,9.63302620069595e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39046,0.0164136708436374,0.0030764343400438,0.0103838595371515,0.0224434821501232,9.67604038197944e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39266,0.0129235464722983,0.00242283993361865,0.00817478020240574,0.0176723127421909,9.74037401116832e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39106,0.0329540178987797,0.00617864160346772,0.020843880355983,0.0450641554415764,9.76922909735362e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,36767,0.0333802114566777,0.00626298602653686,0.0211047588446654,0.0456556640686899,9.9997909725417e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,36747,0.0202162994203643,0.0037970223400324,0.0127741356339008,0.0276584632068278,1.03071863945383e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,38741,0.0327381536164061,0.00615055110086585,0.0206830734587091,0.0447932337741032,1.03664786113059e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,36796,0.0296072456984412,0.00557473759280914,0.0186807600165353,0.0405337313803472,1.10851381862687e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39093,-0.0138565437247984,0.00260981625217543,-0.0189717835790623,-0.00874130387053459,1.11533805250834e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,38987,0.0258769943003722,0.00487460384666466,0.0163227707609094,0.0354312178398349,1.12072172040754e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36261,0.0340408246595211,0.00641202821678658,0.0214732493546194,0.0466083999644228,1.12191243688235e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,38828,-0.0144924042303099,0.00273088163218805,-0.0198449322293985,-0.00913987623122136,1.13120510037408e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,36731,0.0484882312226735,0.0091518808436587,0.0305505447691024,0.0664259176762445,1.18897267668782e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39099,0.0330925719967314,0.00624930574556676,0.0208439327354205,0.0453412112580422,1.204053749124e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,36767,0.0281390642145845,0.00531853650339427,0.0177147326679317,0.0385633957612373,1.23805956917516e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",38987,0.0278216043334653,0.00526097234012428,0.0175100985468217,0.0381331101201089,1.25175911517128e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",36792,0.0424783029975361,0.00803532900978034,0.0267290581383666,0.0582275478567055,1.2674754995387e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,36747,0.0220203506143266,0.00416558238425162,0.0138558091411934,0.0301848920874598,1.26880867324398e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,38832,0.0224869527286698,0.0042544443524019,0.0141482417979621,0.0308256636593775,1.27106797642645e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39255,-0.0149063734087102,0.00282176893164374,-0.020437040514732,-0.00937570630268849,1.29073235387006e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36420,0.0567230209098678,0.0107395905282589,0.0356734234744804,0.0777726183452552,1.30146040201816e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",36792,0.0366910756248244,0.00694756011717425,0.0230738577951629,0.0503082934544859,1.30459529773128e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,36792,0.0136178729112232,0.00257923712524605,0.00856256814574095,0.0186731776767055,1.31414406888691e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39054,-0.0122604990815377,0.00232510753044888,-0.0168177098412176,-0.00770328832185793,1.35984249911275e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,38977,0.0229616719082406,0.00436750026330972,0.0144013713921535,0.0315219724243276,1.48099435845737e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39165,-0.0144101125783515,0.00274171851527066,-0.019783880868282,-0.00903634428842101,1.49305699214285e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39147,-0.0196193484178628,0.00373293093876827,-0.0269358930578486,-0.012302803777877,1.49404954467518e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39291,0.0250860333380511,0.00477620736901944,0.015724666894773,0.0344473997813292,1.5221378080184e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,36747,0.0345346792130429,0.00657571934082059,0.0216462693050345,0.0474230891210512,1.52977351980724e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,36767,0.017838570938195,0.00339914321551102,0.0111762502357934,0.0245008916405966,1.56228858591413e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39147,-0.0153398169853672,0.00292340522847386,-0.0210696912331759,-0.00960994273755839,1.56454821398138e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,36792,-0.0155009988293747,0.00295415345414436,-0.0212911395994977,-0.00971085805925179,1.56879277683127e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,36791,0.0396469485473204,0.00755664733234042,0.0248359197759332,0.0544579773187077,1.57352409092249e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36321,-0.0298890543446223,0.00570103178963393,-0.0410630766523047,-0.0187150320369398,1.60792563685157e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39021,0.0128097680534594,0.00244358582629888,0.00802033983391356,0.0175991962730052,1.60801731784428e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,36743,0.0402622732689257,0.00769441892306444,0.0251812121797194,0.055343334358132,1.69711140615308e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,38727,0.0339656297707306,0.00650125793955679,0.0212231642091993,0.0467080953322619,1.77013370066725e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,36762,0.0069028002648531,0.00132128457129976,0.00431308250510557,0.00949251802460064,1.77528404638213e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36430,0.0565025463845844,0.0108156532025253,0.0353038661076349,0.077701226661534,1.77758398257638e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,38727,0.0326604960510343,0.0062525367797639,0.020405523962697,0.0449154681393715,1.77885469612879e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,38721,0.0281706801552961,0.00539343339033696,0.0175995507102357,0.0387418096003566,1.78285032187514e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,36728,0.0405214565879843,0.00776100756653634,0.025309881757573,0.0557330314183955,1.80576863638756e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,38727,0.0441321888591802,0.00845441942380614,0.0275615267885202,0.0607028509298403,1.81318070221317e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39237,0.0146368723052589,0.00281057241692122,0.0091281503680933,0.0201455942424245,1.93566909100646e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,36731,0.0263783928023783,0.00506804673063532,0.016445021210333,0.0363117643944235,1.97147385164843e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39162,0.0194644412831599,0.00374556582110659,0.012123132273791,0.0268057502925288,2.05505906657537e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39099,0.0386009990961934,0.00745210792099682,0.0239948675710397,0.0532071306213472,2.24862361030873e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39099,0.0434541617365741,0.00839132358885483,0.0270071675024187,0.0599011559707296,2.26569071847678e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,38810,0.0234745687859951,0.00454426705511658,0.0145678053579666,0.0323813322140236,2.42548989995448e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,36767,0.0285298616344099,0.00552461878196915,0.0177016088217504,0.0393581144470695,2.45152127710701e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36420,0.0345507334911911,0.00670313564649705,0.0214125876240569,0.0476888793583253,2.58289388947579e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39099,0.0167527026838089,0.0032530560528796,0.0103767128201649,0.023128692547453,2.63963680827023e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36478,-0.0267638391804955,0.00520113907870321,-0.0369580717747538,-0.0165696065862372,2.70433807705239e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39283,0.0192512066315008,0.00374243841944017,0.0119160273293981,0.0265863859336035,2.7220570163686e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",38727,0.023853538963102,0.0046378218114058,0.0147634082127466,0.0329436697134573,2.73438305636809e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39106,0.0229657902679995,0.00446535607010073,0.0142136923706021,0.031717888165397,2.73584356134165e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39099,0.024662587010784,0.00479786876084326,0.0152587642395312,0.0340664097820368,2.77661757533917e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36421,0.0345032072063866,0.00671250767492734,0.021346692163529,0.0476597222492442,2.78662531401923e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39266,0.0108923174124372,0.0021213835008183,0.00673440575083329,0.015050229074041,2.86288294083921e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,38727,0.0307982030394244,0.00600207748072901,0.0190341311771955,0.0425622749016533,2.9143822644654e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36500,0.0367115698860064,0.00715583778432052,0.0226861278287382,0.0507370119432746,2.93572128313507e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39023,0.0254011678837344,0.00495429546931276,0.0156907487638814,0.0351115870035874,2.97861043766207e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39071,0.0323034772625818,0.00630500792280753,0.019945661733879,0.0446612927912846,3.0364432302801e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39106,0.0162931575523961,0.00318155769275438,0.0100573044745975,0.0225290106301947,3.07417821477835e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39099,0.0484671874044625,0.00947389633133679,0.0298983505950424,0.0670360242138826,3.1609646454197e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,36747,0.0325935651903829,0.00637514016906276,0.0200982904590199,0.0450888399217459,3.22303865925222e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39283,0.0181990349078825,0.00356206223336167,0.0112173929304936,0.0251806768852714,3.275107217009e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,38832,0.0246318028462264,0.00482226039291323,0.0151801724761165,0.0340834332163364,3.29696623574026e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,38987,-0.0275051963191713,0.00538639273350143,-0.0380625260768341,-0.0169478665615085,3.32303098599301e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39106,0.030812942787633,0.00603663733732278,0.0189811336064803,0.0426447519687856,3.35976213234651e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39099,-0.0199694991765327,0.00391366287842743,-0.0276402784182505,-0.012298719934815,3.39209196495238e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,36767,0.0181130854958724,0.00355065115347656,0.0111538092350583,0.0250723617566864,3.42040004052883e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39162,0.0167380602600636,0.00328446269222809,0.0103005133832965,0.0231756071368306,3.50790430816066e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39147,0.0138663079036992,0.00272110240867876,0.00853294718268882,0.0191996686247096,3.51333824058877e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39099,0.0263809272593951,0.00518291667869287,0.0162224105691571,0.0365394439496331,3.62370432363454e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,38727,0.035643225422624,0.00700350779520361,0.021916350144025,0.0493701007012231,3.63697259394812e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39147,0.0126082459955596,0.00248058048776318,0.00774630823954376,0.0174701837515754,3.76339916198591e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39106,-0.0176418804761395,0.00347797210360909,-0.0244587057992133,-0.0108250551530657,3.97313421326319e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,38741,0.0338104697625411,0.00666734312169271,0.0207424772440234,0.0468784622810588,4.00369432609073e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,36723,0.0262411375460865,0.00517873594334875,0.0160908150971229,0.03639145999505,4.0954043981569e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39023,0.0273767075726878,0.00540331340785349,0.016786213293295,0.0379672018520807,4.09633125145367e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36500,-0.0113722903970023,0.0022445628539457,-0.0157716335907359,-0.00697294720326872,4.10711220244829e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39211,0.0285224704868631,0.00563463120708609,0.0174785933209743,0.0395663476527518,4.19693482296551e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,36761,0.0285567815649904,0.00564243653834174,0.0174976059498406,0.0396159571801402,4.22644241747162e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39255,0.0120988899343493,0.00239194075172243,0.00741068606097331,0.0167870938077252,4.28123698047489e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,38922,0.0147430744969958,0.00291505803746605,0.00902956074356238,0.0204565882504293,4.29650275379896e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36500,0.016818350186116,0.00332742688942602,0.010296593482841,0.023340106889391,4.376426223918e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39093,-0.0130180250889013,0.00257941997089003,-0.0180736882318458,-0.00796236194595687,4.54256772523396e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,36747,0.0168778860493187,0.00334479280900558,0.0103220921436677,0.0234336799549696,4.57258325183928e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39291,0.0210638044696136,0.00417559649827862,0.0128796353329875,0.0292479736062397,4.59867529482188e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39189,0.0158328121871173,0.00314452210223615,0.00966954886673443,0.0219960755075001,4.83156493649308e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36500,0.0133190051837943,0.00264517134201519,0.0081344693534445,0.018503541014144,4.83890146181503e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36430,0.0196603583821018,0.00390885488795821,0.0119990028017037,0.0273217139624999,4.98031025556575e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,38692,0.0199358167182164,0.00396549300938597,0.0121634504198199,0.0277081830166129,5.0317223003682e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39223,0.0188406907887297,0.00374848749861095,0.0114936552914523,0.0261877262860072,5.05890295747997e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39241,0.0152440924718511,0.00303348794378085,0.00929845610204064,0.0211897288416616,5.08370730662961e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39106,0.0495499421945327,0.00986511118503342,0.0302143242718672,0.0688855601171982,5.15137685282735e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,36731,0.0392164889064612,0.00781178171384859,0.0239053967473179,0.0545275810656044,5.23155647605374e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36420,0.0231572004383635,0.00461734549821292,0.0141072032618662,0.0322071976148609,5.36841822967397e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,36767,0.0225727696536319,0.00450116552876783,0.013750485217247,0.0313950540900168,5.37735309478776e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36391,0.031952288548405,0.00638089229146351,0.0194457396571365,0.0444588374396734,5.58930139263341e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,36731,0.0286691932540362,0.0057272627252171,0.0174437583126107,0.0398946281954617,5.63834648172766e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36538,0.0325624931243294,0.00651403884975195,0.0197949769788156,0.0453300092698432,5.84532248882941e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,38987,0.0282982793469698,0.00566337120159034,0.0171980717918528,0.0393984869020869,5.89647445660215e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,36767,0.0220225446459367,0.00440874764983964,0.013381399252251,0.0306636900396224,5.95457935154809e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,36731,0.052357269027178,0.0104850304199771,0.031806609404023,0.0729079286503331,6.00635161578406e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,38832,0.0185718243299731,0.00372003203694417,0.0112805615375626,0.0258630871223837,6.03093926628579e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,38841,0.0255864630642909,0.00512746004739802,0.0155366413713907,0.035636284757191,6.10295592239356e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39099,0.0168182298984958,0.00337059547238262,0.0102118627726259,0.0234245970243657,6.11425230297903e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39162,0.0179058065150628,0.00358959919366021,0.0108701920954888,0.0249414209346368,6.15977615619199e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36391,0.030730429811347,0.00616673037518945,0.0186436382759757,0.0428172213467184,6.33560306635858e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,38832,0.0429358738161988,0.00862134921641911,0.0260380293520174,0.0598337182803803,6.42325241599479e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,36792,0.0293285094208202,0.00589266594396394,0.0177788841706508,0.0408781346709895,6.53678223854504e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39095,0.036364373385699,0.00730802962624854,0.0220406353182519,0.0506881114531462,6.56374065049335e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,36743,0.0272472783513743,0.00547767710824572,0.0165110312192127,0.0379835254835359,6.63487560627692e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38007,0.0178699013810493,0.00359452448118167,0.0108246333979332,0.0249151693641653,6.72415291123928e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39106,0.0315012327325234,0.00633964784786004,0.0190755229507177,0.0439269425143291,6.80550457239154e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,36743,0.0218016425020276,0.00438775342629757,0.0132016457864844,0.0304016392175708,6.82515202095376e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36500,-0.0101208974134663,0.00204122971343968,-0.0141217076518081,-0.00612008717512456,7.205957427318e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,38907,0.0163145538750588,0.00329120677440798,0.00986378859721918,0.0227653191528985,7.23643399348075e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,38658,0.038502905328825,0.00777010541617643,0.0232734987131192,0.0537323119445308,7.30313166020595e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,36796,-0.0116074229879677,0.00234423923206403,-0.0162021318828132,-0.00701271409312222,7.45851665128064e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39106,0.0180058948837665,0.00363802475776876,0.0108753663585397,0.0251364234089933,7.52527652736714e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36391,0.0292585674510232,0.00591284086043809,0.0176693993645646,0.0408477355374819,7.58332361764037e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36500,0.0113917825975982,0.0023027540708996,0.00687838461863498,0.0159051805765614,7.63256531168133e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,38741,0.0218095296387226,0.00441269586006124,0.0131606457530025,0.0304584135244426,7.79861737538879e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39241,-0.0102363233529692,0.00207283665013421,-0.0142990831872323,-0.00617356351870617,7.96265777050819e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36420,-0.0103429801888654,0.00209424770650245,-0.0144477056936102,-0.00623825468412057,7.96335504380104e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39147,0.0132712135522043,0.00268852105622362,0.008001712282006,0.0185407148224026,8.04780670998218e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,38987,0.0292837924353844,0.00593698897030061,0.0176472940535952,0.0409202908171736,8.2074561869835e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,36791,-0.0241925885039056,0.00490721282734507,-0.0338107256455019,-0.0145744513623092,8.32473236853086e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36500,0.0243444560464855,0.00494118971834787,0.0146597241985237,0.0340291878944473,8.46279397561832e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,36767,0.0297564137418729,0.00604021038281732,0.017917601391551,0.0415952260921949,8.48022998879858e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39291,0.0247465689007252,0.00502712673036066,0.0148934005092183,0.0345997372922321,8.62809281864346e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,38972,0.0260816657840854,0.00530793908651826,0.0156781051745096,0.0364852263936612,9.03056219586531e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36391,0.054603256686469,0.0111199445141846,0.0328081654386672,0.0763983479342708,9.20418716750918e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,36731,0.025733000195258,0.00524230486830751,0.0154580826533752,0.0360079177371407,9.27970953341386e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,38841,0.0153453778783837,0.0031309434442477,0.00920872872765823,0.0214820270291092,9.62499229905557e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,36806,0.00852155057537586,0.0017388924042447,0.00511332146305624,0.0119297796876955,9.67198859741379e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,38841,-0.0132702432681459,0.0027118862343075,-0.0185855402873886,-0.00795494624890322,1.00158120617005e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36420,0.0211397703529312,0.00432043962138259,0.0126717086950213,0.0296078320108411,1.00559293931254e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,36806,0.0115748340129945,0.00236779751911123,0.00693395087553647,0.0162157171504525,1.02857592060808e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39093,-0.0191282809591204,0.0039136977527608,-0.0267991285545316,-0.0114574333637092,1.03152776592118e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,36731,0.0228667759559019,0.00468240285858818,0.0136892663530691,0.0320442855587347,1.05441641526036e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39099,0.0275905944822642,0.00566011065258101,0.0164967776032055,0.038684411361323,1.10144904413044e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39106,0.030228523662883,0.00620280688893877,0.018071022160563,0.042386025165203,1.10818159903465e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,38987,0.0221948092498746,0.0045638674824318,0.0132496289843083,0.0311399895154409,1.16688924888442e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,38727,0.0231258879920174,0.00476288431679574,0.0137906347310977,0.032461141252937,1.21342436021156e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,36731,0.0232038512142304,0.00478320250567708,0.0138287743031033,0.0325789281253575,1.24208935904616e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36430,0.0435476261555773,0.00897962663786283,0.0259475579453661,0.0611476943657884,1.25190504556921e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,36796,0.0211443463523361,0.00436465568820703,0.0125896212034503,0.0296990715012219,1.28435855367121e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,36747,0.0340803880926005,0.00704634929508027,0.0202695434742432,0.0478912327109578,1.33604446049631e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39117,0.0206963266801208,0.00429211525903407,0.012283780772414,0.0291088725878276,1.43539182434433e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,38727,0.0207800684599464,0.00431142545069754,0.0123296745765792,0.0292304623433136,1.45145847241545e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36430,0.0230707125166553,0.00479458533283743,0.0136733252642939,0.0324680997690166,1.51295281164793e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39241,0.0183760008591831,0.0038196238987177,0.0108895380176964,0.0258624637006698,1.51642792642964e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39283,0.00852003951998091,0.00177188116171645,0.00504715244301666,0.0119929265969452,1.53524395376852e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36391,0.0405720098536888,0.0084823159674008,0.0239466705575832,0.0571973491497944,1.7455347822292e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,36731,0.0472711844077456,0.00988610148561958,0.0278944254959312,0.06664794331956,1.75849090209501e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,38998,0.0157802764850256,0.0033014551661799,0.00930942435931299,0.0222511286107382,1.77123615116859e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,36743,0.0129560647228666,0.00271149590871734,0.00764153274178062,0.0182705967039526,1.78824804415191e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,38727,0.0204102342745896,0.00427280715027266,0.0120355322600552,0.028784936289124,1.79830121092747e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36430,0.0178402030235334,0.00373725035136724,0.0105151923348536,0.0251652137122132,1.82985139109422e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,36791,-0.0117238656272297,0.00245636061366835,-0.0165383324300197,-0.00690939882443973,1.83616100911896e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39241,0.0281829094638436,0.00591777527383578,0.0165840699271254,0.0397817490005617,1.93032909440745e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,36806,0.00892265968647643,0.0018738017085791,0.0052500083376614,0.0125953110352915,1.93957716264466e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39241,0.0283536432742326,0.00597015117393735,0.0166521469733153,0.0400551395751498,2.06031058393768e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36430,0.025536384740816,0.00538185867966583,0.014987941728671,0.036084827752961,2.10905378386622e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,38727,0.0422310717922417,0.00890775715937075,0.024771867759875,0.0596902758246084,2.1470980543e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36430,0.0350226816424114,0.00738828777267919,0.0205416376079602,0.0495037256768626,2.15745398615683e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,38727,0.0331457957857919,0.00699686188600845,0.0194319464892154,0.0468596450823685,2.18654156008833e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39118,0.0211004381950875,0.00445438040469451,0.0123698526018863,0.0298310237882888,2.18849155186006e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39023,0.0200385768109595,0.00423468684658479,0.0117385905916533,0.0283385630302656,2.24314723409648e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39255,0.0161522609907333,0.00341611232166629,0.00945668084026732,0.0228478411411992,2.2846080597102e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,36791,0.0202645769576096,0.00428574037293636,0.0118645258266544,0.0286646280885649,2.28716169929098e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39229,0.0258616995805425,0.0054728422108158,0.0151349288473435,0.0365884703137415,2.31627795466058e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,36767,0.0289128385686436,0.00611910148551649,0.0169193996570313,0.040906277480256,2.32527012095573e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36500,0.0276462723071607,0.00585317883266313,0.016174041795141,0.0391185028191804,2.34553643821585e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39099,0.0398359821439051,0.00844081335247134,0.0232919879730613,0.0563799763147489,2.38587071955561e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36430,0.0177672472047757,0.00376970004851016,0.0103786351096958,0.0251558592998556,2.46505855681212e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,38727,0.0289697691041576,0.00615177136124791,0.0169122972361117,0.0410272409722035,2.50968454174207e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39099,0.0286441727585771,0.00609386176032779,0.0167002037083347,0.0405881418088196,2.61801610029927e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36391,0.0264771439895837,0.00564406818834096,0.0154147703404355,0.037539517638732,2.74551317159239e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39099,-0.0104050412816623,0.00222425671231058,-0.014764584437791,-0.00604549812553356,2.92195509035571e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,38727,0.020718830019187,0.00443101417982379,0.0120340422267324,0.0294036178116416,2.95288606420052e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39057,0.0200946010614491,0.00431238997892051,0.0116423167027649,0.0285468854201333,3.19301247213833e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39023,0.0378248973629666,0.00811824752804666,0.0219131322079951,0.053736662517938,3.20070821088441e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,36767,0.0454825571189183,0.00977048325594527,0.0263324099372656,0.064632704300571,3.27051743671364e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39237,0.0113970061560297,0.00244981929807522,0.00659536033180226,0.0161986519802571,3.31177719533809e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39099,0.0271790774205587,0.00584827330612311,0.0157164617405574,0.03864169310056,3.39013485891411e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39211,0.0251401714335543,0.0054182227054498,0.0145204549308726,0.0357598879362359,3.51408319692814e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,38832,0.013480403078337,0.00291196893893471,0.007772943958025,0.0191878621986491,3.69970244125175e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39085,-0.021506471100405,0.00465219857023531,-0.0306247802980662,-0.0123881619027437,3.81591258095602e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39086,0.012212431096949,0.00264213076722825,0.00703385479318159,0.0173910074007163,3.82827035589267e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36430,0.0190480094976491,0.00412260515437876,0.0109677033950667,0.0271283156002315,3.86840790827951e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39198,0.0480611176230973,0.0104050093999044,0.0276672991992846,0.06845493604691,3.8865999871031e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36420,0.0198183374606212,0.0042968103066092,0.0113965892596672,0.0282400856615753,4.02099802360198e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,38987,0.0140116763976081,0.00303928307035324,0.00805468157971573,0.0199686712155004,4.05590180762998e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39255,0.0150039491925563,0.00325764109163261,0.00861897265295636,0.0213889257321562,4.14231647025706e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39283,0.0119961712695232,0.00260588459442186,0.00688863746445634,0.0171037050745901,4.18778607497814e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,36796,0.00944286168317519,0.00205240694053049,0.00542014407973543,0.0134655792866149,4.24722177673836e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36538,0.0210067671548206,0.00456671691652846,0.0120560019984248,0.0299575323112164,4.2664150581423e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39241,-0.011723272494472,0.0025508010903997,-0.0167228426316555,-0.00672370235728863,4.34273941058375e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,38741,0.0280121477413813,0.00609977204385067,0.016056594535434,0.0399677009473286,4.41922719956941e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,36712,0.0184811760668365,0.00403120975521669,0.0105800049466118,0.0263823471870612,4.5931406379883e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,38841,0.0200013098980099,0.00437254714167272,0.0114311175003313,0.0285715022956884,4.81662664913615e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,36735,0.026701635861052,0.00584356129185135,0.0152482557290234,0.0381550159930807,4.93641993873271e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,36731,0.016571743114247,0.00363217483241561,0.00945268044271238,0.0236908057857815,5.10190109887174e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,38727,0.0238490734901926,0.0052288034008763,0.0136006188244751,0.0340975281559102,5.12939213626044e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39099,0.035929438306824,0.00788107350037971,0.0204825342460798,0.0513763423675682,5.18094095607343e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36420,0.0426902379358777,0.00937237429652128,0.024320384314696,0.0610600915570594,5.29035859044559e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,36767,0.0276913145130636,0.00608960988797351,0.0157556791326355,0.0396269498934916,5.48316927102436e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,36767,0.0259761943297388,0.00571404400214614,0.0147766680855324,0.0371757205739453,5.51651926565223e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39137,-0.0129694879565339,0.00285464279546718,-0.0185645878356496,-0.0073743880774182,5.58054820224228e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,38727,0.0140760334387265,0.00310057585884442,0.00799890475539143,0.0201531621220615,5.67460859704374e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39241,0.0531997894722457,0.0117287658861456,0.0302114083354003,0.0761881706090911,5.7808733563682e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",36767,0.0196073959624573,0.00432318444706931,0.0111339544462015,0.0280808374787132,5.8010811965283e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,38727,0.0281290270947259,0.00620504117964386,0.015967146382624,0.0402909078068279,5.85352020009277e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,36779,0.00936838525302869,0.00206683436487716,0.00531738989786945,0.0134193806081879,5.87514073729955e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36430,0.0237289034296527,0.00524967750095171,0.0134395355277874,0.034018271331518,6.23840976607222e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36391,0.0168060375497612,0.003721862742683,0.00951118657410251,0.0241008885254199,6.37466883706117e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36363,0.0196136868613236,0.00435008191759503,0.0110875263028373,0.0281398474198099,6.5785537149317e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,38741,0.0292059631875242,0.00648288002885367,0.016499518330971,0.0419124080440774,6.68496022744246e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36420,-0.0161336339703828,0.00358267687946668,-0.0231556806541375,-0.00911158728662807,6.7529961618793e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36791,0.0255179200099812,0.0056682078037372,0.0144082327146563,0.0366276073053061,6.79251908778081e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",38994,0.0307501610944647,0.0068315403137102,0.0173603420795927,0.0441399801093367,6.80734681835678e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,38741,0.0302322002101979,0.00672251616480185,0.0170560685271862,0.0434083318932095,6.93893505375078e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,36747,0.0445224840406808,0.00989989502033892,0.0251186898008165,0.0639262782805451,6.94333970124719e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39099,0.0165647056884977,0.00368572157928258,0.00934069139310384,0.0237887199838916,7.0316167727104e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39023,0.023537541028404,0.00524355746931937,0.0132601683885381,0.03381491366827,7.21363970753181e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36538,0.0295390552063332,0.00658812476436988,0.0166263306681682,0.0424517797444982,7.40100086160468e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,36791,-0.0191553173969477,0.00427449932210152,-0.0275333360682666,-0.0107772987256287,7.48265641805047e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,38841,0.0270499046197264,0.00604179822585727,0.0152079800970461,0.0388918291424066,7.62123981088162e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38502,0.0120094129062319,0.0026826259705559,0.00675146600394229,0.0172673598085214,7.63646247254513e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39103,0.0126394116636452,0.0028323240634951,0.0070880564991948,0.0181907668280956,8.15671367105919e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,36747,0.0355834204781018,0.00797537733258875,0.0199516809062278,0.0512151600499757,8.20163576426607e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,38741,0.0206260605631529,0.00462402173383991,0.0115629779648267,0.0296891431614791,8.23170437033313e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36420,0.0127737804204387,0.00286611416263623,0.00715619666167167,0.0183913641792057,8.39011524688555e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39106,-0.0209231521330106,0.00469674714955344,-0.0301287765461353,-0.0117175277198858,8.45620595941534e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,36791,0.0114044895820005,0.00256204004436644,0.00638289109504226,0.0164260880689587,8.60537208048859e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39184,-0.0103513922949882,0.00232719247169797,-0.0149126895395162,-0.00579009505046017,8.72765968213349e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39093,0.0152259236775314,0.00342775412769979,0.00850752558723986,0.021944321767823,8.97738703532745e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39241,0.0150822244243757,0.00339604138650506,0.00842598330682578,0.0217384655419256,9.01160825059727e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39093,0.0215320554133999,0.00485024158094968,0.0120255819147385,0.0310385289120613,9.08533693632263e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39255,-0.0142085906498965,0.0032052258420036,-0.0204908333002235,-0.0079263479995694,9.35973282804553e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39099,-0.0212044080460043,0.00478540164219952,-0.0305837952647154,-0.0118250208272933,9.44245042190286e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,36747,0.00859047017175112,0.00193920485058825,0.00478962866459815,0.0123913116789041,9.50570614056801e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36391,0.015936849935821,0.00360064669433468,0.00887958241492502,0.022994117456717,9.6759534704102e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36452,0.0266906561657639,0.00603061907874719,0.0148706427714194,0.0385106695601084,9.68679660364625e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36420,0.0232909722038031,0.00526271996803628,0.012976041066452,0.0336059033411542,9.69613919032354e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39241,0.0139525900440584,0.0031617177030329,0.00775562334611393,0.0201495567420029,1.02652112480698e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,38741,0.0179515064393047,0.00407157336936216,0.00997122263535488,0.0259317902432545,1.04584000787877e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,36747,0.0356522403389032,0.00808612962226348,0.0198034262792668,0.0515010543985396,1.0466025700398e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,36779,0.005871148546236,0.00133166896578229,0.00326107737330271,0.00848121971916929,1.04752922721404e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36391,0.0147054435321584,0.00333865173009326,0.00816168614117565,0.0212492009231412,1.06855663611222e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",38741,0.0121638483110556,0.0027657745514446,0.00674293019022419,0.017584766431887,1.10016520077209e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39283,0.0128142227841844,0.00292180385260392,0.00708748723308067,0.018540958335288,1.16367019190767e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,36731,0.0210156397133847,0.00480738648128379,0.0115931622100685,0.0304381172167009,1.24346195777794e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,38841,0.0165592419125133,0.00379078754442206,0.00912929832544609,0.0239891854995806,1.26067103349745e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39255,-0.0176836435153483,0.00405115415074434,-0.0256239056508072,-0.00974338137988942,1.27900103204515e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39140,0.0226364507973913,0.00518662223676063,0.0124706712133405,0.0328022303814421,1.28313800636092e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,36571,0.0109902003106677,0.00251829073092408,0.00605435047805653,0.0159260501432789,1.28624879249093e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39241,-0.0123174605239578,0.00282416714868467,-0.0178528281353798,-0.00678209291253586,1.30044383313834e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,36767,0.0271227101237317,0.00623711685314906,0.0148979610915596,0.0393474591559039,1.38061495598142e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39095,0.0205507190135979,0.00473002748109617,0.0112798651506494,0.0298215728765464,1.40345817025617e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,36608,0.00322672543218112,0.000742864733614454,0.00177071055429679,0.00468274031006545,1.4123430443879e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39147,0.0105168652372547,0.00242195055335019,0.00576984215268837,0.0152638883218211,1.41898340850607e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38684,0.0345862952954515,0.00797486875438283,0.0189555525368612,0.0502170380540419,1.45453594456529e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36430,0.0181906220244322,0.00419510857279001,0.00996820922176382,0.0264130348271007,1.46128922187673e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,38664,0.0465671437544981,0.010743530405963,0.0255098241588107,0.0676244633501855,1.47098803383641e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39106,0.0302644349589345,0.00700725910995043,0.0165302071034316,0.0439986628144373,1.57720090203711e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39093,0.0199945864816012,0.00463272715036893,0.0109144412668781,0.0290747316963243,1.59925664273353e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39291,0.0104938281189409,0.00243214750593115,0.00572681900731587,0.015260837230566,1.60861539106056e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39283,0.0287212641252516,0.0066635492631292,0.0156607075695184,0.0417818206809848,1.64114405977079e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36430,0.0250467289102089,0.00582094007541112,0.0136376863624031,0.0364557714580147,1.69877237062515e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,38841,0.0202504902728365,0.00471086685473386,0.0110171912375581,0.0294837893081149,1.72907037234685e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,38700,-0.0110966974711819,0.0025822416207879,-0.0161578910479262,-0.00603550389443763,1.73983278706319e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,38727,0.017339631000916,0.00403790301502492,0.00942534109146722,0.0252539209103649,1.76422841665283e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39244,-0.0206553128091625,0.00481557028187498,-0.0300938305616374,-0.0112167950566875,1.80349692670521e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39147,0.0107910502180909,0.00251769578017274,0.00585636648895229,0.0157257339472294,1.82965376094487e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39283,0.00916588969916867,0.00214002828375188,0.00497143426301498,0.0133603451353224,1.85448219997824e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39237,0.0256190464243274,0.00598238676288008,0.0138935683690824,0.0373445244795723,1.8599962920103e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39241,0.0105664886016422,0.00246742014115625,0.00573034512497598,0.0154026320783085,1.86006669840328e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39283,0.0125104126879362,0.00292472232898425,0.00677795692312709,0.0182428684527454,1.90167543745637e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39124,-0.01512521815381,0.00353845251426183,-0.0220605850817631,-0.00818985122585678,1.92704138717925e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,36765,-0.0189211825498593,0.00442751148986083,-0.0275991050699866,-0.0102432600297321,1.93767248646297e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36430,0.0201743935746489,0.00472712590478176,0.0109092268012766,0.0294395603480211,1.98863435433342e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,38832,0.0126008496915298,0.00295302334442372,0.00681292393645929,0.0183887754466003,1.99246453920446e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39180,-0.0093520277034888,0.00219174795288334,-0.0136478536911402,-0.00505620171583745,1.99374521281963e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36421,0.0207080805546279,0.00485460933599519,0.0111930462560773,0.0302231148531785,2.00777056586736e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39099,0.0382065135718258,0.00896958191171452,0.0206261330248653,0.0557868941187862,2.06054028660005e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39093,-0.0130928931789196,0.0030739886720535,-0.0191179109761444,-0.00706787538169469,2.06342283839373e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36430,0.0176670351544413,0.00414861263508353,0.00953575438967756,0.025798315919205,2.07261445949644e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39046,0.0180327470754976,0.00423978683490085,0.00972276487909197,0.0263427292719033,2.11979269073887e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39023,0.0162655488605518,0.00382971381066185,0.00875930979165454,0.023771787929449,2.17752097187291e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,38841,0.0442853054326508,0.0104381654593318,0.0238265011323604,0.0647441097329412,2.22240076243165e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,36743,0.0420737839370332,0.00991904719332506,0.0226324514381161,0.0615151164359503,2.23366342530761e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36420,0.029963260999517,0.00706431280747441,0.0161172078968671,0.0438093141021668,2.23624477926836e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39241,0.0274160733511088,0.00646697523577488,0.01474080188899,0.0400913448132275,2.25429238406632e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,38987,0.0396197563469175,0.00935872502984765,0.0212766552884161,0.0579628574054189,2.31484880430697e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39084,0.0085942618825463,0.00203110651906964,0.00461329310516981,0.0125752306599228,2.33683620967716e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39241,0.0176456407256126,0.00417225860573683,0.00946801385836841,0.0258232675928568,2.35798438375069e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,38727,0.0170568164959543,0.00404284285657463,0.00913284449706806,0.0249807884948406,2.46826018118263e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39106,-0.0216284689912849,0.00512755444231433,-0.031678475698221,-0.0115784622843488,2.47807116862456e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,36806,0.0116310547170427,0.00275990606610703,0.00622163882747291,0.0170404706066125,2.52260076765557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36155,0.0191595819042562,0.00455794145241763,0.0102260166575176,0.0280931471509947,2.6460714080752e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39191,-0.0128036641427093,0.00304814018854602,-0.0187780189122595,-0.00682930937315907,2.67850498536174e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,38705,0.0173147080193531,0.00412345019531072,0.00923274563654407,0.0253966704021621,2.69561124445974e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,36747,0.0212193191814855,0.00505770116330675,0.0113062249014043,0.0311324134615667,2.74157162415327e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39093,-0.0156812403647196,0.00373788895121978,-0.0230075027091104,-0.00835497802032885,2.74158765055963e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39093,0.017186164538647,0.00409861620497682,0.00915287677689241,0.0252194523004016,2.76646631639443e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39023,0.0176620880479682,0.00422078957257169,0.0093893404857277,0.0259348356102087,2.87346189202705e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39114,-0.0244037438166625,0.00583897997016233,-0.0358481445581806,-0.0129593430751443,2.93839417381924e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39086,0.0688466611822026,0.016474566542455,0.0365565107589908,0.101136811605414,2.94471261305899e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36421,0.0189283713910621,0.00453192138878852,0.0100458054690365,0.0278109373130876,2.97796613050248e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36420,0.0265016508375011,0.00634549676056782,0.0140644771867882,0.0389388244882141,2.98093243113087e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36363,0.0211109308982388,0.00505494717147798,0.0112032344421419,0.0310186273543356,2.98310480865534e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39165,0.0158061794853244,0.003788418324767,0.00838087956878109,0.0232314794018677,3.03288019906174e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36499,0.0201173709684077,0.00482295379394619,0.0106643815322732,0.0295703604045423,3.05060622576651e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39165,0.0145966174371529,0.003509415298823,0.00771816345145982,0.021475071422846,3.21002748655206e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,36747,0.0909585929497895,0.0218711016690735,0.0480912336784054,0.133825952221174,3.21927859050291e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,38841,0.0149916682207885,0.00360701351225986,0.00792192173675921,0.0220614147048178,3.25304106168006e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,36731,0.024300633675305,0.00585467228126508,0.0128254760040255,0.0357757913465846,3.3368154940725e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39108,-0.0103320670008475,0.00249124055179028,-0.0152148984823564,-0.00544923551933855,3.3815464587741e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,38905,0.0142289111769623,0.00343586067961142,0.00749462424492394,0.0209631981090007,3.47235717500524e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39099,0.0280543568124907,0.00677674633953423,0.0147719339870036,0.0413367796379778,3.49482888826747e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,38841,0.0268527417139217,0.00649114480613173,0.0141300978939035,0.0395753855339399,3.54063713857144e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36500,0.0263354930277108,0.00636784196022122,0.0138545227856772,0.0388164632697443,3.56159683149196e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36538,0.0402309640763749,0.00972928372907799,0.0211615679673821,0.0593003601853678,3.57180870066064e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",38951,0.0276223062520903,0.00668930000953479,0.0145112782334021,0.0407333342707785,3.65784551987348e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39182,-0.010463389093493,0.00253476984866738,-0.0154315379968811,-0.00549524019010493,3.67957810102474e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39099,0.0172138182266649,0.00418133012860617,0.00901841117459678,0.025409225278733,3.86145333827968e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,38741,0.013969906948369,0.00340093626249053,0.00730407187388755,0.0206357420228504,4.01817008890445e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39255,0.0149771594835381,0.00364894689420462,0.00782522357089703,0.0221290953961791,4.07251474872057e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36538,0.0143375813154341,0.00349888747421992,0.00747976186596306,0.0211954007649051,4.19773752841337e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39237,0.0447202265460195,0.0109252502352942,0.0233067360848428,0.0661337170071961,4.27465911270183e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,36806,0.00996752496273716,0.00243709393050829,0.00519082085894091,0.0147442290665334,4.34128140365962e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,36731,-0.0141186535001105,0.00345366975218255,-0.0208878462143883,-0.0073494607858327,4.37722926590212e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39023,0.0105711642713097,0.00258751776670068,0.00549962944857641,0.0156426990940431,4.4218429013242e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36500,0.0207038669324763,0.00506748082033147,0.0107716045246267,0.030636129340326,4.42281004018118e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,38674,0.0112411263140903,0.00275217543569706,0.00584686246012407,0.0166353901680565,4.44134339549045e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,38811,0.0201786609007051,0.0049408713794372,0.0104945529970082,0.029862768804402,4.44920691851714e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,36767,0.029124484183927,0.00713867713206289,0.0151326770050838,0.0431162913627703,4.53424298210758e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,36743,0.0283137463957675,0.00694569559589807,0.0147001830278073,0.0419273097637277,4.60039929024975e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36549,0.00933625878855483,0.00229056148170996,0.00484675828440331,0.0138257592927063,4.61022098865378e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,38727,0.0146684768092268,0.00359909456348067,0.00761425146480473,0.021722702153649,4.61339761951555e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39255,-0.0221990758107447,0.00546309979846725,-0.0329067514157405,-0.0114914002057489,4.85909540555204e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36538,0.020019479786931,0.0049314511805544,0.0103538354730444,0.0296851241008176,4.94623337513927e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36500,0.0182928910287428,0.00450703088680408,0.00945911049060677,0.0271266715668788,4.96340105875048e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,36792,-0.0100253871810244,0.00247057520709449,-0.0148677145869296,-0.0051830597751192,4.98035607528801e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39117,-0.00985317646781586,0.00242861468007454,-0.014613261240762,-0.00509309169486976,4.99292377954694e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39023,0.02923619654058,0.00720636611906869,0.0151117189472053,0.0433606741339546,4.99568942882521e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36490,0.0177703613593925,0.00438061438631334,0.00918435716221837,0.0263563655565667,5.00934778199392e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36420,0.0333332047467977,0.0082259623093851,0.0172103186204029,0.0494560908731925,5.10447677985643e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,36731,0.015429947034051,0.00381766633490948,0.00794732101762845,0.0229125730504736,5.33687002135557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36500,0.0162057360940666,0.00401090287908921,0.00834436645105174,0.0240671057370815,5.36710041852796e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,38741,-0.018503536068961,0.00457995197713164,-0.027480241944139,-0.00952683019378299,5.36931412754099e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,36792,0.01185477048958,0.00293492582998515,0.00610231586280916,0.0176072251163509,5.39421773076624e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39099,0.0172040583501572,0.00426012235978288,0.00885421852498273,0.0255538981753316,5.40815911814345e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39106,-0.014377154243941,0.00356758379858395,-0.0213696184891655,-0.00738468999871641,5.60615881930973e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39123,0.0108864438591753,0.00270204997415504,0.00559042590983142,0.0161824618085192,5.62962514392935e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,38841,0.0218012681638471,0.005426401249565,0.0111655217146997,0.0324370146129945,5.90737202017004e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39246,-0.0227564449737267,0.00567360639365605,-0.0338767135052926,-0.0116361764421609,6.07655146020562e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36421,0.029576065666346,0.00737899862379553,0.0151132283637067,0.0440389029689852,6.15520418550361e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36391,0.0206775629611138,0.00516818347603151,0.0105479233480921,0.0308072025741356,6.3455598570247e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,36743,0.0184211354217727,0.00460678628235868,0.00939183430834965,0.0274504365351957,6.4047980582597e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39106,-0.00640357407824586,0.00160300998632782,-0.00954547365144838,-0.00326167450504334,6.5075258989413e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,36747,0.0242017141428155,0.00606407653488569,0.0123161241344395,0.0360873041511914,6.61603432451527e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39260,-0.0129848121869544,0.0032537382466663,-0.0193621391504203,-0.00660748522348842,6.61734797891944e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,36767,0.0342765097042663,0.00859409165072818,0.017432090068839,0.0511209293396935,6.68927481215924e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,38727,0.0201286386217099,0.00505023704750379,0.0102301740086025,0.0300271032348174,6.76078735250874e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,38727,0.0224006992052262,0.00562261421604111,0.0113803753417856,0.0334210230686668,6.80775206904922e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,38909,-0.0138403925162886,0.00347601374728336,-0.020653379460964,-0.00702740557161326,6.87499182591197e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36391,0.0245174053517766,0.00617406473109141,0.0124162384788375,0.0366185722247158,7.19620214992825e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,36767,-0.00929178500849504,0.00234492750833289,-0.0138878429248275,-0.00469572709216259,7.45668098966735e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39291,-0.00325769841625502,0.000822622812809201,-0.00487003912936106,-0.00164535770314899,7.52432921034606e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,36779,0.00680964564501806,0.00171975156319109,0.00343893258116352,0.0101803587088726,7.54563506937396e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",36750,0.0146432705843158,0.003702779009941,0.00738582372483143,0.0219007174438001,7.70500903702222e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",36731,0.0132196576886575,0.00334868684732062,0.00665623146790912,0.0197830839094059,7.93207718212261e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,36747,0.0138959516597636,0.00352144601888568,0.00699391746274766,0.0207979858567795,7.98583763219506e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39099,-0.0124612568839854,0.00316171604759449,-0.0186582203372706,-0.00626429343070015,8.14045687768122e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39099,0.0269919021166739,0.00686651789755535,0.0135335270374654,0.0404502771958824,8.4986751046904e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39241,0.0169476131156749,0.00431151314419428,0.00849704735305408,0.0253981788782957,8.50411905797423e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,38974,-0.0100704595375788,0.00256848969076954,-0.0151046993314871,-0.00503621974367049,8.86557200700242e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39283,0.00561676745882774,0.00143323267113315,0.00280763142340676,0.00842590349424871,8.93194476440378e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39255,0.0118093810728398,0.0030165850732815,0.00589687432920804,0.0177218878164715,9.08622334977961e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39283,-0.00604807626082305,0.00154492790565541,-0.00907613495590766,-0.00302001756573844,9.08700654045998e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39093,-0.0112234005676753,0.00286751500893207,-0.0168437299851821,-0.0056030711501684,9.11815593699792e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,36796,0.00886700950972446,0.00226791880375694,0.00442188865436087,0.0133121303650881,9.28608207807537e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,36679,-0.0101589632022817,0.00260006644372303,-0.0152550934319788,-0.00506283297258453,9.38539776919692e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39093,0.00983513532398434,0.002528169982454,0.0048799221583745,0.0147903484895942,0.000100579502300652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39162,-0.0151976707259136,0.00390725080781793,-0.0228558823092368,-0.00753945914259046,0.000100831296832326
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,38727,0.0203774448988167,0.00524764620065529,0.0100920583455323,0.0306628314521011,0.000103554140769917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36363,0.0228816695952702,0.00591703784997359,0.0112842754093219,0.0344790637812184,0.000110703427883313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,38705,0.0168181217195518,0.00436394756262166,0.00826478449681329,0.0253714589422902,0.000116751040552467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,36791,0.0141447454298349,0.00367109869095879,0.00694939199555566,0.0213400988641141,0.000117242740236852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39057,0.0142585447458015,0.00370875702929844,0.00698938096837654,0.0215277085232264,0.000121260343296321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39099,0.013059753524183,0.00340243871539178,0.00639097364201511,0.0197285334063509,0.000124363756627003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,38727,0.0102205540984989,0.0026643471261814,0.00499843373118338,0.0154426744658145,0.0001255483117172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39291,0.0293370002498843,0.00764968178405324,0.01434362395314,0.0443303765466287,0.000126032017009528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39062,0.00786802261894846,0.00205353311495812,0.00384309771363054,0.0118929475242664,0.000127899283369964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,38727,0.0224027552961311,0.00586352482854162,0.0109102466321896,0.0338952639600727,0.000133616246081455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36507,0.0227889666083989,0.00597975882074433,0.01106863931974,0.0345092938970578,0.000139051741661306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,38727,0.0161608449846964,0.00424127029149098,0.00784795521337409,0.0244737347560187,0.00013931310549796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39106,0.0184886402487667,0.00487877947667196,0.00892623247448968,0.0280510480230437,0.000151468422382982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36421,0.0214926695417942,0.00567594816174919,0.0103678111447658,0.0326175279388226,0.000153420438025838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39023,0.0328691457435431,0.00868110722851506,0.0158541755756535,0.0498841159114326,0.000153505932474227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39283,0.00921302897699327,0.00243503507575941,0.00444036022850482,0.0139856977254817,0.000155204018436098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36420,-0.0225227943855166,0.00595298152835825,-0.0341906381810988,-0.0108549505899344,0.000155388977959478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,36806,0.00804491785268641,0.00212969146624079,0.00387072257885446,0.0122191131265184,0.000159117340476794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39274,0.00670890437391075,0.00177645647129764,0.00322704969016738,0.0101907590576541,0.000159602999191495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39095,-0.0117154349838449,0.00310394262724633,-0.0177991625332477,-0.00563170743444209,0.000161019400013747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39086,0.013156079247293,0.00348680621516681,0.00632193906556607,0.01999021942902,0.000161840659896371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36391,0.020776626198648,0.00550693856364462,0.00998302661390453,0.0315702257833914,0.000162163294797442
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,36747,0.0130926763614986,0.00347511068174737,0.00628145942527372,0.0199038932977234,0.000165587375989762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,36792,0.0274414787223371,0.00729382976622959,0.0131455723805271,0.0417373850641471,0.000169110227414671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,36743,0.00734747625630652,0.00195414834935048,0.00351734549157958,0.0111776070210335,0.000170707050532725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39147,0.0124415128862953,0.00330917477582377,0.0059555303256807,0.0189274954469099,0.000170749062480452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39099,0.00945817727219017,0.00252089730243075,0.0045172185594259,0.0143991359849544,0.000176143728435646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36420,0.0195526844488331,0.00521905771520623,0.00932333132702892,0.0297820375706373,0.000180192168529365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,38939,0.0229481255484575,0.0061422147917,0.0109093845567255,0.0349868665401895,0.000187561645358729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39274,0.0178859811590178,0.00479137671560115,0.00849488279643959,0.0272770795215961,0.00018992885444706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39106,-0.0120291921643155,0.00322630108689084,-0.0183527422946216,-0.00570564203400947,0.000193336991946339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39023,0.0138324117719267,0.00371305115045756,0.00655483151702986,0.0211099920268235,0.000195752597199081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,36703,0.0153245026381158,0.00411529300085814,0.00725852835643382,0.0233904769197977,0.000197090550198644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39001,0.0179379387329836,0.00481872180923794,0.00849324398687729,0.02738263347909,0.00019793428991723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39162,0.00684255032778932,0.00184164982346968,0.00323291667378876,0.0104521839817899,0.000203567481237111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39037,0.0101493324152601,0.0027332887108152,0.00479208654206236,0.0155065782884579,0.000205362483224566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39093,0.0133748355261011,0.00361213004251398,0.0062950606427737,0.0204546104094285,0.000214022761020894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,36792,-0.0115566392346385,0.00312284091148386,-0.0176774074211469,-0.00543587104813018,0.00021591344645047
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,36792,0.0181208489180198,0.00490951072780839,0.00849820789151532,0.0277434899445242,0.00022431968806407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36430,0.0203373130712391,0.00551289330304258,0.00953204219727562,0.0311425839452025,0.000226046710286552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",36806,0.00550467915572011,0.0014928733299677,0.00257864742898343,0.0084307108824568,0.000227568355918189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39073,-0.0245647043872593,0.00667230764840075,-0.0376424273781248,-0.0114869813963939,0.000232585076610582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39117,-0.009965502472688,0.00271214754686748,-0.0152813116645483,-0.00464969328082775,0.000239229398638179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39106,0.0212955624119106,0.00579657289014461,0.00993427954722719,0.032656845276594,0.000239769640827254
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39161,0.0269370565637248,0.00734871467732235,0.012533575796173,0.0413405373312766,0.000247645632919104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36230,0.0109845474224132,0.00299725664275872,0.00510992440260613,0.0168591704422203,0.000248501939772816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36420,0.0154143719224566,0.00420888383470265,0.00716495960643946,0.0236637842384738,0.000250946629574659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39093,0.0300107483213514,0.00819494298610197,0.0139486600685915,0.0460728365741112,0.000250997409798463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39283,0.0194728239635662,0.00533409433193543,0.00901799907297278,0.0299276488541597,0.000262458698576585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,38990,0.0219511120170643,0.00602063920746568,0.0101506591704316,0.0337515648636971,0.000267270896913005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36531,0.0145948558860038,0.00400450510759464,0.00674602587511828,0.0224436858968893,0.000268869293932334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,36747,0.0321121550757223,0.00881471059731702,0.0148353223049809,0.0493889878464636,0.00027051694337382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36339,0.0189569304158882,0.00520460987402835,0.0087558950627926,0.0291579657689837,0.000271271011191468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,36767,-0.0149435752740974,0.00410441319029112,-0.022988225127068,-0.00689892542112682,0.000272796173071444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,38741,0.0201724249140522,0.00554563550456688,0.0093029793251011,0.0310418705030033,0.000276193534722256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39255,0.0179075043010777,0.00492504892303261,0.0082544084119338,0.0275606001902216,0.000277801601828904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",38741,0.0167933553834257,0.0046192277974051,0.00773966890051176,0.0258470418663397,0.000278341927680235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,36702,0.0320437105046465,0.00882036438995071,0.0147557963003432,0.0493316247089499,0.000281320269802248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,36731,0.0267158735407829,0.00736156056812296,0.0122872148272619,0.0411445322543039,0.00028550771559497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,36731,0.0118685663080929,0.00328337101166442,0.00543315912523063,0.0183039734909552,0.000301784707971112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39283,0.0132280009825133,0.00366193667944132,0.00605060509080827,0.0204053968742182,0.000304461323773143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39034,0.0105909365046196,0.00293864423886896,0.00483119379643644,0.0163506792128028,0.000314334301111825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36391,0.00918326350129025,0.00254948495245731,0.00418627299447392,0.0141802540081066,0.000316991123102435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39117,-0.0104779596459404,0.00290952237424122,-0.0161806234994532,-0.0047752957924276,0.000317678455307283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39093,0.0116417207706598,0.00323441086762861,0.00530227547010773,0.0179811660712119,0.000320047135680934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39255,-0.0122146542896515,0.00339700742494006,-0.0188727888425341,-0.00555651973676901,0.000324519643297699
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],38739,0.0158402028272604,0.00441899126610492,0.00717897994569473,0.024501425708826,0.000338708435412345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39145,0.00875512143508764,0.00244269482608921,0.00396743957595279,0.0135428032942225,0.000339157617452829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39106,0.00917598912333144,0.00256310232683425,0.00415230856273631,0.0141996696839266,0.000344619204443867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39023,0.0124492313950434,0.00347902350066346,0.00563034533374298,0.0192681174563437,0.000346822790695572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39237,0.0173168342537974,0.00485391271920257,0.00780316532416034,0.0268305031834344,0.000361357080522631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39098,-0.00707506486938968,0.0019877626660423,-0.0109710796948326,-0.00317905004394678,0.000372960570829873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,36731,0.0143075243238225,0.00402110913267884,0.00642615042377196,0.022188898223873,0.000374885289488993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,38741,0.0164192813489484,0.00461518627940431,0.00737351624131591,0.0254650464565808,0.000375331247931423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39093,-0.0108049674685615,0.00303725316850849,-0.0167579836788382,-0.0048519512582849,0.000375566757763457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36500,0.00884029284002985,0.00248694965614437,0.00396587151398688,0.0137147141660728,0.000379830802349987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36500,0.0173775043423427,0.00488895109253497,0.00779516020097413,0.0269598484837112,0.000380160985614373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,36743,0.0108755436940436,0.00306502067898135,0.00486810316324017,0.0168829842248471,0.000389138874662818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39023,-0.00672012096162275,0.00189407833850258,-0.0104325145050878,-0.0030077274181577,0.000389394618804956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39139,-0.0124249050093408,0.0035128762543924,-0.0193101424679499,-0.00553966755073167,0.000405959372705428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39093,0.0146146363863981,0.00413350676908717,0.00651296311898722,0.0227163096538089,0.000407979360571206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,36791,-0.0187733638129008,0.00531484426332945,-0.0291904585690265,-0.00835626905677511,0.000413473822750975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39264,0.0130804043711368,0.00370408341506248,0.00582040087761432,0.0203404078646592,0.000414656732333437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,38840,0.0169798322973522,0.00482501117869769,0.00752281038710471,0.0264368542075997,0.000434251743691855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,38949,0.0146138444560356,0.0041554052205169,0.00646925022382246,0.0227584386882487,0.000438019856647808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36538,0.0269950496777162,0.00769357944749032,0.0119156339606352,0.0420744653947972,0.00045173383219783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,36743,0.0128961147971062,0.00369303363100903,0.00565776888032854,0.0201344607138839,0.000481004559010225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39057,0.00906713871663967,0.002597472690261,0.00397609224372811,0.0141581851895512,0.000483025328658744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36500,0.0168684131240812,0.00483346952650198,0.00739481285213733,0.0263420133960251,0.000484814987552465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36391,0.0137228395390985,0.00393712319405294,0.00600607807875469,0.0214396009994422,0.000492900350302577
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,36743,0.0217230895530158,0.00623631471047952,0.00949991272047594,0.0339462663855557,0.000496877230302199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39106,-0.00977391180527265,0.00280665992747727,-0.0152749652631281,-0.00427285834741719,0.000498333744906147
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,36763,0.0228989644357168,0.0065758697057598,0.0100102598124276,0.035787669059006,0.000498825273240736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,38677,0.0146809114631363,0.00421765091455632,0.00641431567060593,0.0229475072556667,0.000501307846770043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,38727,-0.00969791930897821,0.0027870965758812,-0.0151606285977054,-0.00423521002025107,0.00050364334752373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39093,0.0177861843048975,0.00511366579967075,0.00776339933754279,0.0278089692722521,0.000506264492232526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,38727,0.0128286978819933,0.00368912873433931,0.00559800556268823,0.0200593902012983,0.000507686619512422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,36806,-0.00607808247298074,0.0017530880101219,-0.00951413497281967,-0.00264202997314182,0.00052786902008805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,36747,0.020062503239844,0.00579861270563161,0.00869722233680601,0.0314277841428819,0.000542165419575187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36421,0.0166794299879356,0.00486912103908089,0.00713595275133709,0.0262229072245342,0.000615513154719421
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36391,0.0199279007674125,0.00582662107458726,0.00850772346122148,0.0313480780736035,0.000627868358502292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39023,0.0214137357945201,0.0062791774083762,0.00910654807410271,0.0337209235149374,0.000650660030422247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39136,0.0170423495400096,0.00499785206679397,0.00724655948909339,0.0268381395909257,0.00065146443440678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,38841,0.0110834794151218,0.00325248952022736,0.00470859995547614,0.0174583588747674,0.00065687356845705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,38727,0.0187735376765118,0.00551324410618661,0.00796757922838601,0.0295794961246375,0.00066297470806921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39023,-0.00747840513149827,0.0021971625957309,-0.0117848438191308,-0.00317196644386571,0.000666603050674411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39197,0.0106964974839355,0.00314545522360309,0.00453140524567347,0.0168615897221976,0.000674046653313578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,36743,-0.0246474928638034,0.00724983377604208,-0.0388571670648458,-0.0104378186627609,0.000676564538492695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39076,0.0197291031532379,0.0058076069891976,0.00834619345441057,0.0311120128520652,0.000682749173785485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,36767,0.018143164924369,0.00534491114812099,0.00766713907405186,0.0286191907746862,0.000689673703701665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,38841,0.0185186842853922,0.00545901793137644,0.00781900913989443,0.0292183594308901,0.000694850917603567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36420,0.0230456247761817,0.00683323248249458,0.00965248911049238,0.0364387604418711,0.000746922296008014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39099,0.028356828686519,0.0084103867794758,0.0118724705987464,0.0448411867742916,0.000749067358572373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,36747,0.0182245853701966,0.0054070497202362,0.00762676791853362,0.0288224028218595,0.000752459209221101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,36686,0.0188708151662381,0.00559918977302051,0.00789640321111793,0.0298452271213583,0.000753143787639104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36420,0.0155714385095253,0.00462895705499127,0.00649868268174238,0.0246441943373082,0.000770737890804211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36500,-0.0288829909323833,0.00859287668303533,-0.0457250292311325,-0.012040952633634,0.000778144235298461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,38741,0.026103189551165,0.00776722415704906,0.0108794302033488,0.0413269488989811,0.000779451193065859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,36772,-0.0109670999498294,0.00326393211284097,-0.0173644068909977,-0.00456979300866105,0.00078143285493777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38578,0.0123921360661355,0.00368856334193925,0.0051625519159346,0.0196217202163365,0.000782506633866977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36430,0.0102422448047594,0.00305245077576906,0.00425944128425204,0.0162250483252667,0.000794800616399461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39162,0.0103424384449807,0.00308399908744185,0.00429780023359467,0.0163870766563667,0.000799668410031479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,36725,0.0128129095386159,0.00382786927193629,0.00531028576562077,0.020315533311611,0.000818457967200763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39099,-0.0118349597184864,0.00354380818703836,-0.0187808237650816,-0.00488909567189124,0.000840954691555591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,36791,0.00699148239124036,0.0020959787586459,0.00288336402429439,0.0110996007581863,0.000853352879016741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39291,0.00788030323031417,0.00236444173392113,0.00324599743182876,0.0125146090287996,0.000861668597227785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36421,0.0177514716450131,0.00533324964457174,0.00729830234165251,0.0282046409483737,0.000875807634946951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39106,-0.0113030027287053,0.00339918180099912,-0.0179653990586636,-0.00464060639874703,0.000885595740129064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39023,0.0127707353888376,0.00384488351947209,0.00523476369067233,0.0203067070870029,0.000897503264037842
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39121,0.00709981509174727,0.00213772418970726,0.00290987567992103,0.0112897545035735,0.000898408141357772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,36767,0.0155829164867375,0.00470058895383292,0.00636976213722497,0.02479607083625,0.000918632860417107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,36731,0.0167201747039663,0.00505660759663852,0.00680922381455479,0.0266311255933778,0.000946944705253629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36391,0.0361871992204437,0.0109640738379933,0.0146976144979769,0.0576767839429106,0.000967736982228547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,36731,0.00984872439615419,0.00298623463910504,0.00399570450350831,0.0157017442888001,0.000976259360119667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36420,0.01649030999456,0.00500342331995658,0.00668360028744513,0.0262970197016749,0.00098411996405857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,38841,0.0120150718134963,0.00364746876152973,0.00486603304089806,0.0191641105860946,0.00098971680967395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36430,0.0060793114857293,0.0018471258801651,0.00245894476060571,0.00969967821085289,0.00100026090753385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,36792,0.00883623882020792,0.0026849050371389,0.00357382494741567,0.0140986526930002,0.00100070598143202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,38727,0.014169030827674,0.00430945444105855,0.00572250012319924,0.0226155615321488,0.00101173989018193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36420,0.00918878751049538,0.00279691169360231,0.00370684059103485,0.0146707344299559,0.00102140811514709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36420,-0.0124121861625349,0.0037806215800822,-0.0198222044594961,-0.00500216786557384,0.00102950164654261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,36731,0.0160704690845293,0.00489840057514735,0.00646960395724046,0.0256713342118181,0.00103803711684945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36430,0.0169359952788938,0.00517174983442245,0.00679936560342584,0.0270726249543619,0.00106055540545935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,36767,0.0126204098338404,0.00385549320383332,0.00506364315432714,0.0201771765133538,0.00106557269847783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36391,0.0211147884107323,0.00645647872654824,0.00846009010669773,0.0337694867147668,0.00107713741370015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36420,0.0127831688439119,0.00391103190263997,0.00511754631473759,0.0204487913730863,0.00108413616011167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36391,0.0150047105435285,0.00459776369398366,0.00599309370332053,0.0240163273837365,0.00110347724334499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36430,0.00783201993967298,0.00240640935127309,0.00311545761117773,0.0125485822681682,0.00113832414480811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39086,0.0338776863311435,0.0104174489901542,0.0134594863104414,0.0542958863518457,0.00114839866654688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,38775,0.0265320540338006,0.00816047091958369,0.0105375310314166,0.0425265770361846,0.00115137772228489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",36792,0.0145647294522403,0.00449129503042469,0.00576179119260788,0.0233676677118726,0.00118628219904683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,38923,-0.019824485991527,0.00611796108527436,-0.0318156897186647,-0.00783328226438927,0.00119631856733939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,38714,0.017466997318624,0.0053924309084305,0.0068978327381002,0.0280361618991478,0.00120141851382421
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,36791,-0.0104934638331184,0.00324026629138624,-0.0168443857642354,-0.00414254190200134,0.00120481270842464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39291,0.0145852948136216,0.00450790967917429,0.00574979184243997,0.0234207977848032,0.00121690182483294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,38987,0.0104600904727741,0.00323341653500987,0.00412259406415479,0.0167975868813935,0.00121905630352246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,36796,-0.00758876409160447,0.00234824469865523,-0.0121913237009687,-0.00298620448224023,0.00123374877719636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36538,0.0197961729369878,0.00612756907370866,0.0077861375525188,0.0318062083214567,0.00123814099353209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39147,0.0159437985937747,0.00493746803621592,0.00626636124279146,0.0256212359447578,0.00124423238435356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,38987,0.0153317075672466,0.00475352428206101,0.00601479997440705,0.0246486151600862,0.00126092732650596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39241,0.0131222706429605,0.00407066818840354,0.00514376099368959,0.0211007802922315,0.00126847042903714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,36667,0.00838709354843648,0.00260326676374698,0.0032846906914924,0.0134894964053805,0.00127725487093252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39029,0.0220577379932609,0.00685284828240815,0.0086261553597409,0.0354893206267808,0.00129012720472495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39041,-0.0548556369673916,0.0170459187545572,-0.0882656377263236,-0.0214456362084595,0.00129309370284962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36391,0.00958566774847491,0.0029817616257756,0.00374141496195473,0.0154299205349951,0.00130881453313859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39106,-0.00822391358168917,0.00255942362425845,-0.0132403838852357,-0.0032074432781426,0.00131542455808036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36430,0.00945136619493842,0.00294861003676091,0.00367209052288704,0.0152306418669898,0.00135229252620355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,38931,0.0123938648963182,0.00386740785988841,0.00481374549093694,0.0199739843016995,0.00135486970359226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,36791,0.0173370340535309,0.00541064193663813,0.00673217585772012,0.0279418922493416,0.00135744722149653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36261,0.0157156197597666,0.00491640536258206,0.00607946524910577,0.0253517742704274,0.00139422216576596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,36767,0.0162422669654272,0.00510343039619987,0.00623954338887545,0.026244990541979,0.0014629629177087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36363,0.021102219534817,0.0066325633886577,0.00810239529304792,0.0341020437765861,0.00146817724420739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38602,-0.0173086973369665,0.00544589660798384,-0.0279826546886148,-0.00663473998531818,0.00148446927041408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,36747,0.0140793406572154,0.00443556028079407,0.00538564250685905,0.0227730388075718,0.00150605149225764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36430,0.0205553368086579,0.00647939657340828,0.00785571952477766,0.0332549540925381,0.00151540345963872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39099,-0.0115216732935688,0.00363737307012662,-0.018650924511017,-0.00439242207612064,0.00154016244881123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,36743,0.0103593994365482,0.00327273153920813,0.00394484561970028,0.0167739532533961,0.00155247558033322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39093,0.00822056545775128,0.00260424511348016,0.00311624503533017,0.0133248858801724,0.00159930084204424
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39070,0.0156526692609699,0.0049654886863694,0.00592031143568583,0.0253850270862539,0.00162308881329909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39106,-0.0190895728128144,0.00605628352130542,-0.030959888514573,-0.0072192571110558,0.00162454971655594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39234,-0.0134224373013976,0.00426623989728868,-0.0217842675000834,-0.00506060710271181,0.00165723265389964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39106,0.012580896694811,0.00401071532855843,0.00471989465083649,0.0204418987387855,0.00171115217436268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',36747,0.0116705413916567,0.00372143310397514,0.0043765325078654,0.0189645502754479,0.00171634389650251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39291,0.0142401799320398,0.004542404840321,0.00533706644501062,0.0231432934190689,0.00172209947628105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,38832,0.0151702804720812,0.00484484326956049,0.00567438766374266,0.0246661732804198,0.00174415496262312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,36747,-0.0131933657209598,0.00421373947610077,-0.0214522950941173,-0.00493443634780225,0.0017458087577356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,36743,-0.0325976239001871,0.0104295225707775,-0.053039488138911,-0.0121557596614632,0.0017788873610488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39140,0.0082848327424301,0.00265107972068444,0.00308871648988859,0.0134809489949716,0.00178090328777717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36363,0.0175628601905363,0.00562468447120798,0.0065384786269687,0.028587241754104,0.00179754788248308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36420,0.0124582946125727,0.00399282213465516,0.00463236322864862,0.0202842259964968,0.00181154425125982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39162,0.0107938552683132,0.00347535103657768,0.00398216723662095,0.0176055433000055,0.00190091506206147
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,36731,0.00609303479172471,0.00197079228184381,0.00223028191931086,0.00995578766413857,0.00199460875343597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,36743,0.013579276339656,0.00439450962717091,0.00496603747040099,0.022192515208911,0.00200545888386205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39086,-0.0137324680240113,0.00444930416724698,-0.0224531041918154,-0.00501183185620722,0.00202938949469085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",38741,0.00767604457303061,0.00248868591007881,0.00279822018927615,0.0125538689567851,0.00204352956366586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36421,0.012391833857438,0.00402041922927881,0.00451181216805149,0.0202718555468244,0.00205904842879913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39064,0.0281392046680878,0.00913710137267288,0.010230485977649,0.0460479233585267,0.00207603608616022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,38987,0.011867375307783,0.00385374295815335,0.00431403910980247,0.0194207115057636,0.0020776083935968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36430,0.00470167413396529,0.0015274125599968,0.00170794551637157,0.00769540275155902,0.00208706863120185
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39283,-0.00879587388173128,0.00286947294943398,-0.0144200408626219,-0.00317170690084068,0.0021780763410888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39106,0.00733734517062243,0.00239467475091744,0.00264378265882425,0.0120309076824206,0.00218761273525576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,38841,0.018482009323574,0.00603335661853071,0.00665663035125378,0.0303073882958941,0.00219295614802641
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36469,-0.0137191180013111,0.00447924343873538,-0.0224984351412324,-0.00493980086138971,0.00219723782844487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,36608,-0.0170807870242987,0.00558029125842084,-0.0280181578908036,-0.00614341615779387,0.00221122046813813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39062,0.013958733263734,0.00456144594538482,0.00501829921077972,0.0228991673166882,0.00221607675504706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36391,0.0106548762497886,0.00348381010977636,0.00382660843462689,0.0174831440649502,0.00222993611704322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,38987,-0.0306767227198061,0.0100661925958457,-0.0504064602076636,-0.0109469852319486,0.00231151456017693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39147,0.00751975026275702,0.00246778888283853,0.0026828840523935,0.0123566164731205,0.002314079755274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,38832,0.021021873013998,0.00690151614258556,0.00749490137453032,0.0345488446534657,0.00232327471908398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36430,0.0133799325634765,0.00439487105814365,0.00476598528951492,0.021993879837438,0.00233594043944672
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,36796,0.0201945061781166,0.00664859691954682,0.0071632562158048,0.0332257561404284,0.00239097170357333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39095,-0.00975603342212061,0.00321207050180749,-0.0160516916056633,-0.00346037523857792,0.00239108672192121
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,36767,0.010217945060509,0.00337166405103218,0.00360948352048588,0.016826406600532,0.00244604621775076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,36791,-0.0238526807785915,0.00788282504089183,-0.0393030178587395,-0.00840234369844352,0.0024837740915375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,36731,-0.0223812566153116,0.00740407006615562,-0.0368932339449766,-0.00786927928564662,0.0025091437852138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36391,0.0098897466461443,0.00327283464568,0.00347499074061151,0.0163045025516771,0.00251810454535723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36339,0.0100179870830598,0.00331918409714144,0.00351238625266259,0.016523587913457,0.00254787758237363
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,38727,0.0159846460785236,0.00529925452589967,0.0055981072077602,0.0263711849492869,0.00256231973527335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,38727,0.0130482318118689,0.00433018634309399,0.00456106657940463,0.0215353970443331,0.00258842481327181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39166,0.0176704927142129,0.00587570068841127,0.00615411936492679,0.029186866063499,0.00263933927242878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36391,0.0154234944268595,0.0051398016978877,0.00534948309899957,0.0254975057547193,0.00269805144749496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39117,-0.00911616439386784,0.00303847522293188,-0.0150715758308143,-0.00316075295692137,0.00270199875158196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39234,0.00735859090793504,0.00246020978465402,0.00253657973001316,0.0121806020858569,0.00278467854632371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36391,-0.00911178901535663,0.00305598099669212,-0.0151015117688732,-0.00312206626184007,0.0028727426907362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",36755,0.0061856687824911,0.00207693559349532,0.00211487501924027,0.0102564625457419,0.00290422635154162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,38951,0.00872213773748525,0.0029357858682799,0.00296799743565665,0.0144762780393139,0.00297326494128874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36420,-0.0197783266566226,0.0066695718071172,-0.0328506873985724,-0.00670596591467292,0.0030280214572092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,36743,0.0262121871043888,0.00884647537197625,0.00887309537531539,0.0435512788334623,0.00305204341205761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36512,-0.00872590441045373,0.00294647051807343,-0.0145009866258777,-0.0029508221950298,0.00306736160830536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39093,-0.00978426466964385,0.00330461567851725,-0.0162613113995377,-0.00330721793975004,0.00307326585644941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36430,0.00869296333198756,0.00293973616002368,0.00293108045834116,0.014454846205634,0.00311169631585436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39241,0.00687177671323056,0.00232768100068455,0.00230952195188884,0.0114340314745723,0.00315996451127439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,38832,0.0100752925448379,0.00341482639115743,0.00338223281816929,0.0167683522715064,0.00317797294451518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,36792,0.00920901315923164,0.00312223768163031,0.00308942730323624,0.015328599015227,0.00318867396521456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39049,0.0160066472182845,0.00542957401736296,0.0053646821442531,0.0266486122923159,0.00320273582338004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39023,0.0283613339987846,0.00963597218364247,0.00947482851884537,0.0472478394787238,0.00325249972086328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36391,0.0119363600669403,0.00406437025069021,0.00397019437558745,0.0199025257582931,0.00332190219009037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36421,-0.00905018514527429,0.00308691212371033,-0.0151005329077465,-0.00299983738280204,0.00337619906125715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36420,-0.0074979528719248,0.00256484588765997,-0.0125250508117383,-0.00247085493211125,0.00346900500249944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,38832,0.0134307871164832,0.00459818826895476,0.00441833810933187,0.0224432361236345,0.00349557695945291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38502,0.0124921790546536,0.00427728896585104,0.00410869268158554,0.0208756654277216,0.00349909759019552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,36652,0.0115784511860923,0.0039671308157919,0.00380287478714017,0.0193540275850444,0.00352224434605027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36420,-0.0167477431419677,0.00573937364780602,-0.0279969154916675,-0.0054985707922679,0.00352859548633214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39023,-0.00880911014604707,0.00302322664056921,-0.0147346343615627,-0.00288358593053142,0.00357567956430823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,36743,-0.00774180255306367,0.00265794451339715,-0.0129513737993221,-0.00253223130680526,0.00358930699477987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,38677,0.0182559767477508,0.00627219972139561,0.00596246529381538,0.0305494882016862,0.00361251997930059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,38832,0.00986879624913109,0.00339359694494825,0.00321734623703253,0.0165202462612297,0.0036420843220469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36430,0.0119401198914103,0.00410614748392517,0.003892070822917,0.0199881689599037,0.00364542766968638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,38969,0.0251749607817499,0.00867690964365593,0.00816821788018427,0.0421817036833155,0.00372066379053661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36421,0.0178556093783879,0.00615574646200849,0.00579034631285126,0.0299208724439246,0.00373046564770185
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36391,0.0162461246848555,0.00561151568842758,0.00524755393553742,0.0272446954341735,0.00379643773621525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,38841,0.0094246560408675,0.00325557042581027,0.00304373800627937,0.0158055740754556,0.00379787984131052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,36731,0.00773392053173838,0.0026730897740132,0.00249466457467252,0.0129731764888042,0.00381915663342181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,36796,-0.00677832732614909,0.00234295741060066,-0.0113705238509264,-0.00218613080137179,0.00382139330375965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,36767,0.00932557008615112,0.00322536654596059,0.00300385165606837,0.0156472885162339,0.00384266219604137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36421,0.0181009573370411,0.00626567341084475,0.0058202374517854,0.0303816772222968,0.00387242398831853
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,38864,-0.00769746946712727,0.0026666485722371,-0.012924100668712,-0.00247083826554256,0.00390021044911475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,38832,0.0150468067559314,0.00521483010621598,0.00482573974774807,0.0252678737641147,0.00391490065558609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39165,-0.00793459609493184,0.00275035926982674,-0.0133253002637922,-0.00254389192607144,0.00392046256291249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39093,-0.0229483836735104,0.00799801469400401,-0.0386244924737583,-0.00727227487326253,0.0041199920694401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39023,-0.0170680110267876,0.00595382973795653,-0.0287375173131824,-0.00539850474039278,0.00415310283382426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39086,0.00977418195646974,0.00341130672438655,0.00308802077667211,0.0164603431362674,0.00417275447093665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36421,0.0112094819003069,0.0039135892172218,0.00353884703455222,0.0188801167660617,0.00418696091737276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38106,0.01252440048312,0.00437637715965583,0.00394670125019462,0.0211020997160455,0.00421830593913881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,38741,0.0150154559404334,0.00528653145446462,0.00465385428968272,0.025377057591184,0.00451290543486183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39023,0.0100768691248104,0.00354811835071657,0.00312255715740587,0.0170311810922148,0.00451650898226991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36500,-0.00732781800458565,0.0025813284610399,-0.0123872217882238,-0.00226841422094745,0.00453588835405991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,36747,-0.00970232050456165,0.00342175934863394,-0.0164089688278842,-0.00299567218123914,0.00458285441123398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39106,-0.00793163970476029,0.00279741740964519,-0.0134145778276649,-0.00244870158185572,0.00458366587333354
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,38987,0.00754785646746868,0.00266287198024769,0.00232862738618321,0.0127670855487541,0.00459611950862319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36407,0.00723575697706846,0.00255883602179117,0.00222043837435777,0.0122510755797791,0.0046950159730699
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39147,0.00658264287040412,0.0023338723548851,0.00200825305482932,0.0111570326859789,0.00480134506538055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,38960,-0.0132633427771202,0.00470661992285349,-0.0224883178259131,-0.0040383677283274,0.00483838019547426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,36776,0.00634208904711213,0.00225246627626365,0.00192725514563537,0.0107569229485889,0.00487569621670096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39185,0.0101414061727805,0.00360234388119728,0.00308081216563382,0.0172020001799271,0.00488053899883537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,38832,0.0145486207030992,0.00516964851450894,0.00441610961466163,0.0246811317915367,0.00489568098172486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39291,-0.00884071088269215,0.0031432911046919,-0.0150015614478883,-0.00267986031749603,0.00492101417962636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39023,-0.00385565402273289,0.00137175584301767,-0.00654429547504753,-0.00116701257041825,0.00494905263451715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36430,0.00671739800906693,0.00239580542265665,0.00202161938065989,0.011413176637474,0.00505791127916434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36363,-0.012574430105816,0.00448514740477758,-0.02136531901918,-0.00378354119245195,0.00506179452470316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,38841,0.0124827886275728,0.0044534562510925,0.00375401437543147,0.0212115628797141,0.00507035187161587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,36731,-0.0278247136257535,0.00994413823191796,-0.0473152245603127,-0.0083342026911943,0.00514802670878109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,36743,0.00850812497124553,0.00304434253585134,0.00254121360097691,0.0144750363415142,0.00520193659939243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39106,0.0197878886826572,0.00709702958481458,0.00587771069642062,0.0336980666688938,0.0053068600743919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,38841,0.0171098649888306,0.00614779007567182,0.00506019644051388,0.0291595335371474,0.0053910975739691
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36391,0.0112690698063299,0.00405643447250825,0.00331845824021372,0.019219681372446,0.00547637270661702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,36747,0.0165734380399997,0.00596589025106363,0.00488029314791502,0.0282665829320844,0.00547682189924325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",36767,0.0110417388049423,0.00397584581615787,0.00324908100527291,0.0188343966046118,0.00549076830646958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39024,0.0169661077415672,0.00611001275980352,0.00499048273235229,0.0289417327507821,0.00549691740954467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,38741,0.00879185103832023,0.00317011871441178,0.00257841835807315,0.0150052837185673,0.00555513585111252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,36731,0.0123414490881106,0.00445037501746155,0.00361871405388593,0.0210641841223352,0.00556005717547489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36421,0.00926372216721734,0.0033428845746933,0.00271166840081848,0.0158157759336162,0.00559363415247534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,36743,0.0128772138146018,0.00464790244053484,0.00376732503115357,0.0219871025980501,0.00560430852393607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,36677,0.0183032684292149,0.0066139447223074,0.00533993677349237,0.0312666000849374,0.00565906785106238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36391,-0.00927087589887802,0.00335253981161735,-0.015841853929648,-0.00269989786810801,0.00569485932760938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,36631,0.016085263009468,0.00582257247478899,0.00467302095888162,0.0274975050600544,0.00574303279123445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,38832,0.0113884907112339,0.00412568108060212,0.00330215579325378,0.0194748256292141,0.00578025536450836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36363,0.019445627889657,0.00705307217738855,0.00562160642197546,0.0332696493573386,0.0058411173904729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,38727,0.00897893017038089,0.0032575239614151,0.0025941832060073,0.0153636771347545,0.0058518689176734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,38743,0.0094867316047894,0.00344495742311438,0.0027346150554852,0.0162388481540936,0.00589788239584356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,38727,0.013045356805563,0.00473932720690445,0.00375627548003026,0.0223344381310957,0.00592001889551382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,36743,-0.0428789820868952,0.0155790902663399,-0.0734139990089215,-0.012343965164869,0.0059253510434271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36420,0.0128688753125957,0.00469017886433688,0.00367612473849545,0.022061625886696,0.00608201989847979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,36747,0.00896140506722464,0.00327379556938591,0.00254476575122827,0.015378044383221,0.00620281709689139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,36698,0.0120846527248338,0.00441845823434445,0.00342447458551869,0.0207448308641489,0.00624586226187935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36538,0.00897553405206149,0.00328263393702618,0.00254157153549018,0.0154094965686328,0.00626098174702189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,38832,-0.0129484080993747,0.0047404684228062,-0.0222397262080748,-0.00365708999067453,0.00631279241505734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39106,0.00788811508853084,0.00289448947078392,0.00221491572579437,0.0135613144512673,0.00643323388529529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36421,0.00798913906364605,0.00293230249630818,0.00224182617088202,0.0137364519564101,0.00644826453645595
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36430,0.011313376692888,0.00415301254008874,0.00317347211431403,0.0194532812714619,0.00645587752372491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,36747,0.00888379570535223,0.00326310738243658,0.00248810523577652,0.0152794861749279,0.00648780268803092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,38832,0.0143619268611568,0.00528153898972919,0.00401011044128763,0.0247137432810261,0.0065501734222815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",38841,0.0149007493157439,0.00548287755291187,0.00415430931203668,0.0256471893194512,0.00658154166939418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,36747,-0.00667486178336131,0.00245952769014732,-0.01149553605605,-0.00185418751067257,0.00665887808042924
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,36767,0.0166379629026325,0.00613698313894022,0.0046094759503097,0.0286664498549554,0.00671495071093271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36430,0.016056873012236,0.00592446448653294,0.00444492261863144,0.0276688234058406,0.00673205422911291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39023,0.018868817710789,0.00696599742316895,0.00521546276137785,0.0325221726602001,0.00676226027928643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,36724,0.0100497553992191,0.00371442579860747,0.00276948083394847,0.0173300299644898,0.0068270679862134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,38741,0.0139926409448387,0.00517329002597127,0.00385299249393504,0.0241322893957424,0.00684262286300493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,38741,-0.0108642182782821,0.00402239883293174,-0.0187481199908283,-0.00298031656573593,0.00692241288570263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39023,0.00530405884265716,0.00196580975808588,0.00145107171680884,0.00915704596850548,0.00698022023587202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",36747,0.0136526329155217,0.00506453089003968,0.0037261523710439,0.0235791134599995,0.00703247021719478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,36731,-0.00978648027424618,0.00363121521961611,-0.0169036621046938,-0.00266929844379861,0.00704593513691281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,36791,0.0124881746516213,0.00463656505527591,0.00340050714328054,0.0215758421599621,0.00708162731261189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,38652,0.0170398435272452,0.00632979765908389,0.00463344011544083,0.0294462469390497,0.00711039212155371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39023,0.00551275044525999,0.00204816581528933,0.0014983454472929,0.00952715544322709,0.00711978501587371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36430,0.0131104671707871,0.00489060913874809,0.0035248732588409,0.0226960610827334,0.00735546981457755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,36767,0.00716641863026085,0.00267688727755239,0.00191971956625818,0.0124131176942635,0.00743461099630898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36538,0.0112293484203416,0.00419680067155669,0.00300361910409044,0.0194550777365927,0.00746708255144809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39204,0.0252516339538833,0.00943771455475792,0.00675371342655781,0.0437495544812089,0.00746727846757917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39241,0.00610611782476821,0.00228433659251474,0.00162881810343932,0.0105834175460971,0.0075247117801322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39283,-0.00751471522917892,0.00281139790183873,-0.0130250551167828,-0.00200437534157501,0.00752674271499197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36421,-0.00760835405212871,0.00285656883903583,-0.0132072289766389,-0.0020094791276185,0.00774404908252457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36420,-0.0106549323318832,0.00400392856871109,-0.018502632326557,-0.00280723233720949,0.00779803586265309
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,38987,-0.00556879973044541,0.00209851532583876,-0.00968188976908937,-0.00145570969180144,0.0079701221017597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,38727,0.0151463548702895,0.00571481220198488,0.00394532295439913,0.0263473867861798,0.00804893017691951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,38961,-0.03035939794794,0.0114945953108356,-0.0528888047571777,-0.00782999113870226,0.00827006993847643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36466,0.00744815723684225,0.00282427445267651,0.00191257930959629,0.0129837351640882,0.00836977773139048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36420,0.00967288895450376,0.00367030604806048,0.00247908910030523,0.0168666888087023,0.00841303159561348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39191,0.0066836940377941,0.00253786357870014,0.00170948142354184,0.0116579066520464,0.00845720661444792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,36767,-0.00845392777920442,0.0032105644034519,-0.0147466340099702,-0.00216122154843869,0.00846954518391733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36430,0.00898159779557888,0.00342199213768435,0.00227449320571755,0.0156887023854402,0.00868380714846891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36500,0.0165642278819835,0.00633712801985672,0.00414345696306431,0.0289849988009027,0.00896375256182569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39291,0.00954099322946564,0.00365491975085571,0.00237735051778844,0.0167046359411428,0.00905100002292087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,38996,-0.0123046936619165,0.00471477992339945,-0.0215456623117794,-0.00306372501205357,0.00906809236503496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,36806,-0.00787603932575011,0.00301840857111326,-0.0137921201251321,-0.00195995852636813,0.00908227131374973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,38741,0.00922165930483241,0.00354201803886753,0.00227930394865204,0.0161640146610128,0.0092367703184286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36066,0.0116646900700247,0.00448055894857623,0.00288279453081527,0.0204465856092341,0.00924157156741675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39099,0.0117890283659571,0.00453874588074286,0.00289308643970109,0.0206849702922131,0.0094017348917591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36538,0.0175811446698341,0.00678896411067989,0.00427477501290152,0.0308875143267667,0.00961791306028238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,36806,0.00433555621203248,0.00167504493001271,0.00105246814920757,0.00761864427485739,0.00965524689539574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,36778,0.0109621148989454,0.00424580754795091,0.00264033210496163,0.0192838976929292,0.00983762329543622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36500,0.00998799890883277,0.00387351646551071,0.00239590663643177,0.0175800911812338,0.0099332217208554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39099,0.010294945382085,0.00399959292458696,0.00245574324989455,0.0181341475142754,0.0100624346727828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39147,-0.0094499869868127,0.00368815658217227,-0.0166787738878703,-0.00222120008575506,0.01040907427434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39165,0.0099206035789706,0.00388298484017879,0.00230995329222017,0.017531253865721,0.0106316890556644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39099,0.0200073776492369,0.00783494152566141,0.00465089225894057,0.0353638630395333,0.01067093633323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,36747,0.00595267211252641,0.00233282980289838,0.00138032569884559,0.0105250185262072,0.0107314470683633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39092,0.00915889816577329,0.00359645504883541,0.00210984627005589,0.0162079500614907,0.0108861198271157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36500,-0.0175166006742778,0.00688381002322618,-0.0310088683198011,-0.00402433302875445,0.0109518231644836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,38727,-0.0194245352143635,0.00763678279466109,-0.0343926294918992,-0.00445644093682773,0.0109832872888834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39140,0.0191329481730536,0.00752461748778935,0.00438469789698649,0.0338811984491207,0.011009308555172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39162,0.00605908097525154,0.00238357421009722,0.00138727552346098,0.0107308864270421,0.0110313236634696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39023,0.00607180994965362,0.00238920593626814,0.00138896631456806,0.0107546535847392,0.0110523856116258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39042,0.00705248172925432,0.0027865393470435,0.00159086460904906,0.0125140988494596,0.0113866989148221
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39241,0.00554967963047585,0.00219326264111102,0.00125088485389824,0.00984847440705345,0.0114053996199872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,36747,-0.00698201653472641,0.00276591932847214,-0.0124032184185318,-0.00156081465092101,0.0116047276217239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39147,0.00498913240041134,0.00197810634971114,0.00111204395497751,0.00886622084584517,0.0116732026528895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36391,0.0174262907205254,0.00694192611322408,0.00382011553860622,0.0310324659024446,0.0120754885746918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,36731,0.0137101577090451,0.00548777886741963,0.00295411112890259,0.0244662042891875,0.0124911720933632
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39080,0.02847683298505,0.0114012935290388,0.00613029766813393,0.0508233683019661,0.0125112157841501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36339,0.0113182065339532,0.00453211508389493,0.00243526096951916,0.0202011520983873,0.0125258721248151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,38939,0.00678142927981403,0.00271763892401946,0.00145485698873589,0.0121080015708922,0.0125943046951501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39099,0.0104470464031966,0.00420246220190509,0.00221022048746264,0.0186838723189306,0.0129318020573168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,38741,-0.00964543145597662,0.00388210757374099,-0.017254362300509,-0.00203650061144428,0.0129811143367301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36470,-0.00824314417063798,0.00331954369545815,-0.014749449813736,-0.00173683852754001,0.0130331081868614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,36767,-0.00573625635438856,0.00232145955846238,-0.0102863170889748,-0.00118619561980228,0.0134875380311339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36203,-0.00888447991717671,0.00359553733987139,-0.0159317331033246,-0.00183722673102878,0.0134879570669538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,36782,-0.0246881398821033,0.00999842667887887,-0.0442850561727059,-0.00509122359150073,0.0135542901374215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36500,0.0192432011318414,0.00780298714587089,0.0039493463259345,0.0345370559377484,0.0136712496691408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,38705,0.00936706463433605,0.00380640655261793,0.00190650779120491,0.0168276214774672,0.013871426959341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39147,-0.00562666493937476,0.00229051271111476,-0.0101160698531597,-0.00113726002558983,0.0140404672277449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,38727,0.0130797906258183,0.00532996110224124,0.00263306686542542,0.0235265143862111,0.014138597034805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,38727,0.0100227806643295,0.00408527943614661,0.0020156329694821,0.0180299283591768,0.0141631063720783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,36792,0.0164411092541195,0.00670518177357276,0.00329895297791687,0.0295832655303221,0.0142195707342661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39205,-0.0120372458354067,0.00492857501073169,-0.0216972528564408,-0.00237723881437257,0.0146036839258093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,38727,0.00888829838643417,0.00364139954609219,0.00175115527609348,0.0160254414967749,0.0146622290688609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,38727,0.021921188059979,0.00900037590223475,0.00428045129159889,0.0395619248283591,0.0148793661374989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,38987,0.00780817572813637,0.00321287063906982,0.00151094927555951,0.0141054021807132,0.0150987055571617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36430,0.00647797851163984,0.00267168329046466,0.0012414792623291,0.0117144777609506,0.0153358638769551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39095,-0.00491519823580763,0.00202917599620389,-0.00889238318836726,-0.000938013283248002,0.0154357652880589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39023,0.00680533649190474,0.00281414691498814,0.00128960853852799,0.0123210644452815,0.0156066705834342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,36806,0.00483002958868376,0.0019974199274842,0.000915086530814721,0.00874497264655279,0.0156140300786493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36430,0.0128346974940356,0.00531692710907059,0.00241352036025726,0.023255874627814,0.0157956301932724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36363,0.00876971441161539,0.00363418534095994,0.00164671114333392,0.0158927176798969,0.0158310311292072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36339,-0.00672213460711209,0.002786425396426,-0.012183528384107,-0.00126074083011714,0.0158596864300376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39099,0.0183810441485161,0.0076214850493236,0.00344293345184181,0.0333191548451903,0.0158883216711601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36339,-0.0180535099454034,0.0074952248566912,-0.0327441506645182,-0.00336286922628863,0.0160252449197856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,36731,0.00899303610111717,0.00374308507743946,0.00165658934933584,0.0163294828528985,0.0162942435357971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,36767,0.00833065705462287,0.0034812413954839,0.00150742391947442,0.0151538901897713,0.0167248363102748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39095,-0.00536105551337449,0.00224065307358667,-0.00975273553760436,-0.000969375489144624,0.0167401028340148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36420,0.0176377796588922,0.00738314700908806,0.00316681152107955,0.0321087477967048,0.0169124515318887
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,36747,0.00715473566100682,0.00299506606679248,0.00128440617009356,0.0130250651519201,0.0169159292501625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39099,0.0108014276984209,0.00452718529656372,0.00192814451715605,0.0196747108796858,0.0170493530385822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,38727,0.00662185903379931,0.00278904994949735,0.0011553211327845,0.0120883969348141,0.0175979934127369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,38741,0.00831770157652097,0.00350727538170121,0.0014434418283866,0.0151919613246553,0.0177259927766618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,36747,0.0133113330920057,0.00561684437359252,0.00230231811976432,0.024320348064247,0.0178077634087457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39255,-0.00926454255273294,0.00391076724596017,-0.0169296463548149,-0.001599438750651,0.0178493244661383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",38741,0.0107065220470295,0.0045279544597621,0.00183173130589581,0.0195813127881633,0.0180653193644193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39144,0.0325694280509203,0.0137859443566888,0.00554897711181024,0.0595898789900304,0.0181641199643089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39283,-0.00526352689098792,0.00223361665349026,-0.00964141553182882,-0.000885638250147014,0.0184602966160574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39253,-0.0129321018765056,0.00549736599611562,-0.0237069392288922,-0.00215726452411895,0.0186643300097829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39291,0.00619070048499327,0.00263283907500927,0.00103033589797511,0.0113510650720114,0.0187184260573307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,36792,0.00654872709344143,0.00281307850011706,0.00103509323321199,0.0120623609536709,0.0199297061146384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,38713,0.0109054970353074,0.00468642304003324,0.0017201078768422,0.0200908861937725,0.0199764738911343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36472,0.0298714892534033,0.0128382789151987,0.00470846257961384,0.0550345159271928,0.0199942316467249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,38741,0.0165512479806178,0.00712152038834918,0.00259306801945345,0.0305094279417822,0.0201326077311429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36391,0.00777209349374912,0.00334590373940669,0.001214122164512,0.0143300648229862,0.0202021616581916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36421,0.0140350615331705,0.00604427545976547,0.00218828163203021,0.0258818414343108,0.0202465802792064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39017,0.00709841812827322,0.00305966962788306,0.00110146565762242,0.013095370598924,0.0203543630880797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39099,-0.00924149859014649,0.00398799524724758,-0.0170579692747517,-0.00142502790554123,0.0204989784502929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36420,-0.00644212202613329,0.00278237916570219,-0.0118955851909096,-0.000988658861357005,0.0206109885194222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,38727,0.00632899877147565,0.00273554104503265,0.00096733832321166,0.0116906592197396,0.0207022207741667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,38951,-0.00997169660066598,0.00431050429433222,-0.0184202850175571,-0.00152310818377482,0.0207168857500528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36391,0.0169538678281226,0.00733781711638281,0.00257174628001233,0.0313359893762329,0.0208778432383875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39291,0.00732000116689616,0.00318376991241854,0.00107981213855582,0.0135601901952365,0.0215090636108061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39283,0.00858459538308371,0.00373692005309886,0.00126023207900995,0.0159089586871575,0.0216185152312847
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,36767,0.0125022564415799,0.00544586572391929,0.00182835962269808,0.0231761532604617,0.0217070770541936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,38741,0.0135171654174829,0.00589181631174789,0.00196920544645708,0.0250651253885088,0.021791310885555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39023,0.00743751787090995,0.00325442739296725,0.00105884018069414,0.0138161955611258,0.0223058320416202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36430,-0.00902412236451864,0.00394908809450558,-0.0167643350297496,-0.00128390969928771,0.0223226346418198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36420,0.00579980036069495,0.0025385812833001,0.000824181045426759,0.0107754196759631,0.0223492498065679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,36737,0.00663010271218596,0.00290261687785939,0.00094097363158155,0.0123192317927904,0.0223770870991922
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39099,0.0127018819353873,0.0055745587589905,0.0017757467677659,0.0236280171030086,0.0227079117094088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36538,-0.00769301844180667,0.00337841414490468,-0.0143147101658198,-0.0010713267177935,0.0227962792028825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,36792,0.0116490665794277,0.0051167491849636,0.00162023817689904,0.0216778949819564,0.0228231714271658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,36792,-0.00606075300921772,0.00266244479126704,-0.0112791448001011,-0.000842361218334328,0.0228391652784875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39099,0.00821597874529913,0.0036134289370362,0.00113365802870817,0.0152982994618901,0.0229957897166087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36430,0.0179614481562932,0.00790852888609174,0.00246073153955344,0.033462164773033,0.0231547893269787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39227,-0.00873470322779558,0.00384967676434123,-0.0162800696859044,-0.00118933676968677,0.0232855000085823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,36731,0.0108603623456769,0.00480136176240738,0.00144969329135843,0.0202710313999954,0.0237181018131343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36538,0.0145434926283261,0.00643330924647889,0.00193420650522747,0.0271527787514247,0.0237975127192831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,36792,0.0069128335774176,0.00306423957090177,0.000906924018450129,0.0129187431363851,0.0240891236157288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39283,-0.00627118716382574,0.0027852837963844,-0.0117303434047392,-0.000812030922912322,0.0243651594264367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,36712,0.0119423258512059,0.00530981746282556,0.0015350836240678,0.022349568078344,0.0245228114600003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36420,-0.00876480748531275,0.00389935116127926,-0.0164075357614201,-0.0011220792092054,0.0246087443140107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,38727,0.0175337860882356,0.0078024111708799,0.002241060193311,0.0328265119831602,0.0246401525760508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,38741,0.0132676298605084,0.00590831401615975,0.00168733438883529,0.0248479253321815,0.0247451260584749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,36743,0.0123665896924201,0.00550797798617445,0.00157095283951818,0.023162226545322,0.0247712832064277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,36767,0.00788910131248397,0.00353117658574061,0.000967995204432368,0.0148102074205356,0.0254916925232962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,38987,-0.0142752265787888,0.0064069000932339,-0.0268327507615273,-0.00171770239605041,0.0258883611353841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39271,0.0106090754976331,0.00477346929581049,0.0012530756778445,0.0199650753174216,0.0262634252567375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,36743,0.0198866765973303,0.00895669789625197,0.00233154872067641,0.0374418044739841,0.0264148317643214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39283,0.00459073568014303,0.00206794120447923,0.00053757091936373,0.00864390044092233,0.0264363298372084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36391,0.00761068845373082,0.00342930178260829,0.000889256959818561,0.0143321199476431,0.026483386064268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36339,-0.0103569471418964,0.00466795526928905,-0.0195061394697029,-0.00120775481408981,0.0265228063811815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36391,0.00870674756337775,0.0039257114202006,0.00101235317978458,0.0164011419469709,0.0265810406010531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36500,-0.00841107778503397,0.00379304311679408,-0.0158454422939504,-0.000976713276117579,0.0266065755052973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,36743,0.00507007704552573,0.00229059686764557,0.000580507184940408,0.00955964690611106,0.0268854318148972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36339,0.0124916950476455,0.00564362927480276,0.00143018166903213,0.023553208426259,0.0268870505459988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,38727,0.0114351139639513,0.00517774431341047,0.00128673510966678,0.0215834928182358,0.027223754894103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36430,-0.00769919498358043,0.00348667066147499,-0.0145330694800714,-0.000865320487089453,0.0272497405012319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,38727,0.0110653897390224,0.00502026584851276,0.00122566867593737,0.0209051108021074,0.0275294726605434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36391,0.0132249277739406,0.00600950189399047,0.00144630406171927,0.0250035514861619,0.0277776020843329
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39255,-0.0118456985484718,0.00538772978681867,-0.0224056489306364,-0.00128574816630724,0.0279180855721003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36430,0.00776972660176133,0.00354396145842002,0.000823562143258093,0.0147158910602646,0.0283700138959499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,38987,-0.00988880967049874,0.00451220840728171,-0.0187327381487709,-0.00104488119222659,0.0284259367019749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,36747,0.00575276654000513,0.00262962728534964,0.000598697060719832,0.0109068360192904,0.0287112773661034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,38741,0.028307535326137,0.0129484430688925,0.00292858691110776,0.0536864837411662,0.0288184827024138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36421,0.0141102871294771,0.00646549842164964,0.00143791022304377,0.0267826640359104,0.0290986734845171
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39099,-0.00690465833396246,0.00316650371711858,-0.0131110056195149,-0.000698311048410052,0.0292333939782061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39089,-0.0122654461781355,0.00563491390766255,-0.0233098774371541,-0.00122101491911688,0.0295192073067356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,36806,0.00487219887926665,0.00223954861940416,0.000482683585234498,0.00926171417329881,0.0296086632727901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,38888,0.00544015627362747,0.0025088113645015,0.000522885999204535,0.0103574265480504,0.0301423961350774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,36743,0.00505927984456197,0.00234064951697496,0.000471606791291047,0.00964695289783289,0.0306762205019729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36391,0.00934896133232934,0.00434324981451391,0.000836191695882083,0.0178617309687766,0.031374925632601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36421,0.0197730626081656,0.00921541389241878,0.00171085137902484,0.0378352738373065,0.0319199366278247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36430,0.0132655129468289,0.00618808426323653,0.00113686779088529,0.0253941581027725,0.0320745483806744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36500,-0.0103657242463046,0.00483622891119342,-0.0198447329122437,-0.00088671558036553,0.0321041495502447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39147,-0.00457584271193458,0.00213807238699991,-0.0087664645904544,-0.000385220833414752,0.0323566461773555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39023,0.0116923821439828,0.00546341675543664,0.000984085303327007,0.0224006789846386,0.0323607620453327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39234,0.0113006088456607,0.00529321377700709,0.000925909842726844,0.0216753078485946,0.0327829872541216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36430,0.00835624051753363,0.00392214078700312,0.000668844575007518,0.0160436364600597,0.0331471987157109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36420,0.00706172423565919,0.00331591502613426,0.000562530784436038,0.0135609176868823,0.0332202613576993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36391,-0.00968547451304528,0.00456155701795934,-0.0186261262682456,-0.000744822757844963,0.03374972274516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,38841,0.0112619646478384,0.00532099037694532,0.000832823509025579,0.0216911057866512,0.0343173354096923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36430,0.00413360159280883,0.00195448534188576,0.000302810322712753,0.00796439286290491,0.034455455304954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36339,0.0179556736408767,0.00849798448347291,0.00129962405326978,0.0346117232284836,0.034626286939187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,36731,-0.012619124582742,0.00597584370859036,-0.0243317782515791,-0.000906470913904932,0.0347323361636941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39246,-0.00863648882465969,0.00409716411036692,-0.0166669304809788,-0.000606047168340524,0.0350541529946528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,36796,-0.00496621918195696,0.00235788755731013,-0.00958767879428481,-0.000344759569629108,0.0352048558041739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39033,-0.00660703502061151,0.00313998740453488,-0.0127614103334999,-0.000452659707723148,0.0353809261261901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,38841,-0.00552029273498008,0.00262417648816446,-0.0106636786517824,-0.00037690681817774,0.0354274835519631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,38841,0.00857584955507295,0.00409327472002106,0.000553031103831668,0.0165986680063142,0.0361782068533105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,38741,0.00714908991210344,0.00341310597564604,0.000459402199837197,0.0138387776243697,0.0362234810928208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,38832,0.0117284941415676,0.00560014293166949,0.000752213995495367,0.0227047742876398,0.0362482080914566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36430,0.00700602969860303,0.00334924026539686,0.000441518778425186,0.0135705406187809,0.0364740496341123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,36731,0.00698370314075403,0.00333858411037319,0.00044007828442259,0.0135273279970855,0.0364745394273131
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36339,0.0139313148684211,0.00667013940147282,0.000857841641534383,0.0270047880953078,0.0367631266126625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36391,0.00810810535722676,0.00388591942843655,0.000491703277491117,0.0157245074369624,0.0369503897652769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,38832,0.0100676047453575,0.00483039801680769,0.000600024632414382,0.0195351848583005,0.0371572099221273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36430,-0.00903315731322539,0.00433985512446084,-0.0175392733571686,-0.000527041269282142,0.0374136431288582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,38841,-0.00626187629256157,0.00301447217802518,-0.0121702417614909,-0.000353510823632222,0.0377935303962384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39117,-0.00449288628643725,0.00217311467018804,-0.00875219104000581,-0.000233581532868691,0.0387051110207932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39113,0.010767665971892,0.00521297292905257,0.000550239030948998,0.0209850929128351,0.0388876648238834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36430,0.00562206847135997,0.00272480577553653,0.000281449151308379,0.0109626877914116,0.0391054309965905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,36737,0.00480980409650645,0.00233206558727007,0.000238955545457118,0.00938065264755578,0.0391834784781528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,38727,0.00957855595039949,0.00465950752604971,0.000445921199342053,0.0187111907014569,0.039828735099443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,36796,0.0114832570787193,0.00559186335953302,0.000523204894034611,0.0224433092634041,0.0400378331782145
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,36791,-0.00631643865025307,0.00308545549946774,-0.0123639314292098,-0.000268945871296303,0.040661984638474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36538,0.0105242346877403,0.00514442939288394,0.00044115307768778,0.0206073162977928,0.0408012152359064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36363,0.020903558342913,0.0102222477627247,0.000867952727972635,0.0409391639578534,0.0408848013632892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39079,0.0123983935521887,0.00606323530293026,0.000514452358445435,0.024282334745932,0.0408870274100239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,36791,-0.00564785045436363,0.00276230845651619,-0.0110619750291354,-0.00023372587959189,0.0409132799074594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,38727,0.0110508438377557,0.00541214683096818,0.000443036049058087,0.0216586516264533,0.0411830739279096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,36784,-0.00703236972409723,0.00346196847711463,-0.0138178279392419,-0.000246911508952563,0.0422428499939515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,36548,-0.00774592145784151,0.00381623681016708,-0.015225745605769,-0.000266097309914032,0.0424050538744446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36052,0.022948848550472,0.011309143195878,0.00078292788655103,0.0451147692143929,0.0424565868934082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36391,0.00679652392878562,0.00335248450714752,0.000225654294776479,0.0133673935627948,0.042651887529547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,36767,0.00511431900637356,0.00252273558600843,0.000169757257797045,0.0100588807549501,0.0426531762736054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39255,-0.00800677789236542,0.00395598462860806,-0.0157605077644372,-0.00025304802029363,0.0429908997321097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,38741,0.0155173919342669,0.00768648033091226,0.00045189048567891,0.030582893382855,0.0435269194434606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,38727,-0.00958069652127432,0.00476301282987915,-0.0189162016678375,-0.000245191374711178,0.0442929811682284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39106,0.00627394535000534,0.00311936593467863,0.000159988118035218,0.0123879025819755,0.044312541094752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39162,-0.00518494917646877,0.00257849402580689,-0.0102387974670503,-0.000131100885887268,0.0443594470102082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36420,-0.0110658812588991,0.00550486376852934,-0.0218554142452166,-0.000276348272581601,0.0444312858950879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39099,0.0272635312685866,0.0135729467825339,0.000660555574820178,0.0538665069623531,0.0445900602101205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36339,-0.00570323685020879,0.00284293785604001,-0.0112753950480472,-0.000131078652370378,0.0448663995211523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36391,0.00905271529406452,0.00452567871789657,0.000182385006987248,0.0179230455811418,0.0454894145975024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36251,-0.00800293401819329,0.00400372000647317,-0.0158502252308807,-0.00015564280550589,0.045643733576435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39076,0.0151191111830983,0.00757191079933223,0.000278166016407093,0.0299600563497894,0.0458715899605137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,36747,0.0158557851440832,0.00795306604991935,0.000267775686241268,0.0314437946019251,0.046209226611017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36339,0.0160296363145865,0.00804311559498691,0.000265129748412186,0.0317941428807609,0.0462871766682909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,36791,-0.00580156638935313,0.0029112097194577,-0.0115075374394902,-9.55953392160393e-05,0.046300282235881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,38841,0.00521659304865564,0.00261866638625601,8.40069315938691e-05,0.0103491791657174,0.0463803959060999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,36743,0.0151722052176155,0.0076342486922629,0.000209077780780274,0.0301353326544508,0.0469006857182575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36363,0.00791272428285871,0.00400004746634013,7.2631248832054e-05,0.0157528173168854,0.0479328474444004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,36718,0.00653300786146544,0.00330288551951748,5.93522432111833e-05,0.0130066634797197,0.047953426285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",36792,-0.0123768895567558,0.00625969541991747,-0.0246458925797941,-0.000107886533717605,0.0480362635139816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39023,0.00524889526117513,0.00265843853268075,3.83557371208612e-05,0.0104594347852294,0.0483512227399982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,36796,0.00965561506246327,0.00489472276061786,6.19584516522702e-05,0.0192492716732743,0.048555776216838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,36792,-0.00596718183031757,0.0030262566746518,-0.0118986449126351,-3.57187480000453e-05,0.0486533848853864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39149,0.00542136670496698,0.00275239566248037,2.6671206505461e-05,0.0108160622034285,0.0488919127754165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,36806,0.00264675635339309,0.00134512765762241,1.0306144453155e-05,0.00528320656233302,0.0491282737971181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,38832,0.010734746850316,0.00548309402827998,-1.21174451127113e-05,0.0214816111457448,0.0502732022951739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36363,-0.0152808337224099,0.00782302161037572,-0.0306139560787464,5.22886339264783e-05,0.0508044288296507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36339,-0.00864162849080193,0.00442680636722294,-0.0173181689705589,3.49119889550345e-05,0.0509470627716064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39099,0.0138465888715535,0.00711001604385139,-8.90425743952164e-05,0.0277822203175022,0.0514959800279992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,38951,-0.0041676258981805,0.00214444565185959,-0.00837073937582531,3.54875794643071e-05,0.0519802091076405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36391,0.00869414253479415,0.00447746906588988,-8.16968343500171e-05,0.0174699819039383,0.0521892965045673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,38976,-0.0050618067098969,0.00261876986310314,-0.0101945956415791,7.0982221785254e-05,0.0532678110219393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36339,0.0119833988098638,0.00621662599048934,-0.000201188131495309,0.0241679857512229,0.0539229508314374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,36747,0.0115336302570885,0.00598691280183841,-0.000200718834514807,0.0232679793486918,0.0540672141717963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,36767,0.00490330990783343,0.00254636834178831,-8.75720420716571e-05,0.00989419185773852,0.0541751513937568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36421,0.00556197014093385,0.00289231833007637,-0.000106973786015831,0.0112309140678835,0.054500808075961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36363,0.0102386170030067,0.0053292908611205,-0.000206793084789436,0.0206840270908029,0.0547296010387102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39182,0.00353365801613264,0.00184366977234253,-7.99347376587208e-05,0.007147250769924,0.0553017956179666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,36731,0.00636418746181556,0.00332195105322418,-0.000146836602503834,0.012875211526135,0.0554129316356194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36500,0.0133726101058517,0.00698402952120158,-0.000316087755703373,0.0270613079674068,0.0555480454972608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38506,-0.0107717862827113,0.00562704711558548,-0.0218007986292588,0.000257226063836274,0.0556028879282246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36430,0.00687361332893067,0.00359245000111891,-0.000167588673262402,0.0139148153311237,0.0557259836512516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36391,0.0075911353066446,0.00397288860047873,-0.000195726350293716,0.0153779969635829,0.0560615050247532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36420,0.00574762200246375,0.00301094504329589,-0.000153830282396198,0.0116490742873237,0.056296516681592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36393,-0.00698144233522213,0.00366344810179821,-0.0141618006147466,0.00019891594430236,0.0567116670320935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36421,-0.00397378608345014,0.00208825881951236,-0.00806677336969437,0.000119201202794086,0.0570740378580063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,38998,0.00419233884776831,0.00220564072849898,-0.000130716980089703,0.00851539467562631,0.0573556884789953
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36391,-0.00538122049383755,0.00283858854647938,-0.0109448540449371,0.000182413057262032,0.0580176691233844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39023,-0.00458502001406557,0.00242074769646147,-0.00932968549913005,0.000159645470998915,0.0582372313366212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39099,0.0102367429278591,0.00540650408199631,-0.000360005072853707,0.0208334909285718,0.0583219468989936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,38667,0.0116023320615904,0.00614093594779211,-0.000433902396082184,0.0236385665192629,0.0588654530178762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39023,0.0226372583162081,0.0119860170396817,-0.000855335081568102,0.0461298517139842,0.0589592965041582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,38727,0.00607982338533295,0.00322258681119091,-0.000236446764601237,0.0123960935352671,0.0592298106241094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36339,-0.00443084891794973,0.00235050802079854,-0.00903784463871487,0.000176146802815413,0.0594449363602558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36430,0.0180735766928551,0.00959572256731213,-0.000734039539076661,0.0368811929247869,0.0596552357767239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,36792,-0.00503788308951174,0.0026765073011279,-0.0102838373997224,0.000208071220698953,0.0598231333403413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,38705,0.0113634813848796,0.00605929884328888,-0.000512744347966611,0.0232397071177258,0.0607602240934104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39241,0.00801836291690584,0.00428807550597121,-0.000386265074797732,0.0164229909086094,0.0615137551569999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39255,0.00778510295797245,0.0041804707812518,-0.000408619773281083,0.015978825689226,0.0625861803517612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,38960,-0.00562097659050714,0.00302059028018149,-0.0115413335396629,0.000299380358648589,0.0627795854388589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",36792,0.00511854004350819,0.00275381282335879,-0.000278933090275045,0.0105160131772914,0.0630909255862417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36363,0.010636471019191,0.00572337812441722,-0.000581350104666797,0.0218542921430487,0.0631321185074507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36538,0.011006998445847,0.00592655665620903,-0.000609052600322704,0.0226230494920167,0.0633011407823618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36391,0.00958101952366936,0.00516817803743403,-0.000548609429701337,0.0197106484770401,0.0637843091298584
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,38706,0.0147084131983644,0.00794390705250438,-0.000861644624544168,0.030278471021273,0.0641126258445357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,38672,0.00923709487575733,0.00500436380011497,-0.000571458172468004,0.0190456479239827,0.0649400270613292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39106,-0.00742142824290232,0.00403046212166609,-0.0153211340013679,0.000478277515563218,0.0655919957768145
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,38727,0.00947498962484131,0.00514908223450425,-0.000617211554787025,0.0195671908044696,0.0657688200635284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",36747,-0.0100839394888144,0.0054900691954572,-0.0208444751119105,0.000676596134281704,0.0662683504071164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36420,-0.00299751387874166,0.00163725104417706,-0.00620652592532871,0.000211498167845387,0.0671509178657022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39095,0.00498497934592387,0.00272819843175138,-0.000362289580308832,0.0103322482721566,0.0676884205248418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,36731,0.0065666173690084,0.00360907825345973,-0.000507176007772676,0.0136404107457895,0.0688626490093056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36363,0.0125011223518111,0.00688021625037975,-0.000984101498933158,0.0259863462025555,0.0692461748481926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,38841,0.00944610118496877,0.00520518923885319,-0.000756069723183478,0.019648272093121,0.069582799828247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,36747,0.0103125365272863,0.00568806677864975,-0.000836074358867202,0.0214611474134398,0.0698531390102245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36420,-0.00543356921863399,0.00299895905929664,-0.0113115289748554,0.00044439053758743,0.0700381328925385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36420,-0.00431848249937323,0.0023838812075051,-0.00899088966608323,0.000353924667336772,0.0700820647953299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36538,0.00568506994824962,0.00314533536243855,-0.000479787362129943,0.0118499272586292,0.0707141750268665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,38727,0.00902976601881029,0.0049991549011364,-0.000768577587417054,0.0188281096250376,0.0708981854210285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36320,0.00419193495914727,0.00232524174006645,-0.000365538851382978,0.00874940876967751,0.071444515875256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,36747,0.0119849965633312,0.00666379819097828,-0.00107604789098626,0.0250460410176486,0.0721175056511274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36420,-0.00856031874679014,0.00475995715685092,-0.0178898347742179,0.00076919728063766,0.072137252394572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,36792,-0.00428144743930921,0.00238746737888267,-0.00896088350191924,0.000397988623300819,0.0729481787899537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36430,-0.00684045053592372,0.00381494842437784,-0.0143177494477043,0.000636848375856858,0.0729865623742084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39283,0.0114455231915901,0.00638511599669374,-0.00106930416192968,0.0239603505451098,0.0730674180682657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36363,0.00777587818500255,0.0043401121446611,-0.000730741618533212,0.0162824979885383,0.073216315952027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,38788,-0.00965679138779613,0.00541682241931199,-0.0202737633296476,0.000960180554055372,0.0746487901390019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,38727,0.00801423271556526,0.00449639936910603,-0.000798710047882548,0.0168271754790131,0.0747098460650601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36363,0.00916903914155876,0.00514472837605264,-0.000914628475504414,0.0192527067586219,0.0747375805145672
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36430,0.0103357369220007,0.00581085652987995,-0.00105354187656397,0.0217250157205654,0.075314069351731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",38741,0.00711051735128774,0.00400045970712532,-0.000730383674677877,0.0149514183772534,0.0755187490038991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,38987,-0.00680490700853254,0.0038298507492026,-0.0143114144769696,0.000701600459904554,0.0756200315196134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,36726,0.00600683819865316,0.00338506477799186,-0.00062788876621088,0.0126415651635172,0.0760021342027162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,38727,0.0086665123129897,0.00488561058707584,-0.000909284437678943,0.0182423090636583,0.0761026054050013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39106,0.0117949116635939,0.00665174996318565,-0.00124251826424998,0.0248323415914378,0.0762148193374037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36339,0.0120451858158511,0.00679281857068386,-0.00126873858268928,0.0253591102143914,0.0762160581769402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,36792,-0.00635275010189178,0.00358791053542883,-0.0133850547513323,0.000679554547548735,0.0766509943966537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,36796,0.00557108912079159,0.00314690374290095,-0.000596842215294264,0.0117390204568775,0.0766940904876642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36421,0.0109496406928065,0.0061874609117599,-0.00117778269424289,0.0230770640798559,0.0768097078620466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39106,0.0102347764084581,0.00581024589722961,-0.00115330555011193,0.0216228583670281,0.0781730312424735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36420,-0.00390014140595533,0.00221524251994869,-0.00824201674505476,0.000441733933144096,0.0783315769613095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,36796,0.0100770497103144,0.00572693435440173,-0.00114774162431297,0.0213018410449418,0.0785011816495612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,38987,0.00897071240682423,0.00510890032112446,-0.00104273222257971,0.0189841570362282,0.0791259102965225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39023,-0.00706441842253384,0.00405222102215172,-0.0150067716259512,0.000877934780883527,0.0812936734719045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36420,0.00827558993445388,0.00475201947562117,-0.00103836823776361,0.0175895481066714,0.0816223715839249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39255,0.00955248871664551,0.0054900414645412,-0.00120799255385524,0.0203129699871463,0.0818848681881129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39093,0.00696605428034033,0.00401283302923874,-0.000899098456967599,0.0148312070176483,0.0825939188562934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36339,-0.018421912321731,0.0106129760290735,-0.0392233453387151,0.00237952069525312,0.0826254120238565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36421,0.00814957867713636,0.0046993064866333,-0.00106106203666491,0.0173602193909376,0.0829055752756688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,38727,0.0117978626418215,0.00683184551469776,-0.00159255456698614,0.0251882798506291,0.0842077470308512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39241,-0.0042101570197391,0.00244318789023942,-0.00899880528460835,0.000578491245130157,0.0848683444542393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36102,-0.01102086176206,0.00641742982521983,-0.0235990242194908,0.00155730069537087,0.085943701479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,38886,0.00841135063944285,0.00492506753142229,-0.00124178172214484,0.0180644830010305,0.087682043985839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39095,0.0459927557174374,0.0269506862575715,-0.00683058934740273,0.0988161007822774,0.0879256761071367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39045,0.00537691358166339,0.00315299612733572,-0.000802958827914625,0.0115567859912414,0.0881524792226402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36500,0.00581098943155817,0.00340825056025888,-0.000869181666549242,0.0124911605296656,0.0882232530542338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36363,0.00767032635297034,0.00450016472489206,-0.00114999650781811,0.0164906492137588,0.0883210406822999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39099,0.014640347175143,0.00859970148667323,-0.00221506773873653,0.0314957620890225,0.0886961132711181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,36731,0.00527819456453062,0.00311105381236437,-0.000819470907703547,0.0113758600367648,0.0897976655695474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36421,0.00718636155437146,0.0042419536793732,-0.00112786765720001,0.0155005907659429,0.090268035475469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,38795,0.0115968108397585,0.00687385130727746,-0.00187593772250527,0.0250695594020224,0.0916067896312451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,38741,0.0100563999645709,0.00596943625447953,-0.001643695094209,0.0217564950233508,0.0920774382169703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,36747,-0.010715619200414,0.0063678313514626,-0.0231965686492807,0.00176533024845268,0.0924431298020524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,38958,0.0069157034072491,0.00411153072587039,-0.00114289681545687,0.0149743036299551,0.0925843919473797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36538,-0.00903712184399269,0.00537614953118264,-0.0195743749251107,0.00150013123712528,0.0927942500100926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36391,-0.00913074676498597,0.00543473558963044,-0.0197828285206616,0.00152133499068969,0.0929682457499795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36430,-0.00505336576631875,0.00301015038518092,-0.0109532605212734,0.000846528988635849,0.0932207221980989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,38841,0.0069829540106677,0.00416618974249527,-0.00118277788462303,0.0151486859059584,0.0937393142265085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36391,-0.00623196306397616,0.0037191074530873,-0.0135214136720273,0.00105748754407495,0.0938295746005544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36538,-0.00676900974959509,0.00404323719875703,-0.0146937546591589,0.00115573515996869,0.0941246139917276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36421,0.00724534618225336,0.00432817300842872,-0.00123787291426694,0.0157285652787736,0.0941561971391493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36414,0.00919682093878679,0.00549453042862116,-0.00157245870131069,0.0199661005788843,0.0941921081174028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36363,-0.0101526086309247,0.00607787287208857,-0.0220652394602183,0.00176002219836892,0.0948610574357484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,38704,0.00667816185410211,0.00400407191936955,-0.00116981910786221,0.0145261428160664,0.0953680627594244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36391,0.0098176655389528,0.00589454029753265,-0.0017356334442112,0.0213709645221168,0.0958276018599639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36363,-0.00712466872747256,0.00428023489251847,-0.0155139291168088,0.00126459166186363,0.0960274504972126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,36747,-0.0107490504144692,0.00646319965620515,-0.0234169217406313,0.0019188209116929,0.0963135450630572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36339,-0.00978847652762073,0.0058948432063855,-0.0213423692121363,0.00176541615689484,0.0968359832992206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,38741,-0.0106117304714994,0.00640813589593265,-0.0231716768275274,0.00194821588452858,0.0977474088192744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39207,0.00346256814569577,0.00209505817549796,-0.000643745878280239,0.00756888216967178,0.0984060237117439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39283,0.00382266574403061,0.00231397042750035,-0.000712716293870077,0.0083580477819313,0.0985560882064389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39093,-0.00287947147879297,0.00174575149616257,-0.0063011444112716,0.000542201453685667,0.0990829373652372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,38841,0.00649599935782898,0.00394189108675218,-0.00123010717220529,0.0142221058878633,0.099385988046537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39093,0.0064364989121485,0.00390953286734612,-0.00122618550784989,0.0140991833321469,0.0997102718971814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39283,-0.00451747589705051,0.00275572980660388,-0.00991870631799411,0.000883754523893099,0.101170585378297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36538,0.00892183404322228,0.0054473943859678,-0.0017550589532746,0.0195987270397192,0.101484732454126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,38841,0.00985173724018713,0.00601920182921575,-0.00194589834507574,0.02164937282545,0.101710367131404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,38841,0.00467052732153103,0.00285657572164204,-0.000928361092887362,0.0102694157359494,0.102068147980836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39283,-0.00338735342553048,0.00207444088587663,-0.00745325756184867,0.000678550710787711,0.102510554549382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,36747,-0.0075898088532151,0.00465252741489479,-0.0167087625864089,0.00152914487997869,0.102845082402781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,36731,-0.0114999034256068,0.00705016659244786,-0.0253182299468046,0.00231842309559106,0.102882414841065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,36731,-0.00560903078335526,0.00345610984719402,-0.0123830060838555,0.00116494451714501,0.104628462099846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36421,0.00904609116647593,0.00561007971897058,-0.0019496650827064,0.0200418474156583,0.106884595683355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36421,-0.00720674144828099,0.00446955108931053,-0.0159670615833296,0.00155357868676765,0.106898233739107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36430,0.00723423348418339,0.00449179576077862,-0.00156968620694271,0.0160381531753095,0.107304316291883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,38832,-0.0171508060315265,0.0106617577649411,-0.0380478512508109,0.00374623918775797,0.107718710874762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,36791,0.00630795363391542,0.00392202465275719,-0.00137921468548867,0.0139951219533195,0.107784896009634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36500,-0.00312389532940816,0.00194324313244429,-0.00693265186899896,0.00068486121018264,0.107954818342976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,36731,0.0143687346887922,0.00894157513192504,-0.00315675256978087,0.0318942219473653,0.108088135890839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36339,-0.00650686395981299,0.00405091443376841,-0.0144466562499991,0.00143292833037309,0.10823981197964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36391,-0.00915513753452629,0.00570105410239694,-0.0203292035752243,0.00201892850617172,0.108328221798816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36391,0.00917304692540743,0.00572350893818297,-0.00204503059343119,0.0203911244442461,0.109026912282367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36363,-0.00639553744453607,0.00399085855470098,-0.01421762021175,0.00142654532267785,0.109060016995129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,36743,0.00717282266257019,0.00447657569222452,-0.00160126569418987,0.0159469110193302,0.109113533778524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36500,-0.00551092315948102,0.00344271099994071,-0.0122586367193648,0.00123679040040278,0.109457065582274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36430,0.0107654900825173,0.00673215608273005,-0.00242953583963364,0.0239605160046681,0.109820241020754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,38832,0.0048264228553675,0.00302433177458025,-0.00110126742280979,0.0107541131335448,0.110540218119012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39151,-0.00567663237826948,0.00355797703499728,-0.0126502673668641,0.00129700261032518,0.110628671039444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39023,0.00518641295598508,0.00325571000793399,-0.00119477865956554,0.0115676045715357,0.111176424281851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36391,-0.00752332708611077,0.00473837866757892,-0.0168105492745655,0.00176389510234391,0.112369717825291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39165,0.00478785275427712,0.00302186034514991,-0.0011349935222167,0.0107106990307709,0.11312208640817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36538,0.00997374278954681,0.00630565588527842,-0.00238534274559889,0.0223328283246925,0.11373987102326
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,38816,-0.00602195150316138,0.00380773971100541,-0.013485121336732,0.00144121833040923,0.11378423567757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36391,0.00483992289335314,0.0030764351004187,-0.00118988990346751,0.0108697356901738,0.115692103676919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36363,-0.00548620440145044,0.00348879653864419,-0.0123242456171931,0.00135183681429216,0.115855170244371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36430,0.00540204704158979,0.00343855330436652,-0.00133751743496859,0.0121416115181482,0.116202427545776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,36731,-0.00860163192759481,0.00548508317255084,-0.0193523949457945,0.00214913109060483,0.116862258459601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,36792,-0.0036831365023501,0.00235261077848832,-0.00829425362818722,0.000927980623487012,0.117477804207169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,36743,0.00768696784724725,0.00491410970029248,-0.001944687165326,0.0173186228598205,0.117780003385708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39023,-0.00290173874619152,0.00185698454993158,-0.00654142846405743,0.000737950971674382,0.118165715641994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36339,-0.00517107618720696,0.00331095716937053,-0.0116605522391732,0.00131839986475928,0.118358812621245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39136,0.0072274939563351,0.00463859397789892,-0.00186415024034677,0.016319138153017,0.119225116049912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39147,0.0141436053578141,0.00907749521859001,-0.0036482852706223,0.0319354959862505,0.119231288324224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39023,0.0054648237808722,0.00350766966850018,-0.00141020876938815,0.0123398563311325,0.119262604044869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39099,0.0108857755802162,0.00698750927771832,-0.00280974260411174,0.0245812937645441,0.119279930852873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36430,-0.00452308875922295,0.00291667358422734,-0.0102397689843085,0.00119359146586264,0.120982080980734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36391,-0.00814435893919067,0.00528004404615791,-0.0184932452696602,0.00220452739127884,0.122982401927155
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36339,-0.00780729050699544,0.00507015500284321,-0.0177447943125681,0.00213021329857725,0.123621683156104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,38813,0.00594704243694423,0.0038712467074597,-0.00164060110967679,0.0135346859835652,0.124508388457288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39106,0.0104769399105134,0.00683326827274787,-0.00291626590407243,0.0238701457250992,0.125241097944368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36398,0.00545816966710042,0.00356817424907788,-0.00153545186109223,0.0124517911952931,0.126120845230721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,36731,0.00396375193330701,0.0025975157011899,-0.0011273788410252,0.00905488270763921,0.127039903090776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36430,0.0152637496399601,0.0100036459568069,-0.00434339643538151,0.0348708957153017,0.127080192048219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39265,0.0077316533669938,0.00507634828004294,-0.00221798926189036,0.017681295995878,0.127760754305932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,36747,0.00307882733363768,0.00202337415357022,-0.00088698600735994,0.00704464067463531,0.128126286807544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,36767,0.00450163895173788,0.0029649779050017,-0.00130971774206546,0.0103129956455412,0.128970674135927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36391,0.00547275743011639,0.00361017616467318,-0.00160318785264304,0.0125487027128758,0.129563462721226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39106,0.0096168509496507,0.00638006775199657,-0.00288808184426259,0.022121783743564,0.131747476569854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,36743,-0.0042233471373471,0.00280826661833328,-0.00972754970928033,0.00128085543458613,0.132632091269286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,36610,0.00434045921841045,0.00289044579220032,-0.00132481453430218,0.0100057329711231,0.133210383466109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36339,-0.0110408913767573,0.00735312435753436,-0.0254530151175247,0.00337123236401002,0.133245431810103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36538,-0.00735324023275487,0.00489746628972366,-0.0169522741606133,0.00224579369510351,0.133267308423775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36421,0.00625491781131663,0.00416719315387196,-0.00191278077027242,0.0144226163929057,0.133383124303154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,38741,-0.00437615966270396,0.00292253962869178,-0.0101043373349399,0.00135201800953193,0.13431497161256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36538,-0.01181191458042,0.00792514752413999,-0.0273452037277344,0.00372137456689439,0.136134861633458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,38841,0.0123088046229455,0.00826301156637585,-0.00388669804715112,0.0285043072930422,0.136343406301936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,36743,0.0036744848930993,0.00247170324275012,-0.00117005346269095,0.00851902324888954,0.137139522451168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36391,0.00523760638078504,0.00352884950852317,-0.00167893865592037,0.0121541514174905,0.137774412811298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,36737,0.00635398875190882,0.0042816324311488,-0.00203801081314283,0.0147459883169605,0.137830532230878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36339,-0.00974039031994948,0.00656583435754138,-0.0226094256607306,0.00312864502083162,0.137967880065025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36363,-0.00555494265173212,0.00376907129200715,-0.0129423223840661,0.0018324370806019,0.140554522998251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,38832,-0.00492951635844504,0.00334769224649981,-0.0114909931615847,0.0016319604446946,0.140903741403725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,38727,0.00623800332574003,0.00423681017286473,-0.00206614461307484,0.0145421512645549,0.140951641545629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,38841,0.0057896790907648,0.00393588355115421,-0.00192465266949746,0.0135040108510271,0.141312505878779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36538,0.00556418530294216,0.00378672470483106,-0.00185779511852672,0.012986165724411,0.141751143198747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,38727,0.00973750120938537,0.00665871416379017,-0.00331357855164337,0.0227885809704141,0.143661091342608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36420,0.00816830262151585,0.00558640962648286,-0.00278106024639056,0.0191176654894223,0.143718568071687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39023,0.00311853375625628,0.00213451708063613,-0.00106511972179054,0.0073021872343031,0.144035609121154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,38727,-0.0160795359903243,0.0110278690795516,-0.0376941593862454,0.00553508740559682,0.144839101012802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36339,0.00706048239501594,0.00484245181244782,-0.00243072315738178,0.0165516879474137,0.144855027473657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,36806,0.0025824117837292,0.00177749222004865,-0.000901472967566149,0.00606629653502455,0.146292422042137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39023,-0.0057347803823103,0.00395595519120337,-0.0134884525570689,0.00201889179244831,0.147174715746849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39219,0.00399115285056047,0.00275405096033772,-0.00140678703170146,0.00938909273282241,0.147303958406802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36430,0.00847125482430792,0.00593009256500027,-0.00315172660309261,0.0200942362517085,0.153167137602493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36430,0.0117085852714222,0.00820349912173992,-0.00437027300718805,0.0277874435500324,0.153527729351513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36391,-0.00735229005953073,0.00517111168530794,-0.0174876689627343,0.00278308884367284,0.155109012618717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39165,0.00354660977413632,0.0024995945894625,-0.00135259562121017,0.00844581516948282,0.15595611696838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36538,-0.0043705113922232,0.00308178222417857,-0.0104108045516132,0.0016697817671668,0.156163794987094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",38841,-0.0156971884851639,0.0110987483836029,-0.0374507353170256,0.00605635834669782,0.157288572750996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,38841,-0.0039509017090876,0.00279835918661096,-0.00943568571484507,0.00153388229666987,0.158010872496028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,36806,0.00390804576192251,0.0027728521807134,-0.00152674451227576,0.00934283603612079,0.158742234024642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,36791,0.0102024838468415,0.00725348586254365,-0.00401434844374405,0.0244193161374271,0.159581082763466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36450,0.0056335450632809,0.00401025953600275,-0.00222656362728448,0.0134936537538463,0.160110439296811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,36731,0.00627046563932789,0.00446904587626385,-0.00248886427814927,0.015029795556805,0.160614654617072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36363,0.00548335704531561,0.00390857064883839,-0.00217744142640763,0.0131441555170389,0.160669715359815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,36743,0.00424225681025253,0.0030245978994911,-0.00168595507275003,0.0101704686932551,0.160764608997421
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,38987,-0.00460148111613843,0.00328094185993189,-0.0110321271616049,0.00182916492932808,0.160790135837882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36510,-0.00822240876215949,0.00590714695674828,-0.0198004167973861,0.00335559927306714,0.163964289214035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36363,0.00406047458739293,0.00293215211800848,-0.0016865435639037,0.00980749273868955,0.166135176277252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36421,-0.00523752516382208,0.00378862302237975,-0.0126632262876864,0.00218817596004223,0.16686274650196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39117,0.00298539737045362,0.00216748580849909,-0.00126287481420459,0.00723366955511183,0.168422730063091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,38727,0.0110757039125509,0.00806153780992551,-0.00472491019490307,0.0268763180200049,0.169495094881664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39099,0.00829098460071826,0.00604299790018924,-0.00355329128365266,0.0201352604850892,0.170084072747832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,36767,-0.00272475172644873,0.00198734629396137,-0.00661995046261303,0.00117044700971556,0.170383115435606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,36718,0.00398207008322896,0.00290496880725784,-0.00171166877899641,0.00967580894545432,0.170467802525014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39239,0.0117359143818777,0.00857354879302917,-0.00506824125245942,0.0285400700162149,0.171065718596161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36538,0.0066841261754634,0.0048898326270519,-0.00289994577355831,0.0162681981244851,0.171667172940427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,36616,-0.00660399775822348,0.00483445574400166,-0.0160795310164667,0.00287153550001977,0.171954526815855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39291,-0.00457188941196622,0.00334807618711792,-0.0111341187387173,0.0019903399147849,0.172107285216357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36339,0.00375303635028156,0.00275469731430393,-0.00164617038575415,0.00915224308631726,0.173092066172603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36363,-0.00664871947394288,0.00488483323540303,-0.0162229926153328,0.00292555366744705,0.173508369120676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36430,0.00686129239209067,0.00504117794509092,-0.00301941638028753,0.0167420011644689,0.173522466747297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39255,0.00559352727975976,0.00411344125749973,-0.00246881758493971,0.0136558721444592,0.173907760621918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36391,0.00575396723329729,0.00423368534319563,-0.00254405603936614,0.0140519905059607,0.174141945205414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39165,0.00584407056957568,0.00430900282495056,-0.00260157496732742,0.0142897161064788,0.175040716493212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36391,0.0049173598275213,0.00362609901156843,-0.00218979423515283,0.0120245138901954,0.175091177241582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36421,0.00755598317152874,0.00557628518827435,-0.00337353579748899,0.0184855021405465,0.175435254569603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,36743,0.0181257401198688,0.0134035212310879,-0.00814516149306342,0.044396641732801,0.176299323003517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39106,0.00773771480016377,0.00572470935684516,-0.00348271553925274,0.0189581451395803,0.176512313708532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36363,0.00943758318604862,0.0069851349842655,-0.00425328138311177,0.023128447755209,0.176689348218462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36538,0.00629364736462575,0.00466136223202628,-0.00284262261014576,0.0154299173393973,0.176984466136028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39033,0.00319940765280426,0.00237373964774892,-0.00145312205678362,0.00785193736239215,0.177731814681525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39255,0.00473653818767595,0.00352612775961964,-0.00217467222117854,0.0116477485965305,0.179204679597178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36391,-0.0058734875290449,0.00438307251024388,-0.0144643096491229,0.0027173345910331,0.180257006093004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,38741,0.00629703344741514,0.00470286057354438,-0.00292057327673184,0.0155146401715621,0.180597830574891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,38727,0.00666374949238747,0.00498130565369273,-0.00309960958885029,0.0164271085736252,0.180997894363559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,36791,-0.00283464704814556,0.00212128970778126,-0.00699237487539682,0.0013230807791057,0.181479738476281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36421,0.00545313835910697,0.00408175336552396,-0.00254709823732,0.0134533749555339,0.181580214117249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,38741,0.0047158909227161,0.00353072866545737,-0.00220433726158034,0.0116361191070125,0.181677349097069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,38832,0.0032787804871062,0.0024614502327773,-0.0015456619691373,0.00810322294334971,0.182863273244272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,36731,0.00594933289759541,0.00447779175238482,-0.00282713893707885,0.0147258047322697,0.183993296777579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36363,0.00570793162636001,0.00429612411681819,-0.00271247164260364,0.0141283348953237,0.18399645017967
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36538,0.00924232985549465,0.0069602736160442,-0.00439980643195198,0.0228844661429413,0.18424537484302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36430,0.00527780208603704,0.00397541563103654,-0.00251401255079457,0.0130696167228686,0.184331043606307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39165,0.00335715225663389,0.00253116119137858,-0.00160392367846813,0.00831822819173592,0.184750567002603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36421,0.00734593491312129,0.00554892826416298,-0.00352996448463815,0.0182218343108807,0.18557778207114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36363,0.0102344213560505,0.00778955028380478,-0.00503309720020687,0.0255019399123079,0.188915577414106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",36767,0.00432932558560519,0.00331505161655461,-0.00216817558284184,0.0108268267540522,0.191589355316727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39216,-0.00478758657064969,0.0036755748345399,-0.0119917132463479,0.00241654010504852,0.19275107820707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39291,0.00396428418765818,0.00304488303420373,-0.00200368655938112,0.00993225493469748,0.192953056089517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36363,0.00658240230390298,0.00505656146274166,-0.00332845816307067,0.0164932627708766,0.1930242604037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,38727,0.00476031834443314,0.00365974886119865,-0.00241278942351621,0.0119334261123825,0.193373556977777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39083,0.00372420698373035,0.00286806387885375,-0.001897198218823,0.00934561218628371,0.194132128902148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,38950,-0.00859581619769011,0.00664775054888378,-0.0216254072735023,0.00443377487812209,0.196016561118171
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39252,0.0024562659967193,0.00190171135566647,-0.00127108826038698,0.00618362025382558,0.196512254520039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39099,0.00835920042825371,0.00648036563804116,-0.00434231622230696,0.0210607170788144,0.197095481945561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36538,0.00396610417009836,0.00307822981577702,-0.0020672262688246,0.00999943460902133,0.197617513533642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",36767,0.00767238233645947,0.00595489562982768,-0.00399921309800278,0.0193439777709217,0.197624314623279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36420,0.0102845213517643,0.00798746477570035,-0.00537090960860843,0.0259399523121369,0.197914993492778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,36791,0.0159682533993668,0.0124046610295239,-0.00834488221849998,0.0402813890172335,0.198020275971654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36363,-0.00449670258129012,0.00349345327140525,-0.0113438709932444,0.00235046583066416,0.198055444231776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,36767,0.00945810394594833,0.00734965607255036,-0.00494722195625038,0.023863429848147,0.198160213936353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39057,0.00471341440282208,0.00367002732906573,-0.00247983916214676,0.0119066679677909,0.199056746290683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39093,0.00352823156937018,0.00275027944107373,-0.00186231613513433,0.00891877927387469,0.199559617177489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36430,-0.00348355928279585,0.00272135987040429,-0.00881742462878825,0.00185030606319655,0.200540502958512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,38750,0.00575859314577178,0.00449902527658235,-0.00305949639632962,0.0145766826878732,0.200577522715427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,38741,0.00550969052197641,0.00431487002084549,-0.00294745471888076,0.0139668357628336,0.201654778507508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39255,-0.00440755286520751,0.00345242184118166,-0.0111742996739236,0.00235919394350854,0.201743202858745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36363,-0.0090444440905088,0.00708689434928909,-0.0229347570151154,0.00484586883409783,0.201901078188361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36391,0.00595387145998745,0.00467057606462958,-0.00320045762668653,0.0151082005466614,0.20241723879694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36391,0.00302705687279711,0.00237518798845361,-0.00162831158457197,0.00768242533016619,0.202527832196346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36391,-0.00487882215496437,0.00383018939598235,-0.0123859933710898,0.00262834906116104,0.202764695634679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36339,0.00623351778481913,0.00489560105458599,-0.00336186028216942,0.0158288958518077,0.202939022646241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,38741,0.00804585516175651,0.00632844341310213,-0.00435789392792366,0.0204496042514367,0.203613434163915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36430,-0.00538670005126585,0.00425141005608938,-0.013719463761201,0.00294606365866933,0.205165012444735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,38741,0.00470425770997813,0.00372576974309011,-0.00259825098647848,0.0120067664064347,0.20674302231916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,38705,0.00397543176841646,0.00315394413827614,-0.00220629874260477,0.0101571622794377,0.207521984148015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39023,0.02137897726253,0.0169639462059823,-0.0118703573011953,0.0546283118262553,0.207595097367788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39099,0.00624376634855685,0.00496009448906232,-0.00347801885000529,0.015965551547119,0.208121906692748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36430,0.00316228441338118,0.00251248002855123,-0.00176217644257922,0.00808674526934158,0.208187140289944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36430,0.00370105859037553,0.00294103966854742,-0.00206337915997742,0.00946549634072848,0.208263834529596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,38727,0.0107809998210818,0.00856767755766412,-0.00601164819193985,0.0275736478341035,0.208290757114673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39162,0.00882564660722622,0.00701401703828428,-0.00492182678781097,0.0225731200022634,0.208307171804779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",36767,-0.00452673077908028,0.00360978699762617,-0.0116019132944276,0.00254845173626702,0.209858888148396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,38727,0.00675221999175021,0.00538804507783137,-0.00380834836079928,0.0173127883442997,0.210157912348068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39162,-0.00321692424552819,0.00256778641912871,-0.00824978562702046,0.00181593713596408,0.210297444810236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,36747,0.00428233405481514,0.00341850733538714,-0.00241794032254366,0.0109826084321739,0.210340840589271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36421,-0.00786763084977697,0.00628097206411839,-0.020178336095449,0.00444307439589508,0.210369693009239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36363,0.011078000905518,0.00885123823253628,-0.00627042603025314,0.0284264278412891,0.210747672720798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36311,0.00603920947663132,0.00482755410162631,-0.00342279656255625,0.0155012155158189,0.210962570890777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,38681,-0.0103467251175445,0.00829731049504123,-0.0266094536878254,0.00591600345273626,0.212418134156725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,38841,-0.00691079508246299,0.00554935917837297,-0.017787539072074,0.00396594890714804,0.21302918106044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,36791,-0.00408226849378783,0.00327955854127728,-0.0105102032346913,0.00234566624711565,0.213241958769276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36363,-0.0039371841532462,0.00316379517167827,-0.0101382226897356,0.0022638543832432,0.213357404547731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,38841,0.00587881829464133,0.00473444386635805,-0.00340069168342044,0.0151583282727031,0.214362083335898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36430,0.00406840369124732,0.00328136553474435,-0.00236307275685161,0.0104998801393462,0.215053728773311
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36339,-0.00474875280971928,0.00383062165333839,-0.0122567712502625,0.00275926563082396,0.215116339816197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36421,0.00497445664328701,0.00401423914636239,-0.00289345208358328,0.0128423653701573,0.215293534086939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36538,-0.00459359704537577,0.00370873723050849,-0.0118627220171724,0.00267552792642086,0.215521084814805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36500,0.00760212439703276,0.00614329447330961,-0.00443873277065407,0.0196429815647196,0.215936732319075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36430,0.00676794048937317,0.00546997939726879,-0.00395321912927365,0.01748910010802,0.21600325188948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36421,0.0117840693158144,0.00954352419216146,-0.00692123810082206,0.0304893767324509,0.216938746594451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39283,0.00308506692117199,0.00249933465305553,-0.00181362899881686,0.00798376284116083,0.217089352829324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,38741,0.00777423087637344,0.0063082281080959,-0.00458989621549452,0.0201383579682414,0.217820914300824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,38727,-0.00490997633008624,0.00398680977862924,-0.0127241234961995,0.00290417083602707,0.218134763073695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36363,0.00659064693106557,0.00536902593749279,-0.0039326439064203,0.0171139377685514,0.219646107588946
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",36731,0.00494031700988727,0.00403009126920239,-0.00295866187774941,0.012839295897524,0.220274788875441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39224,0.00518102701981822,0.00423049353037833,-0.00311074029972331,0.0134727943393598,0.220712254589218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,36731,0.00384659614899077,0.00316032295086501,-0.00234763683470466,0.0100408291326862,0.223568374198541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36391,0.0122290010628156,0.0100509263719003,-0.00747081462610888,0.0319288167517401,0.223739819688568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36531,-0.0109455059815518,0.00899645998191455,-0.0285785675461043,0.00668755558300076,0.223761639622134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,38841,0.00582335087490544,0.00479327682503753,-0.00357147170216811,0.015218173451979,0.224423472095557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36339,0.00799117971004872,0.00659030150222056,-0.00492581123430358,0.020908170654401,0.2253185069055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39086,0.00757243597948095,0.00626635598901007,-0.00470962175897879,0.0198544937179407,0.226901690849592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36339,0.00957703008015303,0.00794527228130152,-0.00599570359119796,0.025149763751504,0.228081545216846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,38997,0.00663147542202091,0.00550431824220543,-0.00415698833270173,0.0174199391767435,0.228308278879386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,36792,0.00291355116615315,0.00241866146710244,-0.00182702530936763,0.00765412764167393,0.228374761654118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,36731,0.00587165770585979,0.00487764144229945,-0.00368851952104714,0.0154318349327667,0.228692758371259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38391,0.00307800985163922,0.00256100495469512,-0.00194155985956321,0.00809757956284164,0.22943124236767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36339,-0.00286785018822732,0.00239752263386117,-0.00756699455059521,0.00183129417414057,0.231652050798134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36430,0.00344217434726724,0.00287901451646333,-0.00220069410500089,0.00908504279953538,0.23187191098585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39241,0.00826796016017228,0.00692216473254744,-0.00529948271562071,0.0218354030359653,0.232332804665507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36538,0.00479456482600988,0.00401508145209903,-0.00307499482010422,0.012664124472124,0.232445992426979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,36792,-0.00539861233960368,0.00453425430656438,-0.0142857507804699,0.0034885261012625,0.233821318065576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36430,0.00438149942163562,0.00369311159067577,-0.0028569992960889,0.0116199981393601,0.235487668011431
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39283,0.00605345966601952,0.00510662759664865,-0.00395553042341183,0.0160624497554509,0.235872695787537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,38841,-0.00535137604189724,0.00451568712032885,-0.0142021227977418,0.00349937071394731,0.236011134349661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,36791,-0.00848230783551867,0.00717821755542806,-0.0225516142441577,0.00558699857312033,0.237357097743786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39178,0.00335734146548871,0.00284249836724212,-0.00221395533430585,0.00892863826528327,0.237572025140377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39260,0.00739176731992511,0.00627438807987635,-0.00490603331663253,0.0196895679564827,0.238780617956036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,38741,-0.00375378880081661,0.00319176853615769,-0.0100096551316857,0.00250207753005246,0.239580013065555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36421,-0.00522932320197751,0.00444654066234123,-0.0139445429001663,0.0034858964962113,0.239599965426262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,38741,0.00525927737193871,0.00447682522315424,-0.0035153000654436,0.014033854809321,0.24010219962049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36363,0.00529538872590822,0.00453780986484976,-0.0035987186091973,0.0141894960610137,0.243253573970622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36538,-0.00328990106430301,0.00282190128130818,-0.00882082757566703,0.00224102544706102,0.243698827238826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36538,0.00450018337911798,0.00386382265726362,-0.00307290902911871,0.0120732757873547,0.244163503053899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36421,0.00904546780304235,0.00776823194755564,-0.0061802668141667,0.0242712024202514,0.244276839344057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36430,0.00462523509798439,0.00398610837137023,-0.00318753730990127,0.0124380075058701,0.245933043354836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,36767,-0.00366133289295462,0.00316379697191886,-0.00986237495791558,0.00253970917200634,0.247187926948954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,38987,0.00364564220077735,0.00316293427320317,-0.00255370897470087,0.00984499337625556,0.249087084081208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39140,0.00321898479947574,0.00279378653791513,-0.00225683681483793,0.0086948064137894,0.249259283835619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,38741,0.0031820159439068,0.00277463923081431,-0.00225627694848925,0.00862030883630285,0.251473837390899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36391,-0.00407328146251492,0.003555256578146,-0.0110415843556811,0.00289502143065124,0.251938388774626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36421,0.00403406548792967,0.00353071838340177,-0.0028861425435378,0.0109542735193971,0.253242170153704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36500,-0.0033378318667076,0.00292411971084539,-0.00906910649996457,0.00239344276654937,0.25369075949587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",38741,0.00564143768210452,0.00497594680875903,-0.00411141806306319,0.0153942934272722,0.256921236367186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36391,-0.00536345907852445,0.00473307661050771,-0.0146402892351196,0.00391337107807066,0.25715757266996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39099,0.00572977479256759,0.00506336255443548,-0.00419441581412595,0.0156539653992611,0.257814322612751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36339,-0.00475074301633064,0.00420221693902624,-0.0129870882168221,0.0034856021841608,0.258273619915528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36391,0.0043141679506774,0.0038204249191781,-0.00317386489091167,0.0118022007922665,0.258819179231106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39051,0.0040572017852671,0.00362334681013064,-0.00304455796258896,0.0111589615331231,0.262842815507697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36430,0.00349283001095559,0.00312281417162259,-0.00262788576542469,0.00961354578733586,0.263380025778543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,36806,0.003243344437904,0.00290088960058291,-0.00244239917923851,0.0089290880550465,0.263565676219499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",38832,0.00440627917494503,0.00394747329357355,-0.00333076848045912,0.0121433268303492,0.264342579178808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36538,0.00738067224383073,0.00661307817394908,-0.00558096097710947,0.0203423054647709,0.264412413408416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36538,-0.00848558516120985,0.00761578271598008,-0.0234125192845308,0.0064413489621111,0.265210008850849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39241,0.0037119267750126,0.00334068181387663,-0.00283580958018559,0.0102596631302108,0.266530410166913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36420,0.00476241224030641,0.00429356557247333,-0.00365297628174132,0.0131778007623541,0.267366223897781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36339,-0.00262516989860041,0.00237516060310422,-0.00728048468068468,0.00203014488348386,0.269068273493214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,38727,-0.00341885945652542,0.00310270493865589,-0.00950016113629096,0.00266244222324013,0.270524544282894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36339,-0.003385469350058,0.00307572994157397,-0.00941390003554298,0.00264296133542698,0.271046580187331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36339,-0.00422594140798662,0.00385049336712497,-0.0117729084075516,0.00332102559157832,0.272441227668341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,36731,-0.00448948509379141,0.0040997699756563,-0.0125250342460778,0.00354606405849493,0.273511805383608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36391,-0.00418591403638314,0.00382670942869527,-0.0116862645166259,0.00331443644385959,0.274034010739811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,36767,-0.00353059713776333,0.00322852376549617,-0.00985850371813583,0.00279730944260916,0.274166684786684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36430,0.00336815309190346,0.00308550808361331,-0.00267944275197863,0.00941574893578555,0.275028101587183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36430,-0.00603316672446071,0.0055411507181578,-0.01689382213205,0.00482748868312859,0.276266004524453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36538,-0.00291388489905452,0.00267729909720798,-0.00816139112958216,0.00233362133147313,0.276453661764049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36430,0.00596461122401718,0.00548866386250161,-0.00479316994648598,0.0167223923945203,0.277183791997312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36339,0.00361548213497985,0.00332903058915792,-0.00290941781976967,0.0101403820897294,0.277479383143694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,36743,0.00714647117139755,0.00658135286475918,-0.00575298044353044,0.0200459227863255,0.277558339046233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36430,0.00453694815559953,0.00418137996091898,-0.00365855656780167,0.0127324528790007,0.277926481023644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36538,0.00585101837874438,0.00540051605852243,-0.00473399309595958,0.0164360298534483,0.278643363336013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36391,-0.00637969914872548,0.00590968915035243,-0.0179626898834162,0.00520329158596528,0.280371368839725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36391,-0.00514969923990154,0.00477433020340964,-0.0145073864385844,0.00420798795878136,0.280776877656518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36538,-0.00531783371940022,0.00493643191823309,-0.0149932402791371,0.00435757284033664,0.281383441622328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36420,0.00516066874612827,0.00479608588688137,-0.00423965959215921,0.0145609970844158,0.281940433581598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36339,0.00624839888870133,0.00583520646327068,-0.0051886057793092,0.0176854035567119,0.28427546708774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,38832,-0.00603235824007671,0.00564897370530134,-0.0171043467024673,0.00503963022231392,0.285597277542893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36363,-0.008991926245319,0.00843363942869831,-0.0255218595255677,0.0075380070349297,0.286354907632514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36538,-0.00560299854142404,0.00526124375392595,-0.0159150362991189,0.00470903921627082,0.286915655218338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36430,-0.00856666753513649,0.00804594020481732,-0.0243367103365784,0.00720337526630546,0.287023441269838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39044,0.00635784845633803,0.00598898552568957,-0.00538056317401353,0.0180962600866896,0.28843864034876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,36767,0.0112441586100053,0.010595613048565,-0.00952324296518209,0.0320115601851927,0.288614843068734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39013,0.00543295068176673,0.00512458988493577,-0.00461124549270738,0.0154771468562408,0.28908290202845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39241,-0.00446250686202816,0.00422360931001898,-0.0127407811096654,0.00381576738560904,0.290727934661091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,36767,-0.00498052130414087,0.00471962045831789,-0.0142309774024439,0.0042699347941622,0.291317015826382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36421,0.00482833350600785,0.00458463425253876,-0.00415754962896811,0.0138142166409838,0.292289915106126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36420,0.0247958919976392,0.0236333775369617,-0.0215255279748057,0.0711173119700841,0.294111089364614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,38941,0.00458741775871544,0.00437366725090294,-0.00398497005305433,0.0131598055704852,0.294253774628695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36500,0.00208054443228922,0.00198700107758112,-0.00181397767976977,0.0059750665443482,0.295083784889903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,36747,-0.00545981453956083,0.00521955865589465,-0.0156901495051143,0.00477052042599268,0.295566836351102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,36767,0.00457715519301743,0.0044036478856203,-0.00405399466279836,0.0132083050488332,0.298637836239676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36339,-0.00413634851425724,0.00398342174277172,-0.0119438551300898,0.00367115810157533,0.299108267370429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36421,-0.00569832878029653,0.00548832777883602,-0.0164554512268151,0.00505879366622207,0.299167520306935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",36791,0.00401451649923883,0.00386856339689792,-0.0035678677586811,0.0115969007571588,0.299416116391665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,38832,-0.00569051100861714,0.00548409868219775,-0.0164393444257247,0.00505832240849044,0.299455222586154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36421,-0.00489952811230847,0.00474833885753308,-0.0142062722730733,0.00440721604845637,0.302166732105207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36391,-0.00579626771641096,0.00563257855495328,-0.0168361216841194,0.00524358625129747,0.303470806841165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36311,0.00825502092363563,0.00805172846304218,-0.00752636686392705,0.0240364087111983,0.305265960775906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,38841,0.00337420289672347,0.00329138842025475,-0.00307691840697585,0.00982532420042279,0.305303800646606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,38832,0.00378254722294466,0.00369344201171992,-0.00345659912002637,0.0110216935659157,0.305792665888111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,36747,0.0041719274759896,0.00407587797754806,-0.0038167933600046,0.0121606483119838,0.306059830633333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36430,-0.00393596508025693,0.00385172409172184,-0.0114853443000317,0.00361341413951787,0.306861633902285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,36796,0.0133888989083588,0.0131488750359711,-0.0123828961621445,0.0391606939788621,0.308576150361406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,38987,-0.00388955065934883,0.00382028472705649,-0.0113773087243796,0.0035982074056819,0.30863194439634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,36731,0.00532868148019176,0.0052380844161909,-0.00493796397554239,0.0155953269359259,0.309031837117964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39106,0.00325457607435063,0.00320057067149157,-0.00301854244177284,0.00952769459047411,0.309229662309023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36339,-0.00674646914671451,0.00664615724436575,-0.0197729373456714,0.00627999905224236,0.3100810742692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36430,0.00426324631351079,0.00420081940068309,-0.00397035971182806,0.0124968523388496,0.310191790643722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39147,0.007277361403086,0.00718022600323764,-0.00679588156325977,0.0213506043694318,0.31082398320028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39115,0.00453690361795436,0.00449231717223567,-0.00426803803962756,0.0133418452755363,0.31254722107777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36363,0.00521068786422338,0.00517547900150861,-0.00493325097873349,0.0153546267071803,0.314048929185533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36421,-0.0056277410277322,0.00559519182212861,-0.0165943169991043,0.00533883494363989,0.314522813279329
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36500,0.00310845915613315,0.00309074952636011,-0.00294940991553266,0.00916632822779897,0.31456477698562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39283,0.00477236683877315,0.00475290954633388,-0.00454333587204126,0.0140880695495876,0.31534917347754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36339,0.00523784717016478,0.00521878596287706,-0.00499097331707427,0.0154666676574038,0.315565638056393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,36767,-0.00307446399226199,0.00306837361722078,-0.00908847628201471,0.00293954829749074,0.316369676117674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36391,-0.00423470055125826,0.0042281019249172,-0.012521780324096,0.00405237922157945,0.316575169021771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,38841,-0.00284105871421865,0.00283673090376207,-0.00840105128559231,0.00271893385715502,0.316588930181487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36363,-0.00654641178165878,0.00654014748144952,-0.0193651008452998,0.00627227728198228,0.316866571012473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39030,0.00984203844308516,0.00983640379880006,-0.00943731300256295,0.0291213898887333,0.317049327753439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36430,-0.00313801057088371,0.00314209062323846,-0.00929650819243109,0.00302048705066367,0.317958545639279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39023,-0.00767081466217057,0.00768101120999275,-0.0227255966337564,0.00738396730941521,0.317969303404962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36339,-0.00840679371319886,0.00841814767133481,-0.0249063631490151,0.00809277572261736,0.31798302667635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36339,0.00238945834030813,0.0024022283824369,-0.0023189092892682,0.00709782596988447,0.319909223825603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,36731,0.00354363617583201,0.00356814301157688,-0.00344992412685866,0.0105371964785227,0.320664414309267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36420,-0.00375643271275383,0.0037832156686445,-0.011171535423297,0.00365866999778939,0.320767785449027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36391,0.00415434449118818,0.00419475164271882,-0.00406736872854071,0.0123760577109171,0.322013787802704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36538,0.0059463849079468,0.00600683306579414,-0.00582700790100972,0.0177197777169033,0.322223919310405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,38841,0.00434666230324295,0.00440245648708263,-0.00428215241143901,0.0129754770179249,0.323498510345632
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,36731,0.00505491232078493,0.00513162986331247,-0.00500308221130752,0.0151129068528774,0.324617996776755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36430,0.0027856748227549,0.00283109228077747,-0.00276326604756895,0.00833461569307874,0.325155289118422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36421,-0.00390596180273615,0.00397916414212601,-0.0117051235213031,0.00389319991583082,0.326314084443934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",36731,0.00455039554448898,0.00463856818417183,-0.0045411980964878,0.0136419891854658,0.326615416145694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,38832,0.00439021845748801,0.00447631590804126,-0.00438336072227285,0.0131637976372489,0.326723994902527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36430,0.00369406966727403,0.00377270693470855,-0.00370043592475472,0.0110885752593028,0.327521613903596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,36791,-0.00807478857652228,0.00826541821763845,-0.0242750082830936,0.00812543113004908,0.328618876068453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36363,-0.0057276701134801,0.00586728262547214,-0.0172275440594055,0.0057722038324453,0.328981816870757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36391,-0.0035767917206501,0.00368636964751424,-0.010802076229778,0.0036484927884778,0.331928242060108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36339,-0.00317638349869828,0.00327425366986513,-0.00959392069163393,0.00324115369423737,0.332010882328022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,38915,-0.0052017550824551,0.0053799262083234,-0.015746410450769,0.00534290028585876,0.33361843933838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,38741,0.00699473479151708,0.00723656034195753,-0.00718892347871967,0.0211783930617538,0.333768342116215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,36731,-0.00244169414973564,0.00253016436171567,-0.00740081629869836,0.00251742799922707,0.334546009421001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36538,-0.00757609018042542,0.0078589505834143,-0.0229796333239174,0.0078274529630666,0.335060369067753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,36792,0.00295324535940069,0.00307813118255065,-0.00307989175839858,0.00898638247719997,0.337361093218402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,36631,0.00483599763226876,0.00506880915401305,-0.00509886830959682,0.0147708635741343,0.340066379609126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36500,0.00325158591478087,0.00341188874223144,-0.00343571601999276,0.0099388878495545,0.340599986784569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36391,0.00417386183644574,0.00438469142110156,-0.00442013334891332,0.0127678570218048,0.341157491293381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,38773,-0.00407923364771743,0.00429151113329541,-0.0124905954689764,0.00433212817354156,0.341855632620708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36363,0.00283226767549855,0.00298590263955003,-0.0030201014980195,0.0086846368490166,0.342869614969786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,36767,-0.0136738637489182,0.0144302466695848,-0.0419571472213044,0.0146094197234679,0.343359265952129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39093,-0.00261795341683961,0.00276303927426565,-0.00803351039440028,0.00279760356072106,0.343403933401614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,36731,0.00950451199963785,0.0100591389698093,-0.0102114003811884,0.0292204243804641,0.344746368015128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36421,-0.00312571033373354,0.003308204034105,-0.00960979024057934,0.00335836957311226,0.344760772769118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",36747,-0.00218565893364297,0.00231729900881837,-0.00672756499092699,0.00235624712364104,0.345600154958151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36363,0.00508380735311523,0.00541158216576953,-0.00552289369179306,0.0156905083980235,0.347527716587742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36430,0.0025565418793937,0.00272156953988991,-0.00277773441879053,0.00789081817757793,0.3475624240723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39147,0.00231189753025605,0.00246486747463902,-0.00251924272003642,0.00714303778054852,0.348290119484262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,38795,0.0061875738446583,0.00660029760642226,-0.00674900946392934,0.0191241571532459,0.348532564811614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36363,-0.00526091083795278,0.00561382614384866,-0.0162640100798961,0.00574218840399058,0.348707415557524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,36731,0.00375024569492267,0.00400255398439656,-0.0040947601144946,0.0115952515043399,0.348795079987078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,38987,0.00401558436133524,0.00430183892142547,-0.00441601992465868,0.0124471886473292,0.350598636401449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,36731,0.00456389025315568,0.00488983658574714,-0.0050201894549087,0.0141479699612201,0.35066088290912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39052,0.00500410461709733,0.00536956139534213,-0.00552023571777324,0.0155284449519679,0.351382770253627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36430,0.00538133346666043,0.00577650177212754,-0.00594061000670955,0.0167032769400304,0.351566149620274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,38841,0.00238473611028655,0.00256753167828336,-0.00264762597914883,0.00741709819972193,0.353005147751572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,38832,0.00283576499928827,0.00305368287202509,-0.0031494534298809,0.00882098342845745,0.353091854699905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39291,0.00320883163439385,0.003467434888834,-0.00358734074772079,0.0100050040165085,0.354762245264706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36430,-0.00185274382393959,0.00200293554192778,-0.00577849748611803,0.00207300983823885,0.354976276949382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36391,0.00536027881334457,0.00580445219013048,-0.00601644747931117,0.0167370051060003,0.355776397587496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36339,-0.00334848946391977,0.00362923155544139,-0.0104617833125849,0.00376480438474535,0.356210488965046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36421,-0.00546535605292699,0.00595042074704847,-0.017128180717142,0.00619746861128801,0.358384064423339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,36731,0.00565654761839578,0.00617461770501766,-0.00644570308343883,0.0177587983202304,0.359633281051802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36339,0.00456713661689987,0.00498803311636511,-0.00520940829117574,0.0143436815249755,0.359884589231267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,36767,0.0064140241860029,0.00700758244121651,-0.00732083739878147,0.0201488857707873,0.360052458521788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,36731,0.0034715428988709,0.00379982576024017,-0.00397611559119983,0.0109192013889416,0.360941124561971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36339,-0.00503645129713483,0.00551368241857381,-0.0158432688375395,0.00577036624326984,0.361025655303274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,38841,-0.00433994727523435,0.00475989681337232,-0.0136693450294441,0.00498945047897541,0.361902689817827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36339,-0.00309854560859306,0.00339911880909935,-0.00976081847442779,0.00356372725724167,0.362011044369797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,36743,0.00387009220846725,0.00425855472009009,-0.00447667504290934,0.0122168594598438,0.363482912406187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36391,0.00386068465022317,0.00426166634572364,-0.00449218138739517,0.0122135506878415,0.365001096285036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36538,0.0018831266221273,0.00208443064409031,-0.00220235744028971,0.00596861068454431,0.366317575231022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,38713,-0.00293310632438978,0.00326205777199162,-0.00932673955749335,0.00346052690871379,0.368582924049119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,38741,-0.00500355145801841,0.00559152841458125,-0.0159629471505977,0.00595584423456084,0.370884403798715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,36731,0.00415647562669082,0.00465088293886322,-0.0049592549334811,0.0132722061868627,0.371501258998297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39100,-0.00775806588545858,0.00869903725729103,-0.024808178909749,0.00929204713883183,0.372497924442218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36538,0.00431990426958861,0.00484822878316111,-0.00518262414540716,0.0138224326845844,0.372931426177097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36430,0.00405776906856281,0.00456161138346919,-0.00488298924303679,0.0129985273801624,0.373726040351551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,36747,0.00254520568341254,0.00287632185930572,-0.00309238516082667,0.00818279652765176,0.376236740804528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36339,-0.00322489996950017,0.00364836991102602,-0.0103757049951112,0.00392590505611082,0.376751569959997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36391,-0.00551949735377504,0.00627311345437036,-0.0178147997243409,0.00677580501679086,0.378948941386923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,36731,0.00415438978763183,0.00473082708934944,-0.00511803130749307,0.0134268108827567,0.379877110577878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36420,-0.0032886717813997,0.00374593187775031,-0.0106306982617903,0.00405335469899092,0.379997659347518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,38841,0.00394437991703114,0.00451441997594911,-0.00490388323582912,0.0127926430698914,0.382279827168824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36363,-0.00276130980907124,0.00316451279576941,-0.00896375488877928,0.00344113527063681,0.382905488338684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,38987,0.00263818553310263,0.0030244702079713,-0.00328977607452112,0.00856614714072637,0.383069371300357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36391,0.00661842615837973,0.00760899569472802,-0.00829520540328719,0.0215320577200466,0.384417629813969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36538,-0.00418953493224273,0.00482165814074404,-0.0136399848881011,0.00526091502361559,0.384918711973971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36391,0.00321888700920475,0.00370999404362351,-0.00405270131629733,0.0104904753347068,0.385615764305522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36339,-0.00448577949252327,0.00517524861090444,-0.014629266769896,0.00565770778484942,0.386081610266359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36339,-0.00353992304767181,0.00409116435201604,-0.0115586051776232,0.00447875908227962,0.386912440828966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,38841,0.00514152753651896,0.00595496111599495,-0.00653019625083114,0.0168132513238691,0.38793009956841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36339,-0.00528455014791611,0.00613222007149323,-0.0173037014880428,0.00673460119221061,0.388831835078021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,38736,-0.00330037587315467,0.00384976944825605,-0.0108459239917365,0.00424517224542718,0.391297436325925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36430,0.00744745348740153,0.00873107237230389,-0.00966544836231409,0.0245603553371172,0.393685163253188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36421,0.00588247367302665,0.00690108905990686,-0.00764366088439079,0.0194086082304441,0.39400954916072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,36747,0.00235181774889159,0.00276340431286823,-0.00306445470433014,0.00776809020211331,0.394752867062432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,38727,0.00380858792903067,0.00448588249973139,-0.00498374177044285,0.0126009176285042,0.395885822317389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,36767,-0.00247218453623913,0.00291338866205598,-0.00818242631386885,0.00323805724139059,0.396142013803975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,36767,0.0070442439506295,0.00831099102966196,-0.00924529846750794,0.0233337863687669,0.3966866828595
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,36711,-0.003146432947841,0.00371387947650688,-0.0104256367217945,0.00413277082611248,0.396894290489057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39023,-0.00152650134603386,0.00180802457992641,-0.00507022952268963,0.0020172268306219,0.398519372354467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,36743,-0.0038518529987809,0.00456247644542823,-0.0127943068318202,0.00509060083425843,0.398547568504341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,36743,0.00472190876981447,0.00560595842296244,-0.00626576973919192,0.0157095872788209,0.399634689807617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36391,-0.00240140112526663,0.00285306815655289,-0.0079934147121103,0.00319061246157703,0.399977129800417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,36767,0.0022914656116017,0.00272327789943315,-0.00304615907128728,0.00762909029449069,0.40011899519441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,38942,0.00483157107867806,0.00575527864690989,-0.00644877506926532,0.0161119172266214,0.401200667422328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39093,-0.00493791981063526,0.00588256062369392,-0.0164677386330753,0.00659189901180482,0.401248671228238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,36731,-0.00380088744507963,0.0045372150889852,-0.0126938290194906,0.00509205412933137,0.40220704680836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,36791,-0.00226870334455962,0.00271678126842246,-0.00759359463066764,0.00305618794154839,0.403693556604876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36391,-0.00389504312644326,0.00467091719047245,-0.0130500408197693,0.00525995456688275,0.404357421278168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,36731,0.00526725948651028,0.00632064784083579,-0.00712121028152788,0.0176557292545484,0.404667502145952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36391,0.00308532014044228,0.0037115469502135,-0.00418931188197618,0.0103599521628607,0.405833532232801
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],38841,0.00414339122352107,0.00498546643736743,-0.00562812299371909,0.0139149054407612,0.40593377668103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,36618,0.00817088661738593,0.00984430023539533,-0.0111239418439889,0.0274657150787608,0.406547570311349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36421,0.00705884448686006,0.00850790810087316,-0.00961665539085133,0.0237343443645714,0.406735280212209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,38992,0.00173805911779372,0.00210467759762415,-0.00238710897354961,0.00586322720913706,0.408926163840502
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36421,-0.00286904893129773,0.00348296885899791,-0.00969566789493363,0.00395757003233816,0.41010487714912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36538,0.00537841503780886,0.00653271818570884,-0.00742571260618046,0.0181825426817982,0.410350449399622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36538,0.00663667886801565,0.00807224913648064,-0.00918492943948641,0.0224582871755177,0.411001407125952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36391,0.00408097329159358,0.00496877941025624,-0.00565783435250865,0.0138197809356958,0.411477880246645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,36792,-0.00225814430101315,0.00274959371013047,-0.00764734797286887,0.00313105937084257,0.411510639664821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36391,0.00282599267094157,0.00344564123739148,-0.00392746415434572,0.00957944949622887,0.412137928728349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,38741,0.00424012685433684,0.00519262017684045,-0.00593740869227043,0.0144176624009441,0.414188487976622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,38727,-0.00581298486065363,0.00714746336721545,-0.0198220130603959,0.00819604333908865,0.416062878236082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,38841,0.00619265493286873,0.0076276524293749,-0.00875754382870608,0.0211428536944435,0.416879674781376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36363,0.00393569363291258,0.00485203037256344,-0.00557428589731177,0.0134456731631369,0.4172986208822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39023,-0.00153509607474547,0.00190892543585985,-0.00527658992903077,0.00220639777953983,0.42131276843548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36339,0.00392510042964326,0.00489099851790821,-0.00566125666545683,0.0135114575247434,0.422270308885113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36430,-0.00337188322077825,0.00420199784050232,-0.0116077989881628,0.00486403254660631,0.422309239743266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36538,-0.00256153117855038,0.00321808065816111,-0.00886896926854615,0.0037459069114454,0.42605796101639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39162,0.00146529717012592,0.00184408216973725,-0.00214910388255909,0.00507969822281092,0.426861861675384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39091,0.00425345762560705,0.005361719246125,-0.00625551209679795,0.014762427348012,0.427614790053262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36421,0.0051762768494513,0.00652884967558695,-0.00762026851469912,0.0179728222136017,0.42789104971457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36538,0.00573354171158181,0.00723320970612358,-0.0084435493124204,0.019910632735584,0.427985479780709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36421,0.00358873649018318,0.00453532058247601,-0.00530049185146979,0.0124779648318361,0.428791953127257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36421,-0.00297403121230963,0.00376542775172256,-0.0103542696056858,0.00440620718106659,0.429644538808995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,36731,-0.00262134801788464,0.00332609023981682,-0.00914048488792561,0.00389778885215632,0.430642829270906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36363,-0.0064908648565201,0.00824732427284416,-0.0226556204312946,0.00967389071825445,0.431281122134998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36391,0.00243080798086617,0.00309866313899131,-0.00364257177155679,0.00850418773328914,0.432779262585742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,38807,0.00387989987472838,0.0049568846433812,-0.00583559402629878,0.0135953937757555,0.433798371190824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,36791,-0.00154326220456778,0.00198388967549986,-0.00543168596854751,0.00234516155941194,0.436643856938966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36363,0.00752029303598034,0.00967322654722801,-0.0114392309965866,0.0264798170685472,0.436917601096051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,36792,0.00210039244767119,0.00270468031929461,-0.00320078097814625,0.00740156587348863,0.437422596480102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,36747,-0.00159061076805059,0.00205513376339829,-0.00561867294431123,0.00243745140821005,0.438963049815747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,36702,-0.0034131578753714,0.00441854420570787,-0.0120735045185588,0.00524718876781602,0.439855009667436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38605,-0.00600029586234152,0.0077794207114588,-0.0212479604568008,0.00924736873211772,0.440539308320628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39255,-0.00176743701564609,0.00230247570727826,-0.00628028940191148,0.00274541537061929,0.442722010348232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36391,0.00142021895931362,0.0018511325563634,-0.00220800085115863,0.00504843876978588,0.442967413583418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36391,-0.00361914788789549,0.00472651966133161,-0.0128831264241054,0.00564483064831446,0.443862728665449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,36767,-0.00313379027625336,0.0041261484644147,-0.0112210412665062,0.00495346071399944,0.447570208301108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36420,-0.00419925644839072,0.00553434230721638,-0.0150465673705348,0.00664805447375339,0.448008334735141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36391,0.0027601091456001,0.0036449891192921,-0.00438406952821242,0.00990428781941262,0.448924011387601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36339,-0.00279811704358443,0.00373309503196877,-0.0101149833062432,0.00451874921907435,0.453543831376683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36538,0.00498538786431428,0.00670808953100424,-0.00816246761645404,0.0181332433450826,0.457380174740143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36391,0.00415215179298185,0.00559940880508533,-0.00682268946498539,0.0151269930509491,0.458383644527278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,36731,0.00304545677886507,0.00413020479112073,-0.00504974461173156,0.0111406581694617,0.460915573984068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,38841,0.00329145523393299,0.00448018459328659,-0.00548970656890872,0.0120726170367747,0.462552263802367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,38946,0.00190869276335804,0.00259944088500287,-0.00318621137124759,0.00700359689796367,0.462795304290912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,36743,0.00283208678580099,0.00386566083186311,-0.00474460844465072,0.0104087820162527,0.463799399900723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36363,-0.00394662300365563,0.00539146970783919,-0.0145139036310204,0.00662065762370917,0.46417468314343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,36767,0.00518740408521401,0.00708686603217722,-0.00870285333785333,0.0190776615082814,0.464197520084697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,38987,-0.00082384235326169,0.00112570988384305,-0.00303023372559407,0.00138254901907069,0.464276033144808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36430,-0.00233415827439278,0.0031894759388571,-0.00858553111455269,0.00391721456576714,0.464285194772151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36538,-0.00457104375979308,0.00625021532426702,-0.0168214657953564,0.00767937827577027,0.464583917982744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36430,-0.00319970565890603,0.00437882201799483,-0.0117821968141759,0.00538278549636385,0.464962025578146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36456,0.00550552851526491,0.00760031715476016,-0.00939109310806501,0.0204021501385948,0.468845059006494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,38841,0.00277895403511697,0.0038487110844031,-0.0047645196903131,0.0103224277605471,0.470276253705458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36430,0.00183926394415507,0.00255347332786868,-0.00316554377846755,0.00684407166677768,0.471354395997639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39023,0.00359855047604183,0.00500275097984229,-0.00620684144444906,0.0134039423965327,0.471958353205532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36430,-0.00673552951208613,0.00938425740840522,-0.0251286740325604,0.0116576150083881,0.472926182162067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39165,-0.00296916152585294,0.00414265544445872,-0.011088766196992,0.00515044314528615,0.473552230531616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,38727,-0.00389852801174489,0.00552241257590305,-0.0147224566605149,0.0069254006370251,0.480232449792398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36420,-0.001890114116621,0.00268080905374212,-0.00714449986195556,0.00336427162871355,0.480789944841247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,36743,-0.0054010285878902,0.00767073937986574,-0.020435677772427,0.00963362059664665,0.481378275312633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,36731,0.00271395727669954,0.00386333647757213,-0.00485818221934185,0.0102860967727409,0.48238601167954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36339,0.00265092381863211,0.0037890100245864,-0.00477553582955724,0.0100773834668215,0.484168354555134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36363,-0.0033868505119076,0.00484093113749957,-0.0128750755414068,0.00610137451759157,0.48417272653919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35080,-0.00651212020693753,0.00930850131066026,-0.0247567827758316,0.0117325423619566,0.484198847239206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36391,0.00484070983316317,0.00692496660600148,-0.00873222471459974,0.0184136443809261,0.484550729997723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36664,-0.00194318832751347,0.00278472342780771,-0.00740124624601658,0.00351486959098965,0.485313081607596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,36767,0.00226804704256472,0.00325926891643616,-0.00412012003365014,0.00865621411877959,0.48651901306319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36363,-0.00192550501193384,0.0027791995606879,-0.00737273615088213,0.00352172612701444,0.488430877096272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36421,-0.00337875343531806,0.00488226506535432,-0.0129479929634125,0.00619048609277641,0.488921050142265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36391,0.00450061862003552,0.0065058007194227,-0.00825075079003297,0.017251988030104,0.489084859124544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36363,-0.00342206157270606,0.00494697345023487,-0.0131181295351664,0.00627400638975428,0.489108114331932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,38713,0.00390069269587533,0.00563954058399952,-0.00715280684876372,0.0149541922405144,0.489156330887835
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,38882,-0.0108380786393917,0.0156781890469749,-0.0415673291714626,0.0198911718926792,0.489397871232397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36391,-0.00615641848920272,0.00891070402030287,-0.0236213983689963,0.0113085613905909,0.489640261191525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36430,-0.0016491724378593,0.00239115819278221,-0.00633584249571243,0.00303749761999382,0.490398062015646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,36679,0.0016964733254679,0.00246010032731917,-0.00312532331607767,0.00651826996701348,0.490461282535386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36339,-0.00270784525556943,0.00393374200065114,-0.0104179795768457,0.00500228906570682,0.491236563758098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36391,0.00290981455125636,0.00427229048871022,-0.00546387480661568,0.0112835039091284,0.49582709672418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,36791,0.00155371795836796,0.00228797580847242,-0.002930714626238,0.00603815054297391,0.497099509051575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39147,-0.00236159356158264,0.00348233486163019,-0.00918696989037782,0.00446378276721254,0.497678085214583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36377,0.00248295182221987,0.00367803773073091,-0.00472600213001272,0.00969190577445246,0.499640498909681
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,36743,0.00261900348612338,0.00388348726956484,-0.00499263156222371,0.0102306385344705,0.500072470680148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39023,0.00331249736185858,0.00491498905398883,-0.00632088118395952,0.0129458759076767,0.500348138428466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36421,0.00167828177773502,0.00249150402767002,-0.00320506611649821,0.00656162967196825,0.500576856542386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36391,-0.00335854578156369,0.0049970525794882,-0.0131527688373606,0.00643567727423318,0.501529021098893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36339,0.00567082746423441,0.0084497347151373,-0.0108906525774347,0.0222323075059035,0.502153380010124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,38741,0.00328547900418198,0.0049059171365377,-0.00633011858343191,0.0129010765917959,0.503061223298413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39017,0.00178287657584977,0.00266264206875316,-0.00343590187890643,0.00700165503060596,0.50312985166611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36445,-0.00207650427311803,0.00310687858289756,-0.00816598629559724,0.00401297774936118,0.503917948287618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39079,-0.00595703403213773,0.00892209610372953,-0.0234443423954476,0.0115302743311722,0.5043530907944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36363,0.00297039532302107,0.0044651773296143,-0.00578135224302297,0.0117221428890651,0.50591202674104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36391,0.00533899365703123,0.00802796450480851,-0.0103958167723934,0.0210738040864559,0.506031082108199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,38841,-0.00228843355252108,0.00344294277084114,-0.00903660138336973,0.00445973427832756,0.506269441964535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,38841,0.00378615312896504,0.00570208903742413,-0.00738994138438626,0.0149622476423163,0.506704345095522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36363,-0.00374321535317336,0.00565880699067926,-0.0148344770549047,0.00734804634855798,0.508313587413419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,36767,-0.00316350919127694,0.00478613643702823,-0.0125443366078523,0.00621731822529839,0.508641127240393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36421,0.00236904442433039,0.00358754160530459,-0.00466253712206661,0.0094006259707274,0.509039334308461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36391,-0.00308924377843472,0.00468708517288056,-0.0122759307172806,0.00609744316041118,0.509845592689933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36430,-0.0040889929240422,0.0062200169911475,-0.0162802262266913,0.00810224037860689,0.510940567924024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,38841,-0.00284613878962999,0.0043336458467068,-0.0113400846491753,0.00564780706991535,0.511349262100419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36538,-0.00312700851747373,0.00476679427303456,-0.0124699252926215,0.00621590825767401,0.511837179675716
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,38935,-0.00156219364130435,0.00238660267695436,-0.00623993488813489,0.00311554760552619,0.51275594575523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36339,0.00357273862832926,0.00546777867928109,-0.00714410758306168,0.0142895848397202,0.513499628513361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,36731,-0.00265802846076337,0.00409250613267078,-0.0106793404807981,0.00536328355927135,0.516035405333074
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39023,0.00188483529824989,0.00290771618590085,-0.00381428842611577,0.00758395902261555,0.516853481657183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36430,-0.00321885920881952,0.00499537984039748,-0.0130098036959986,0.00657208527835955,0.51934906923058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39093,0.00138848863650411,0.00215700950600389,-0.0028392499952635,0.00561622726827173,0.519773180747427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,36791,0.002337656824236,0.00363560690422717,-0.00478813270804925,0.00946344635652125,0.520242357222811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36339,-0.00240805028380622,0.00374585200498856,-0.0097499202135838,0.00493381964597135,0.520328167099635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36339,0.00174661513338498,0.00271716027632441,-0.00357901900821086,0.00707224927498083,0.520359839932331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,35842,-0.00302533073589268,0.00474428711505978,-0.0123241334814099,0.00627347200962449,0.523695053008058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36421,0.00184177414464779,0.00289480986356504,-0.00383205318793969,0.00751560147723527,0.52463602900822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36430,0.00263639933021502,0.00414550990539727,-0.00548880008436363,0.0107615987447937,0.524810793932709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39106,0.006691655016308,0.0105292253082155,-0.0139456265877944,0.0273289366204104,0.525091326780115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36363,-0.00279238232307268,0.00441318666647208,-0.011442228189358,0.00585746354321259,0.526917591860378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36363,-0.00446762364931485,0.00708178370967021,-0.0183479197202685,0.00941267242163877,0.5281427147646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38575,0.00146319507672591,0.00232423941923148,-0.00309231418496778,0.0060187043384196,0.529007224377415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36517,0.00303001649955314,0.00481471836860579,-0.0064068315029142,0.0124668645020205,0.529148500436396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,38727,0.00727501758407119,0.0116097813549869,-0.0154801538717031,0.0300301890398455,0.530912532945395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36339,-0.00269871193534654,0.00430789973435007,-0.0111421954146727,0.0057447715439796,0.531026997323472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36391,0.00273420464692717,0.00437110509445921,-0.00583316133821289,0.0113015706320672,0.531642570220898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,36743,-0.00287592914866611,0.00460292596449399,-0.0118976640390743,0.00614580574174212,0.532110400453858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39099,-0.00329123921407607,0.00528402618945254,-0.013647930545403,0.0070654521172509,0.533382032775854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36391,-0.00233690904294741,0.0037641597471829,-0.0097146621474259,0.00504084406153107,0.534721769029736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36421,0.00311795496913486,0.00502531588387918,-0.00673166416326833,0.012967574101538,0.534973116572523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36430,-0.00518035760542022,0.00836756229798204,-0.021580779709465,0.0112200644986246,0.535861719840955
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,36806,-0.00127881959698702,0.00206928988932946,-0.00533462778007276,0.00277698858609871,0.536586705034057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36519,-0.00308819054783686,0.00500685820646873,-0.0129016326325156,0.00672525153684184,0.537382960877582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36538,0.0041824446153874,0.00678172575156367,-0.0091097378576774,0.0174746270884522,0.537428681169298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36421,0.00222658760704935,0.00361603799933525,-0.00486084687164775,0.00931402208574644,0.538068459871873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38336,0.0016267351079553,0.00264334574029491,-0.00355422254302273,0.00680769275893333,0.538295235599688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36391,-0.00180699953964521,0.0029668371641365,-0.00762200038135275,0.00400800130206232,0.542491757558163
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36391,-0.00198730107951682,0.00327424907053793,-0.00840482925777116,0.00443022709873751,0.54389598173652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,38841,-0.00259492581635833,0.00431487988685776,-0.0110520903945995,0.00586223876188288,0.547589326232251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39099,-0.00231902448720399,0.00386393207524199,-0.00989233135467829,0.00525428238027031,0.548400425239131
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36430,0.00256837130840768,0.00428339511170435,-0.00582708311053285,0.0109638257273482,0.548776247005133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36420,-0.00389829878922217,0.00650694460608345,-0.0166519102171457,0.00885531263870139,0.549118208469301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36420,-0.00329660393366882,0.00550808886197441,-0.0140924581031387,0.00749925023580102,0.549515607639952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36363,-0.00351694134760895,0.0059034889390972,-0.0150877796682395,0.00805389697302157,0.551360072262248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39283,-0.00189529524306088,0.00318561244849865,-0.00813909564211823,0.00434850515599646,0.551882449984705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36339,-0.00346349223546055,0.00583171065234699,-0.0148936451140606,0.00796666064313955,0.552585259217378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36430,0.00221922658239468,0.00374209354316291,-0.00511527676220463,0.00955372992699399,0.553162293353439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,38741,0.00252141773929785,0.00429983001445863,-0.00590624908904106,0.0109490845676368,0.557616042146219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36430,0.00159953123261693,0.00272809078138434,-0.00374752669889638,0.00694658916413024,0.557671749050666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36538,-0.00274013503690296,0.00468216812503946,-0.0119171845619803,0.00643691448817438,0.558404957938383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39283,-0.00153878211436099,0.00262959610044117,-0.00669279047122569,0.0036152262425037,0.558436513384435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39211,-0.00376256384648342,0.00645169558499208,-0.0164078871930679,0.00888275950010106,0.55977402172763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,36748,0.00126683232422466,0.00218006177764137,-0.00300608875995242,0.00553975340840174,0.561183707127657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,38832,-0.00376744619840369,0.00651445237316332,-0.0165357728498038,0.00900088045299643,0.563055952968617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39255,0.00108181089515667,0.00187108925936927,-0.00258552405320709,0.00474914584352043,0.563156646717198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,38832,-0.0025425917488053,0.00444221136453108,-0.0112493260232862,0.0061641425256756,0.567079437265635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36339,-0.00219141589476999,0.00383113901391389,-0.00970044836204121,0.00531761657250122,0.567331503614027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36339,-0.00156811122712864,0.00274722518897443,-0.00695267259751853,0.00381645014326125,0.568146712804756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36363,-0.00364227962111444,0.00638539750467825,-0.0161576587302838,0.00887309948805492,0.568411488444946
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,38987,-0.0074968965011748,0.0131483280989809,-0.0332676195751773,0.0182738265728277,0.568564975641278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,38832,-0.00167458539533921,0.00293882229798127,-0.00743467709938251,0.00408550630870409,0.568811645301063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36538,0.00324117986811877,0.00571718165143132,-0.00796449616868661,0.0144468559049242,0.57077913691979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,36747,0.003394426517991,0.00599683309513786,-0.00835936634847921,0.0151482193844612,0.571378812803768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,38987,-0.00364575142937517,0.00645858288054361,-0.0163045738752406,0.00901307101649031,0.572434764268928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,36791,0.00388155296961322,0.00690871778313381,-0.00965953388532905,0.0174226398245555,0.574238820471622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,36731,0.00217406706292445,0.00387204667715661,-0.0054151444243025,0.0097632785501514,0.574481844714733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,38987,-0.00171290603542125,0.00305153815447249,-0.00769392081818733,0.00426810874734482,0.574584008587852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,36743,-0.00222576661165726,0.00396854223783483,-0.0100041093978135,0.00555257617449902,0.574907885864944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36421,-0.00285626644170745,0.00511781248042199,-0.0128871789033346,0.00717464601991965,0.576784006711972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,38741,-0.00326737834873669,0.00586005547160386,-0.0147530870730803,0.00821833037560687,0.577147923319234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,38727,-0.00163744349083885,0.00294967961799531,-0.00741881554210966,0.00414392856043195,0.578816914711888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39068,0.00133340860224491,0.00240464711919408,-0.00337969975137549,0.00604651695586531,0.57923581919613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,38841,0.00153164967887823,0.00276218603578108,-0.00388223495125268,0.00694553430900915,0.579240643173785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,38832,-0.00153452264928444,0.00280414812928956,-0.00703065298269199,0.0039616076841231,0.584226761087426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,38741,-0.00191223570655393,0.0034947488389763,-0.00876194343094749,0.00493747201783963,0.584267401117635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36339,-0.00249417073096659,0.00458207599212791,-0.0114750396755373,0.00648669821360411,0.586222734598501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36430,0.00217373354151691,0.00401396698526488,-0.00569364174960226,0.0100411088326361,0.588143340138075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36391,-0.00333605608160328,0.00616161488733913,-0.015412821260788,0.00874070909758142,0.588223886455618
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36391,0.00196304518783501,0.00363728685818721,-0.00516603705421193,0.00909212742988194,0.589413250968506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36375,-0.00412544492725999,0.00768431116521366,-0.0191866948110788,0.0109358049565588,0.591369763977962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36391,-0.00231880168812034,0.00432316930064013,-0.010792213517375,0.00615461014113432,0.591715039919209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36421,-0.00180046755988381,0.00336507236202709,-0.00839600938945691,0.0047950742696893,0.592627715003491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36339,0.00264954202619106,0.00498167442843399,-0.00711453985353955,0.0124136239059217,0.59483400690023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,38841,0.00258618033599927,0.00490524367028941,-0.00702809725776797,0.0122004579297665,0.598043282452342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36363,0.00192659374500637,0.00366794785105175,-0.00526258404305506,0.00911577153306779,0.599417940796942
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36391,-0.00281829360053732,0.00540760448304831,-0.013417198387312,0.00778061118623737,0.602255966862566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36538,-0.00208709388603601,0.00404186817627935,-0.0100091555115435,0.00583496773947152,0.605605985385946
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36430,-0.00226730916432145,0.00440644413183473,-0.0109039396627175,0.00636932133407462,0.60688078815422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36430,0.00356760615762197,0.00695530937062332,-0.0100648002087997,0.0172000125240437,0.608007357666314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39023,0.00204698459449395,0.00402816211921339,-0.00584821315916431,0.0099421823481522,0.611342660390454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39255,-0.00258637429861476,0.00510815253703443,-0.0125983532712022,0.00742560467397272,0.612637282347682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36363,-0.00223506155845472,0.00442567927750768,-0.0109093929423698,0.00643926982546033,0.613552894899644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39106,-0.00426764453757573,0.00848008890704987,-0.0208886187953935,0.012353329720242,0.614792486593535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36355,-0.00158758188064323,0.00315885526209784,-0.007778938194355,0.00460377443306854,0.615267470785124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36339,0.00272491932204057,0.00543932329825207,-0.00793615434253349,0.0133859929866146,0.616403462274897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36421,0.00223046610938186,0.00447092048308369,-0.00653253803746217,0.0109934702562259,0.617870565150339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36421,-0.00133093836903129,0.00266915243897325,-0.00656247714941885,0.00390060041135627,0.618043811736939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36421,0.00378318789858194,0.00764631366402359,-0.0112035868829043,0.0187699626800682,0.620769171405289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36363,-0.00284261543000414,0.00575049491054363,-0.0141135854546696,0.00842835459466137,0.621085107087052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,38727,0.00395566983574964,0.00801722187834823,-0.0117580850458129,0.0196694247173122,0.621739688219756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36538,0.00285496871606205,0.00582126763129029,-0.00855471584126691,0.014264653273391,0.623832739955255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36391,0.00177209993096959,0.00364982750377959,-0.0053815619764384,0.00892576183837758,0.627309084898359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36363,-0.00333134992510188,0.00689381304346141,-0.0168432234902862,0.0101805236400825,0.628935476169921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36339,-0.00212899309542339,0.00445368254563545,-0.0108582108848689,0.00660022469402208,0.632637349677881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36363,0.00186737294004065,0.00392314277739415,-0.00582198690365187,0.00955673278373318,0.634090507218186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,36767,0.00208020854351107,0.00437538057445774,-0.0064955373824261,0.0106559544694482,0.634485082982247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36363,-0.00140146967652269,0.00294794679948432,-0.00717944540351196,0.00437650605046659,0.634506387779394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36430,0.00116401040801572,0.00246043513963263,-0.00365844246566424,0.00598646328169569,0.636156273007964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36421,0.00158216407665523,0.00335409489938615,-0.00499186192614162,0.00815619007945208,0.637141146402703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39224,0.0012944334398318,0.00275790629552147,-0.00411106289939029,0.00669992977905389,0.638823519344045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36538,0.00168646127038174,0.00359369999548225,-0.00535719072076347,0.00873011326152696,0.638875642778313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36391,0.00209274351222182,0.00450869104462055,-0.00674429093523446,0.0109297779596781,0.6425428522567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39025,0.00174135696764154,0.00377539284555446,-0.0056584130096452,0.00914112694492829,0.644634035085697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36339,0.00139467010505381,0.00303320263260757,-0.00455040705485703,0.00733974726496466,0.645666957042397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36391,-0.00147519803811869,0.00322737157883653,-0.00780084633263828,0.0048504502564009,0.647614556723256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39197,-0.00123815418479845,0.00272077158042305,-0.00657086648242762,0.00409455811283073,0.6490619735767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36538,0.00216327426543529,0.00476827236709693,-0.00718253957407469,0.0115090881049453,0.650066256396762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,36743,0.00160177916722919,0.00354375031413225,-0.00534397144847002,0.0085475297829284,0.651275773895322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36500,0.00116791555694178,0.00259400593737494,-0.00391633608031311,0.00625216719419666,0.652547808085873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",38832,-0.00343648851238124,0.00766698525087624,-0.0184637796040987,0.0115908025793362,0.65400163282742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36391,0.00151194766618513,0.00337353906097983,-0.00510018889333533,0.0081240842257056,0.654032128597695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39078,0.000992264820717014,0.00221646134285481,-0.00335199941127841,0.00533652905271244,0.654390723229636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36339,0.00590345235364319,0.0132115381230612,-0.0199911623675568,0.0317980670748432,0.654997869198846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39229,-0.0012280990255688,0.00275322566400313,-0.00662442132701494,0.00416822327587734,0.655561452516073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,38841,0.0031295452060053,0.00702859205828822,-0.0106464952282396,0.0169055856402502,0.656138889891684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36421,0.00143251547408903,0.00322348960336879,-0.0048855241485138,0.00775055509669185,0.656761810895989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36421,-0.00141033224829637,0.00318871167018081,-0.00766020712185075,0.00483954262525802,0.65828767030819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36397,-0.00271388616199593,0.00613803275286316,-0.0147444303576077,0.00931665803361586,0.658393598754733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",38939,-0.00161339687726226,0.0036679745485844,-0.00880262699248769,0.00557583323796317,0.660044497820198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,36767,-0.00181227148191535,0.00412396291126995,-0.00989523878800445,0.00627069582417374,0.660343567054058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36363,-0.00263842007195037,0.006047870121756,-0.0144922455105921,0.0092154053666914,0.662658480964457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36363,0.00190950072527688,0.00437870308721247,-0.00667275732565956,0.0104917587762133,0.662780271109495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36430,0.00272986196864484,0.00626375237438206,-0.00954709268514399,0.0150068166224337,0.662975579242625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39165,-0.00180062142952992,0.00417064138378842,-0.00997507854175521,0.00637383568269537,0.66593843967518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36363,0.00134189594266351,0.0031159614228544,-0.00476538844613112,0.00744918033145814,0.666728632916249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36430,0.00111428682869153,0.00259874923785607,-0.00397926167750636,0.00620783533488942,0.668092046358909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39101,-0.00224875459787219,0.00525696122111219,-0.0125523985912521,0.00805488939550771,0.668826799418995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,38741,0.00184853135538638,0.00432345836454056,-0.00662544703911312,0.0103225097498859,0.668978775194817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,36747,0.00147953092792501,0.00346616517386767,-0.00531415281285563,0.00827321466870565,0.669496068532565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39023,-0.00133357085753187,0.00313639458664747,-0.00748090424736091,0.00481376253229716,0.670702523829148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,38841,-0.00241012003791252,0.00567215893374486,-0.0135275515480524,0.0087073114722274,0.670913144254763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39099,-0.00149927149248756,0.00352949615415234,-0.00841708395462615,0.00541854096965103,0.671000553164241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36421,0.00262478984386167,0.00621550049216786,-0.00955759112078734,0.0148071708085107,0.672815166425652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39241,-0.00112182668217571,0.00266159530186374,-0.00633855347382864,0.00409490010947723,0.673405703881153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,36792,0.00226658460820889,0.00538353355985226,-0.00828514116910153,0.0128183103855193,0.673746211650936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,36791,-0.0017123308043653,0.00407396149162806,-0.0096972953279563,0.0062726337192257,0.674265263476927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36363,0.00223052698868235,0.005314952576475,-0.00818678006120864,0.0126478340385733,0.674733638859466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,36796,-0.000872123719782194,0.00207907547726331,-0.00494711165521828,0.0032028642156539,0.674874745498683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36430,-0.00293570491631971,0.00701198945490873,-0.0166792042479408,0.0108077944153014,0.675464967432389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36538,0.00250639485373677,0.00598722141625433,-0.00922855912212172,0.0142413488295953,0.675498004385551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,36591,-0.00131060323215727,0.00313715825458939,-0.00745943341115247,0.00483822694683793,0.676124050746463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,36767,-0.00138995026571762,0.00333024994963516,-0.00791724016700254,0.00513733963556729,0.676413892490209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36430,0.00219742316252403,0.00526740779323225,-0.00812669611221118,0.0125215424372592,0.676558601095013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36421,0.00300802140627385,0.0072111958901567,-0.0111259225384333,0.017141965350981,0.676588903136026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36345,0.00373830610823472,0.00899323578287738,-0.013888436026205,0.0213650482426744,0.677651496459094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39241,0.000882060095325432,0.00212876025228513,-0.00329030999915342,0.00505443018980428,0.678620729433302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36420,-0.00098552674267001,0.0024358544905049,-0.00575980154405961,0.00378874805871959,0.685784479722397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39035,0.00129534587733223,0.0032358301347263,-0.00504688118673132,0.00763757294139578,0.688931399649273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36391,0.00260906803353949,0.00654838597823408,-0.0102257684837993,0.0154439045508783,0.69032064279335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39023,0.00198590435734002,0.0049887075791549,-0.00779196249780359,0.0117637712124836,0.690576873456839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36391,0.00171244411997742,0.00430696275795615,-0.00672920288561664,0.0101540911255715,0.690932564356874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36421,-0.00240753086313162,0.00609787489614315,-0.0143593656595722,0.00954430393330896,0.692986322945779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,38841,-0.00505481412374086,0.0131190587511304,-0.0307681692759565,0.0206585410284747,0.700018328745222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39283,-0.00174803253621724,0.00454322792942209,-0.0106527592778845,0.00715669420545005,0.700423778450551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36339,0.0020404286441393,0.00531458094791038,-0.00837615001376505,0.0124570073020436,0.701036651106958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,36731,0.00155800413052813,0.00405836036452173,-0.00639638218393446,0.00951239044499071,0.701058983260874
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36391,0.00298321328314395,0.00780763270060016,-0.0123197468100324,0.0182861733763203,0.702401572424301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,38741,0.00175253624804894,0.00460916504457821,-0.00728142723932435,0.0107864997354222,0.703781177676165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36421,-0.00117266889423109,0.00308734192478275,-0.00722385906680529,0.0048785212783431,0.704077116791235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39283,-0.000555778586121536,0.00146500794875303,-0.00342719416567747,0.0023156369934344,0.704419097685375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,38727,0.00198686510137918,0.00525155417062736,-0.00830618107305044,0.0122799112758088,0.705184554006333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36538,0.00198369897625284,0.00543806054915946,-0.0086748997000997,0.0126422976526054,0.71528127392751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36363,-0.00147997105938729,0.00406820616428997,-0.00945365514139563,0.00649371302262105,0.716021286604136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36430,-0.00183045750715022,0.00507941826323112,-0.0117861173030832,0.00812520228878278,0.718578346190702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36339,-0.0015166203218435,0.00422364014972923,-0.00979495501531279,0.00676171437162579,0.719542094389671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36339,-0.0018312977669582,0.00511396044853926,-0.0118546602460952,0.00819206471217876,0.720276214326138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,38987,0.000828254891909661,0.00231688183902105,-0.00371283351257159,0.00536934329639091,0.720732323390507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,36767,-0.00078162449687246,0.00218669930033006,-0.00506755512551938,0.00350430613177445,0.720764618275119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36339,0.00199498866400397,0.00558569146590058,-0.00895296660916116,0.0129429439371691,0.72097765303215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36363,0.00184227251701022,0.00516682823374437,-0.00828471082112875,0.0119692558551492,0.721428947616038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36421,0.00168019474283967,0.00471826958793576,-0.00756761364951442,0.0109280031351938,0.721768651300106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36421,-0.00139680571284756,0.00393234616047381,-0.00910420418737623,0.00631059276168111,0.722438802916709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,36806,-0.000721269511948707,0.00203538507669977,-0.00471062426228025,0.00326808523838284,0.723071029681208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36421,-0.00190587127042816,0.00540355485085374,-0.0124968387781015,0.00868509623724518,0.724314077571168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36363,-0.00236808250721676,0.00674064287161412,-0.0155797425355804,0.0108435775211469,0.725358679614509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,36731,-0.00109388500037164,0.00311871678284726,-0.00720656989475227,0.00501879989400898,0.725782832850064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36538,0.00187320171035418,0.00537339166174956,-0.00865864594667496,0.0124050493673833,0.727390193577777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36507,0.00161692892790711,0.00466473785615931,-0.00752595727016513,0.0107598151259794,0.728876546416489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,38713,0.00221307385934895,0.00643647988700255,-0.0104024267191761,0.0148285744378739,0.730976786749978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39057,0.0021207547311335,0.00619075696837341,-0.0100131289268784,0.0142546383891454,0.731928277971137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",36767,-0.00128618178614895,0.00379393225442337,-0.00872228900481875,0.00614992543252085,0.734607550630172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",38741,0.00166218618729382,0.00493613560834559,-0.00801263960506353,0.0113370119796512,0.736318895303762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36363,-0.00221222867566532,0.0066333297727628,-0.0152135550302804,0.0107890976789498,0.738760980528762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36421,-0.00153814895993928,0.00461424562858428,-0.0105820703919645,0.00750577247208592,0.738877271209676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36391,-0.00153666775702129,0.00464910130133592,-0.0106489063076397,0.00757557079359711,0.741005005004623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39283,-0.000800304348985719,0.00245221238013316,-0.00560664061404671,0.00400603191607527,0.744156328082537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39099,-0.000962900982041804,0.0029749928908276,-0.00679388704806391,0.0048680850839803,0.74619613652557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36363,-0.000837839865680539,0.00258886339020416,-0.0059120121104807,0.00423633237911962,0.746221828652663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,36767,0.000880668386994263,0.00272876803883457,-0.0044677169691215,0.00622905374311003,0.74690132795896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36311,0.00103844901548281,0.00324467853971236,-0.00532112092235343,0.00739801895331904,0.748938216362285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,38727,-0.00480828055889299,0.0150431252759553,-0.0342928060997653,0.0246762449819793,0.749250981135806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,38960,-0.00143318237474295,0.00448556925883374,-0.0102248981220571,0.00735853337257118,0.749344543911008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36363,0.00128250565664004,0.00402066422569514,-0.00659799622572244,0.00916300753900253,0.749748104768119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39071,0.00245359253544179,0.00775506941615075,-0.0127463435202137,0.0176535285910973,0.751714162994692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,38841,0.00112445869379856,0.00358090210199827,-0.00589410942611804,0.00814302681371516,0.753513653733674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,36743,0.00157663267791636,0.00506549593134997,-0.00835173934752957,0.0115050047033623,0.755616050694873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36363,-0.00177755293536773,0.00572431592365315,-0.0129972121457279,0.00944210627499244,0.756165634464697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36538,-0.00130830136938582,0.00422741439673544,-0.00959403358698729,0.00697743084821564,0.756961300650609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36363,-0.00209494686128259,0.00680527562259123,-0.0154332870815614,0.0112433933589962,0.758208001625098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,38841,-0.00164766388186227,0.00536399264493742,-0.0121610894659396,0.00886576170221507,0.758717360100643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36363,0.00163907213971611,0.00535602320060331,-0.00885873333346637,0.0121368776128986,0.759591397182763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39106,-0.000919088310460755,0.00300992438101533,-0.00681854009725081,0.0049803634763293,0.760101768214766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36339,0.00151432203837733,0.00496806015592563,-0.0082230758672369,0.0112517199439916,0.760514779446148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36391,-0.00136339102348288,0.00449033559065068,-0.0101644487811582,0.00743766673419246,0.761416458398389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36421,0.00222234085853778,0.007334470284374,-0.0121532208988353,0.0165979026159108,0.761895257252692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36391,-0.00102192671868632,0.00337957548409617,-0.00764589466751482,0.00560204123014217,0.762365008346703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36421,-0.00218042668499529,0.00723631962496957,-0.0163636131499356,0.0120027597799451,0.763177707063608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39023,-0.00117821034581125,0.00391546388593119,-0.00885251956223638,0.00649609887061387,0.763485671406213
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36538,-0.00211789509728254,0.00704474550211268,-0.0159255962814234,0.0116898060868583,0.76369798182327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36363,-0.00206896625466306,0.00690680056940581,-0.0156062953706985,0.0114683628613723,0.764521635839849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,36743,-0.000797136132082428,0.00268930620833835,-0.00606817630042559,0.00447390403626073,0.766922085706791
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39106,0.000751155579462532,0.00253806699637743,-0.00422345573343724,0.0057257668923623,0.76726788805545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36420,-0.00100646913227951,0.00340615617613759,-0.00768253523750918,0.00566959697295016,0.76762805283191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36363,0.000914905157363842,0.00310468587512626,-0.00517027915788362,0.0070000894726113,0.768239218428976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36408,0.00188269354509339,0.00639511992946215,-0.0106517415166524,0.0144171286068392,0.768460692469933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,38727,0.000846542397225027,0.00287694568714111,-0.00479227114957156,0.00648535594402161,0.768570684587064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38625,0.00267959958272217,0.00912072153162285,-0.0151970146192586,0.020556213784703,0.76892059575547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36420,0.00104970468153875,0.00378632784226192,-0.00637149788929461,0.0084709072523721,0.781603806641827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36500,0.000570699710520482,0.00206784296147087,-0.00348227249396243,0.0046236719150034,0.782561844240518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36538,-0.00105963695524878,0.00384274701612335,-0.00859142110685053,0.00647214719635298,0.782744690475197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36363,0.00228803272974554,0.00830442586219982,-0.0139886419601661,0.0185647074196572,0.782921563762793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39253,-0.00308189084238154,0.0112520173425491,-0.0251358448337779,0.0189720631490148,0.784167653788817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39093,0.00469877193417187,0.0172927680672129,-0.0291950534775654,0.0385925973459092,0.785841849278332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,38727,0.00339020138445828,0.012573955884208,-0.0212547521485893,0.0280351549175059,0.787455656655316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,36747,-0.00139137394837849,0.00516059761958744,-0.0115061452827699,0.00872339738601289,0.787460862299072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36421,-0.00189745613052335,0.00705333542068425,-0.0157219935550645,0.0119270812940178,0.787922219560165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,36796,0.000972540852231957,0.00362709243034893,-0.00613656031125194,0.00808164201571585,0.788601713354115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,38727,-0.00129088404636465,0.00481741494700378,-0.0107330173424921,0.00815124924976275,0.788732302067903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36391,-0.00158240958715037,0.00593661393848317,-0.0132181729065774,0.0100533537322766,0.789819376137963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36363,-0.00229175357134606,0.00866335223128139,-0.0192719239446576,0.0146884168019655,0.791372620567533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,36791,0.000537293532620868,0.0020343721329415,-0.00345007584794447,0.0045246629131862,0.791701068511054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36339,-0.000813974259422024,0.00308249737846938,-0.00685566912122201,0.00522772060237796,0.791735545926289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36363,0.000686655814532824,0.00263685209931548,-0.00448157430012552,0.00585488592919116,0.794553819293627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,36747,0.00093428645937751,0.00360953379518785,-0.00614039977919068,0.0080089726979457,0.795763953894605
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,36792,-0.00248190540257674,0.00963824938988662,-0.0213728742067545,0.016409063401601,0.79679241297986
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,36791,0.0011647061876091,0.00454977740942292,-0.00775285753485982,0.010082269910078,0.797961159756055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36391,0.00081680383171634,0.00321331453735003,-0.00548129266148972,0.0071149003249224,0.799350203585317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36391,-0.00233142194365137,0.00917665328325124,-0.0203176623788238,0.0156548184915211,0.799453254734462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36320,-0.00110117737255529,0.00436922971527965,-0.0096648676145034,0.00746251286939282,0.801021960200809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36339,-0.00185388018764268,0.00735806733913644,-0.0162756921723501,0.0125679317970647,0.801082272090275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,36747,0.00086344835329538,0.00348198078352959,-0.00596123398242261,0.00768813068901337,0.804156774537912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,36731,-0.000858157308600115,0.00346719924837451,-0.00765386783541416,0.00593755321821393,0.8045195494976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36391,-0.00108147247031358,0.00439664314120903,-0.00969889302708328,0.00753594808645612,0.805704174673573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,36747,0.000795605167043362,0.00328729198175349,-0.00564748711719347,0.00723869745128019,0.80876503768393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,38727,-0.000815448027604777,0.00339651452971901,-0.00747261650585404,0.00584172045064449,0.810268622742234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36420,0.00127260099209492,0.00535394551637063,-0.00922113221999151,0.0117663342041813,0.812122276093862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,36747,0.00253165844229423,0.0106827490809078,-0.0184065297562851,0.0234698466408735,0.812671674636048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,38960,0.000675129976173861,0.00284985873806729,-0.00491059315043803,0.00626085310278575,0.812738007945615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36430,0.00125536478032857,0.00537662667940313,-0.00928282351130156,0.0117935530719587,0.815388170331636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36421,0.000754321979692682,0.00324865965836495,-0.00561305095070262,0.00712169491008799,0.816390475182671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,38727,-0.000744513795124365,0.00321631676586817,-0.00704849465622598,0.00555946706597725,0.816944916068024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39160,-0.000571018388451102,0.00246924755127307,-0.00541074358894632,0.00426870681204411,0.817122141323291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,38832,-0.000672949552306175,0.00292321233935587,-0.00640244573744367,0.00505654663283132,0.817932576823603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36538,0.000834483542577088,0.00366885315494466,-0.00635646864111445,0.00802543572626863,0.820076899178806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39165,0.000881150725616076,0.00393796999561192,-0.00683727046578329,0.00859957191701544,0.822948908174592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,38741,-0.00132237627534934,0.00591770010634241,-0.0129210684837805,0.0102763159330818,0.823179656964218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36421,-0.0013935264751862,0.00630944152213137,-0.0137600318585637,0.0109729789081913,0.825202167759981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36339,0.00160571430470485,0.00729377763103217,-0.0126900898521182,0.0159015184615279,0.825759094162601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36421,0.000728373349240912,0.0033117616816836,-0.00576267954685895,0.00721942624534077,0.82592510611803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39106,-0.000655943661819136,0.00299006634639273,-0.0065164737007489,0.00520458637711062,0.826361437832925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,38832,0.00251171976576665,0.0115339272093463,-0.0200947775645522,0.0251182170960855,0.827612879584408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36421,0.00127659821785441,0.00594418565283613,-0.0103740056617044,0.0129272020974132,0.829954659955717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36430,0.000575548874368864,0.00268173860272803,-0.00468065878697807,0.0058317565357158,0.830068786111094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,38741,0.000776218942233308,0.00361953893989119,-0.00631807737995342,0.00787051526442004,0.830197193210613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36363,0.00162686533395567,0.00759909287500842,-0.0132673567010608,0.0165210873689722,0.830482874962357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36538,-0.000877455734208345,0.00413371164571927,-0.00897953055981812,0.00722461909140143,0.831901176824382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,38987,0.00116665959175,0.00551221293190879,-0.00963727775479124,0.0119705969382912,0.832382988792821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,36796,-0.000893772183015616,0.00426183933740581,-0.00924697728433101,0.00745943291829978,0.833893320030674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,38832,-0.000411059116263155,0.00196229456511084,-0.0042571564638804,0.00343503823135409,0.834077331310841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,36743,0.00485932685802695,0.0232460769759277,-0.0407029840147913,0.0504216377308452,0.834421428497377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36391,-0.000914212212244974,0.00437922229094005,-0.00949748790248748,0.00766906347799753,0.834637963760048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36430,0.00102797587885799,0.00494792693490511,-0.00866996091355602,0.010725912671272,0.835420587705404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39106,-0.00124015254138406,0.00602697951493011,-0.0130530323906471,0.010572727307879,0.836975790534829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36421,-0.00125190039133881,0.00608704974831154,-0.0131825178980294,0.0106787171153518,0.837054995433338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36538,-0.000616659527287049,0.00301699925309711,-0.00652997806335738,0.00529665900878328,0.83804812715292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39117,0.000605465948231663,0.00297440510273572,-0.00522436805313035,0.00643529994959368,0.838701107767658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,38832,0.00098963523808655,0.00489303251306756,-0.00860070848752586,0.010579978963699,0.839720932998749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,36714,0.000930128571841973,0.00460651284786685,-0.00809863660997705,0.00995889375366099,0.839985601750054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,38727,-0.00186728628941051,0.00926268634561795,-0.0200221515268217,0.0162875789480007,0.840238219624111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39291,0.00110488923927233,0.00555779888507004,-0.00978839657546494,0.0119981750540096,0.842421981035433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36339,-0.0011669812347575,0.00587081873500382,-0.012673785955365,0.01033982348585,0.842440759797456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39099,0.00110747657980584,0.00561326541728401,-0.00989452363807082,0.0121094767976825,0.843598294478605
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36538,-0.000771190330204336,0.00396881073931725,-0.00855005937926615,0.00700767871885748,0.845934155376457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36420,-0.00151155035574465,0.00780558215063246,-0.0168104913709843,0.013787390659495,0.846453139273138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36538,0.00120114608008811,0.00627572439649741,-0.0110992737370468,0.013501565897223,0.848218726548389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39128,0.00047787521582168,0.00255824194474796,-0.00453627899588433,0.00549202942752769,0.851821271100829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36311,0.00134743242164748,0.00724340490932074,-0.0128496412006212,0.0155445060439161,0.852430565977475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39093,0.00087143295156391,0.0048180389583657,-0.00857192340683286,0.0103147893099607,0.85647296073526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,36747,0.000628357436410573,0.00352622099917942,-0.00628303572198109,0.00753975059480223,0.858572083702056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,38741,0.000847352348324904,0.00481849826037965,-0.00859690424201921,0.010291608938669,0.860411012249194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36538,-0.0011678946959612,0.00664398040388201,-0.0141900962875699,0.0118543068956475,0.860467719290664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,36767,-0.000984927087732238,0.00561403464624401,-0.0119884349943705,0.010018580818906,0.860736545705531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36391,0.00157096903639842,0.00902868295808913,-0.0161252495614563,0.0192671876342531,0.861870170338921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,38741,-0.000832555472944724,0.00478497258307162,-0.0102111017357651,0.00854599078987564,0.861872716298526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39099,-0.000405376335244937,0.00235113122687287,-0.00501359353991576,0.00420284086942588,0.863111549019374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39241,0.000463803942662362,0.00269217999104007,-0.00481286883977617,0.0057404767251009,0.863221082849496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36391,0.000729469544499416,0.00426769656396187,-0.00763521572086585,0.00909415480986468,0.864283009435966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36470,-0.00044440940035347,0.0026113207171273,-0.00556259800592297,0.00467377920521603,0.864866840807276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,38832,0.00042360346383879,0.00249761479780306,-0.00447172153985521,0.00531892846753279,0.865324496619899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36430,-0.000396034843129876,0.0023673432245715,-0.00503602756329002,0.00424395787703027,0.867143900085872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,36731,-0.00128583874514527,0.00769005508144772,-0.0163583467047828,0.0137866692144923,0.867209015192495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36420,0.00049483075468285,0.00297168320761578,-0.00532966833224408,0.00631932984160978,0.867754115015404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38575,0.000522897974343136,0.00316347064746929,-0.00567750449469668,0.00672330044338295,0.868716031785561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36430,0.000617218170601953,0.00375857302192125,-0.00674958495236369,0.0079840212935676,0.869563674348047
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36391,-0.000671836856899217,0.00421384338047396,-0.00893096988262818,0.00758729616882975,0.873328223309474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38500,-0.000428941851715432,0.00282148882572311,-0.00595905995013273,0.00510117624670186,0.879167911234531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,36731,0.000663511392491973,0.00442552534669443,-0.0080105182870291,0.00933754107201305,0.880823550811065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36421,0.000561287846517187,0.0037463996076402,-0.00678165538445761,0.00790423107749198,0.880908559765971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36391,0.000845473433088927,0.00568946085111071,-0.0103058698350881,0.0119968167012659,0.881868952522495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39099,0.000444826744369177,0.00307793924455289,-0.00558793417495448,0.00647758766369284,0.885091015100049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39063,-0.000255347527859424,0.00179410246947359,-0.00377178836802765,0.00326109331230881,0.886824352612727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,36743,0.000580141724929605,0.00415785367648629,-0.00756925148098352,0.00872953493084273,0.889034216166137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,36731,0.000745340308006051,0.00542296461449448,-0.00988367033640312,0.0113743509524152,0.890683991968646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36339,0.000388588329142581,0.00297038941758745,-0.00543337492932882,0.00621055158761399,0.895919281208242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39283,0.000371125426327875,0.00286047331055943,-0.00523540226236861,0.00597765311502436,0.896771719129059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36391,-0.000509034835033764,0.00395262892331161,-0.00825618752472452,0.00723811785465699,0.897530738768597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,38832,0.00126114414756377,0.00985581138000493,-0.0180562461572459,0.0205785344523734,0.898182786439487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36538,0.000501706719644448,0.0039615800157216,-0.00726299011116988,0.00826640355045878,0.899224901895753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,36796,-0.000574199406017587,0.00472551764841509,-0.00983621399691117,0.008687815184876,0.903288687465621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39255,-0.000316657258583296,0.00265401796157114,-0.00551853246326273,0.00488521794609614,0.905029414910761
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36430,-0.00100801347094228,0.00850032650649182,-0.0176686534236662,0.0156526264817817,0.905605834717695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,36791,0.000272214740682881,0.0023357548078981,-0.0043058646827974,0.00485029416416316,0.907224403048261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39291,-0.00029363241494838,0.00253315514819382,-0.00525861650540826,0.0046713516755115,0.907720872786765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36391,-0.000295091562501266,0.00255136700653613,-0.00529577089531209,0.00470558777030956,0.907923720885599
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,38741,0.000584807158070282,0.00511650394454998,-0.00944354057324768,0.0106131548893882,0.909002956464917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36363,-0.00100225814199085,0.00882118641868278,-0.0182917835226091,0.0162872672386274,0.909541311189768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,38741,0.000759124475226759,0.00670860720155676,-0.0123897456398245,0.013907994590278,0.909907776323762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39216,-0.000635526258481771,0.00567208193825916,-0.0117528068574697,0.0104817543405062,0.910789493083278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,36731,-0.000621713302719161,0.00558734443631069,-0.0115729083978881,0.0103294817924498,0.911402632755395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36339,-0.000501545643867604,0.00452910405135766,-0.00937858958452862,0.00837549829679341,0.911825591420135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36430,-0.000229106782001197,0.00207687026535991,-0.00429977250210662,0.00384155893810423,0.912162529808962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36500,-0.00040077864283893,0.00364305877991531,-0.00754117385147295,0.00673961656579509,0.912401939711791
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",38832,0.000838368733785509,0.00811204414604398,-0.0150612377924607,0.0167379752600317,0.917687656956709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,38841,0.000566483320792573,0.00551234248938956,-0.010237707958411,0.0113706745999961,0.918149787657485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36339,-0.00055899764385329,0.00549678320055046,-0.0113326927169322,0.0102146974292256,0.919000076164549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36500,0.000361348274676004,0.00356904328561608,-0.00663397656513151,0.00735667311448352,0.919357472872694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36421,0.000454073997823397,0.00450682411544052,-0.00837930126844003,0.00928744926408682,0.919748506980514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36391,-0.000663575280287735,0.00661009671360772,-0.0136193648389589,0.0122922142783834,0.920037795170165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36538,0.0002597697705841,0.0026107236333262,-0.00485724855073526,0.00537678809190346,0.920742018993143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36430,0.000250434384772287,0.00253938348047172,-0.00472675723695228,0.00522762600649686,0.921441441581764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36391,-0.000398402467843244,0.0040854846785294,-0.00840595243776086,0.00760914750207437,0.922317732633419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36311,-0.000361953718782762,0.00373071408353825,-0.00767415332251773,0.00695024588495221,0.922712107626069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36421,0.000688603863758017,0.00715844334310414,-0.0133419450887261,0.0147191528162421,0.92336752416923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36538,-0.000234609214343442,0.00254317271396898,-0.00521922773372264,0.00475000930503575,0.926500392237422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39099,-0.000343046210775773,0.00374652156450104,-0.00768622847719781,0.00700013605564626,0.927045720051146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,36806,-0.000155558617384937,0.00171210637535985,-0.00351128711309024,0.00320016987832037,0.927606802766187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36391,-0.000315648718487126,0.00349088648318046,-0.00715778622552082,0.00652648878854657,0.927954280392221
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36430,-0.000262488800086493,0.00294774714229139,-0.00604007319897761,0.00551509559880462,0.929045771500068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36538,-0.0013334772126212,0.015138588230964,-0.0310051101453107,0.0283381557200683,0.92981078944593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36391,-0.000413716773086981,0.00476306772981636,-0.00974932952352705,0.00892189597735309,0.93078473153382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38645,-0.000508151382433996,0.00592709445908816,-0.0121252565222468,0.0111089537573788,0.931679320628755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36430,-0.000261083537817139,0.0032470708592046,-0.00662534242185816,0.00610317534622388,0.935915743269686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,36743,0.000419620647174008,0.00524601631620169,-0.0098625713325813,0.0107018126269293,0.936247694617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,38832,-0.000568963766369404,0.00717262752296651,-0.0146273137113838,0.0134893861786449,0.936775726646166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36391,-0.000331278263109075,0.00436978486233623,-0.00889605659328808,0.00823350006706993,0.939570583232677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,36792,0.000164713909889455,0.00220164454415803,-0.00415050939666027,0.00447993721643918,0.940363832738558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36391,-0.000217214815898814,0.0029111552388441,-0.00592307908403326,0.00548864945223563,0.940522512262225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36531,0.000677216777254867,0.00907954554769744,-0.0171186924962321,0.0184731260507419,0.940544432697535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36421,0.000323675079617066,0.00444769201362177,-0.00839380126708161,0.00904115142631574,0.941987345029346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36421,0.000270538854378423,0.0038744262122207,-0.00732333652157415,0.007864414230331,0.944332613056035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,38841,-0.000250783107936141,0.00368284995915107,-0.00746916902787224,0.00696760281199995,0.945711040357373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,36743,-0.000421798025678285,0.006445979030611,-0.0130559169256758,0.0122123208743193,0.947828007647687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36339,-0.00028960916847003,0.00464049973607521,-0.00938498865117743,0.00880577031423737,0.950238089647869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36363,-0.000191606975687277,0.0031291828950856,-0.00632480545005506,0.0059415914986805,0.951175207944892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36500,-0.000216397925480357,0.00355991214046617,-0.00719382572079405,0.00676102986983333,0.951529458803166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36391,0.000187624480697079,0.00315844819042241,-0.00600293397253084,0.006378182933925,0.952631268257664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,38841,-0.00022869416695018,0.00393075516630193,-0.00793297429290196,0.0074755859590016,0.953605453640406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36363,0.000372199842367526,0.00683759483924316,-0.0130294860425491,0.0137738857272841,0.956590003721043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,36747,-0.000138097330787096,0.00257166301123413,-0.00517855683280599,0.00490236217123179,0.957175316601852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39023,9.08726757469689e-05,0.00172034691256341,-0.00328100727287731,0.00346275262437124,0.957874191620056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,36774,0.000158590631335112,0.00311130802560395,-0.00593957309884862,0.00625675436151885,0.959348354622266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36363,-0.000276952466141765,0.00551092661796927,-0.0110783686373615,0.010524463705078,0.959919863232379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,38960,0.000180350154290134,0.00361084816065768,-0.00689691224059893,0.0072576125491792,0.960165477990288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39106,0.000190210678017564,0.00381616812975548,-0.00728947885630317,0.0076699002123383,0.960247858710606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39273,0.000145344546827543,0.00296018943390609,-0.0056566267436284,0.00594731583728348,0.960840442693523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36286,-0.000143473421532049,0.00314969497616234,-0.00631687557481024,0.00602992873174614,0.963668435397713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36430,-0.000138375248305579,0.00327656204971376,-0.00656043686574455,0.00628368636913339,0.966314550314353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39093,-0.000179954020058375,0.00435495606664845,-0.00871566791068934,0.00835575987057259,0.967040006056028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38608,0.000281899148177235,0.00700890456726094,-0.0134555538036542,0.0140193521000087,0.967918162776065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36391,0.000307891194363834,0.00795192208664263,-0.0152778760954557,0.0158936584841834,0.96911496925227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36339,0.000286611390851339,0.00766724807429226,-0.0147411948347615,0.0153144176164642,0.970181612815143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39106,9.40111975184503e-05,0.00257560406352444,-0.00495417276698944,0.00514219516202635,0.970883646023127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36430,-0.00012881760739949,0.0039120736988506,-0.00779648205714667,0.00753884684234769,0.973732354761881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36339,0.000143558374137574,0.00548833283263015,-0.0106135739778175,0.0109006907260927,0.979132523820935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36339,-0.000147213087235767,0.00607218826850663,-0.0120487020935088,0.0117542759190372,0.98065850643594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36421,5.90295171080631e-05,0.00271405832843611,-0.00526052480662671,0.00537858384084284,0.982648092266193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36421,0.000125542840166785,0.00577262951370636,-0.0111888110066977,0.0114398966870312,0.982649362144251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,38841,-6.48439074558714e-05,0.00307310743751884,-0.0060881344849928,0.00595844667008106,0.983165817938177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36391,-5.88403386235396e-05,0.00334644267363285,-0.00661786797894392,0.00650018730169684,0.985971837381594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,38741,-4.32724622897496e-05,0.00298138229130509,-0.00588678175324772,0.00580023682866822,0.988419922741743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36538,4.93160526328634e-05,0.00386430031340087,-0.00752471256163285,0.00762334466689857,0.989817904988334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36421,-4.037106501451e-05,0.00338669421828845,-0.00667829173285988,0.00659754960283086,0.990489237169274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36363,0.000110578645486639,0.0106666253170606,-0.0207960069759521,0.0210171642669254,0.991728813300838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,36731,3.69367508395374e-05,0.00422335811380655,-0.00824084515222129,0.00831471865390037,0.993022065789179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39147,-3.78732321252491e-05,0.00447335616458355,-0.008805651314709,0.0087299048504585,0.993244979638685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,36767,1.69863004335736e-05,0.00246083169908987,-0.00480624382978256,0.00484021643064971,0.99449261941746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36391,6.54738728635929e-05,0.0106342365354736,-0.0207776297366647,0.0209085774823919,0.995087637948003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36430,-2.82235616125104e-05,0.00542058576265319,-0.0106525716564128,0.0105961245331877,0.995845726749448
